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The epidermis is a stratified squamous epithelium with each layer of keratinocytes 
expressing a different set of keratins to reflect the shifting cell states of proliferation and 
differentiation during growth and repair. This thesis is focused on how keratin 1 (K1), a 
marker of early differentiation, regulates the rate of migration during wound healing. This 
was examined by isolating HaCaT clones to represent slow-, moderate- and fast-healing 
HaCaT cell line, and analyzing if differential KRT1 expression reflected this variation in the 
rate of wound closure.  
Bioinformatics was used to identify putative regulatory elements, including enhancers and 
promoters, in and near the KRT1 locus. The DNA methylation at these putative regulatory 
elements were assessed using a MSRE-qPCR, to identify if DNA methylation changes 
correlate with the differential KRT1 expression. Additionally, the identified putative regulatory 
elements were sequenced using Nanopore sequencing technology, to identify the allelic 
differences between HaCaT cell lines.  
This study has provided evidence to suggest KRT1 has a functional role in migration during 
wound healing, and this is mediated by a dynamic regulatory landscape at the KRT1 locus. 
The cell model developed in this study can be used to study the migratory role of other 
keratins during wound healing. Additionally, through bioinformatics analyses, MSRE-qPCR 
and Nanopore sequencing can be used to assess the epigenetic and genetic profiles of 




Chapter 1: Introduction 
 
1.1 Keratinocytes 
1.1.1 Skin structure 
The skin is composed of two major layers – the upper epidermis and lower dermis (Rognoni 
and Watt, 2018). The epidermis is responsible for retaining water, preventing entry of toxins, 
regulates the immune response during injury and infection, and protects against mechanical 
stress (Simpson et al., 2011). The epidermal barrier is established and maintained by tightly 
regulating proliferation, differentiation, apoptosis and shedding (Botchkarev, 2015). The 
development of the stratified epithelium begins at the inner basal layer and ends at the outer 
stratum corneum. As keratinocytes move from the basal layer and up to the stratum 
corneum, keratinocytes decrease their proliferative capacity and increase differentiation. The 
major protective function of the stratified epithelium is to maintain structural integrity to 
protect internal organs from external assaults, however, it must also exhibit cellular plasticity 
during repair and regeneration (Simpson et al., 2011).  
The major class of proteins responsible for maintaining the structure of the epidermis are 
keratins (labelled KRT for genes and K for proteins) (Blanpain and Fuchs, 2006). Keratins 
are a family of intermediate filament proteins that are abundantly expressed in epithelial 
tissues and skin appendages, including hair, sweat glands and nails (Toivola et al., 2015). 
Currently, there are over 54 mammalian keratins which constitute approximately 30-80% of 
total protein in keratinocytes, mainly forming the cytoskeletal proteins (Fischer et al., 2016). 
Keratins are categorised into two types – the neutral-basic type II keratins (K1-8) and acidic 
type I keratins (K9-40). The genes encoding these keratin types differ in nucleotide 
sequence homology and genomic structure (Luo et al., 2011). Type I and II keratins will differ 
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in size and sequence of their N-terminal head and C-terminal tail ends (Fig. 1.1). 
Additionally, keratins can be distinguished by their unique central -helical rod domain at 
310-315 residues (Steinert and Roop, 1988). The amino-terminal and carboxy-terminal 
domains are also the target of post-translational modifications which alters the assembly and 
organisation of keratin filament assembly, and their interactions with other proteins (Wang et 
al., 2016). Type I keratins contain a more acidic amino acid sequence and lower molecular 
weight. Conversely, type II keratins are more neutral-basic and have a higher molecular 
weight. Under normal circumstances, type I and type II keratins will have a higher affinity 
towards each other to form acidic-basic heterodimers (Luo et al., 2011; Ramms et al., 2013; 
Toivola et al., 2015). However, during pathological conditions, uneven keratin heterodimers 
can form such as the type I keratins K1 forming a complex with type II keratins K14 and K15 
(Reichelt et al., 2001).  The genes encoding type I and type II keratins localise on separate 
chromosomes with type I keratins at chromosome 17q12-q21 and type II keratins at 12q11-
q13 (Zhang et al., 2019). 
The type I and type II keratin heterodimers form the resilient structural components of 
epithelial cells, such as cytoskeletal fibres, specifically actin filaments; intermediate 
filaments; and microtubules (Ramms et al., 2013; Zhang et al., 2019). Intermediate keratin 
filaments are the primary structural components forming the stratified epithelium (Bragulla 
and Homberger, 2009). Type I and type II keratin heterodimers are co-regulated to be 
expressed at a cell type- and differentiation-dependent manner (Wang et al., 2016). Type I 
and type II keratin heterodimers are expressed by distinct types of keratinocytes at each 
layer of the epithelia. In addition to the cells that express them, keratins are categorised 
based on their molecular structure and physicochemical properties, such as their molecular 
weight in kDa and isoelectric point (Bragulla and Homberger, 2009; Luo et al., 2011).  
The innermost layer of the epithelia is the stratum basale that contains the basal cell 
population. In these proliferating progenitor cells, type II keratin K5 will partner with type I 
keratin K14 to form intermediate filaments (Blanpain and Fuchs, 2006). These basal cells 
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are firmly attached to a basement membrane and are responsible for replenishing the cell 
population in the epidermis (Simpson et al., 2011). Basal cells attach themselves, via 
integrins, to the basement membrane which is an extracellular matrix separating the 
epidermis from the underlying dermis (Koster and Roop, 2007). In addition to the stratum 
basale, hair follicles contribute to regulating the stem cell population. During the natural 
turnover of skin cells or injury, cells are replaced by a population of skin stem cells in the hair 
follicles and innermost basal layer (Koster and Roop, 2007). K6, K16 and K17 are highly 
expressed in the hair follicles as these keratins stimulate high rates of proliferation. In the 
stratum basale, mitotically active cells are divided into basal stem cells and their progeny, 
called transit amplifying cells (TACs). During cell division, basal stem cells will undergo 
asymmetric division with one daughter cell exhibiting a horizontal division axis, therefore, 
allowing it to remain as a basal cell and continue to divide and replenish the stem cell 
population in the epidermis. The second daughter cell will repress the expression of 
adhesion proteins, integrins and laminins, to detach from the basement membrane (Blanpain 
and Fuchs, 2006; Segre, 2006). This loss of anchorage results to cell shape changes which 
contributes to differentiation (Simpson et al., 2011). The second daughter cell will become a 
TAC which are more mature than basal stem cells and are in transition between proliferation 
and differentiation. TACs will undergo several rounds of replication and then position its 
mitotic plane of division in a vertical orientation, thus allowing it to migrate up to the stratum 
spinosuma, also called the ‘suprabasal layer’ (Blanpain and Fuchs, 2006). These migrating 
TACs will commit to terminal differentiation and lower their expression of K5/K14, resulting to 
the loss of their proliferative potential (Simpson et al., 2011).  
At the suprabasal layer, cells will begin to express type I keratins K9 or K10 paired with type 
II keratins K1, K2, K77 or K80 to commit to terminal differentiation. Suprabasal keratinocytes 
predominantly express K1/K10 dimers which is a marker of early differentiation (Fischer et 
al., 2016; Luo et al., 2011). This keratin pair is important for contributing to the early stages 
of stratification and cornifying epithelial layer (Bragulla and Homberger, 2009). Next, cells 
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will move into the stratum granulosum, and the expression of K1/K10 will decrease (Zhang 
et al., 2019). These terminally differentiated cells will express Loricrin (LOR), Involucrin (INV) 
Transglutaminase and Filaggrin (FLG) which are markers of late differentiation. Cells are still 
transcriptionally active in the spinous and granular layers, however, will terminate all 
transcriptional activity once granular cells migrate into the final layer, stratum corneum. Once 
cells have ceased all transcriptional activity, they will alter their cell morphology into dead, 
flattened bodies of cells to create tightly linked cornified sheets of cells to construct a 
cutaneous barrier that is impervious to water transfer (Simpson et al., 2011; Zhang et al., 
2019) (Expression of keratins and keratin associated proteins are summarised in Fig. 1.1) 
 
Figure 1.1. Illustration of each layer of stratified epithelia with keratins and keratin associated 
proteins predominantly found at given layer.  
Keratins can be redundant where different combinations of type I and type II keratins can be 
used to compose keratin filaments, such as K1/K9, K1/K10, K2/K9 or K2/K10. Keratin 
redundancy is seen in keratin gene deletions where the loss of expression in one keratin can 
be replaced by another, therefore resulting to less severe phenotypes (Bragulla and 
Homberger, 2009). For example, KRT10-/- mice are still born with the epidermis still forming. 
There are mild differences such as a decrease in K1 expression in suprabasal keratin 
filaments. This functional redundancy assists in preventing loss of function in keratin filament 
formation. K10 is a redundant keratin that is replaced by increases in K14 expression in 
suprabasal cells following its gene deletion. K1 will dimerise with K5 and K14 in the 
suprabasal layer. However, keratin filaments are typically composed of keratin heterodimer 
pairs, and with the unequal keratin combination of K1/K5/K14, it leads to hyperproliferation 
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and thickening of the epidermis (Reichelt et al., 2001; Wallace et al., 2012). Similarly, KRT1-/- 
mice showed a complementary reduction in K10. The loss of K1 did not show redundancy as 
seen with the KRT10-/- knockout mice, with no other keratins substituting for its deletion. In 
suprabasal KRT1-/- cells, a slight increase of K5/K14 expression was observed but without 
K1, it was not stable enough to create intermediate filaments along the suprabasal layer 
(Wallace et al., 2012). Additionally, confocal imaging showed that in the absence of K1, K10 
did not form heterodimers with another type II keratin such as K5 or wound healing induced 
keratin K6. However, homozygous deletions of both KRT1 and KRT10 displayed no 
compensation from the wound healing-associated keratin K6 or basal epidermal keratins K5 
and K14. The absence of KRT1 and KRT10 in suprabasal cells resulted in a complete 
absence of intermediate filaments along the suprabasal layer (Roth et al., 2012). These 
results suggest KRT1 is the key keratin in the K1/K10 heterodimer pair and is essential for 
forming intermediate filaments in suprabasal cells. The presence of K1 in KRT10-/- assisted 
in the formation of intermediate filaments with basal keratins K5 and K14. However, its 
absence in a single homozygous KRT1-/- deletion or double homozygous deletion of KRT1-/-
/KRT10-/- showed a lack of substitution for its deletion. In contrast, a single homozygous 
deletion of KRT10-/- where K1 was still present, K5/K14 were able to form stable 
intermediate filaments in the suprabasal layer (Reichelt et al., 2001). It remains unclear why 
basal keratins are increased during KRT10 deletions.  
Several studies have shown keratin gene mutations result to the development of skin 
pathologies such as epidermolysis bullosa simplex, epidermolytic hyperkeratosis, and other 
skin diseases (Chamcheu et al., 2011; Virtanen et al., 2003). Keratin gene mutations causes 
changes in the amino acid sequence of the keratin gene, therefore resulting to the 
development of skin pathologies. On the other hand, homozygous deletions of the entire 
keratin gene can be substituted for another keratin to still allow for keratin filament formation. 
Changes in phenotype can still occur in partial or complete keratin deletions, although, they 
are usually characterised as mild phenotypes with delayed epithelialisation or cell 
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differentiation. Over 90% of keratin associated genetic disorders are classified as missense 
mutations along the coding regions of keratin genes. Other mutations include minor in-frame 
insertions or deletions, and large-scale in-frame deletions from perturbed splicing across 
intronic sites (Chamcheu et al., 2011; Virtanen et al., 2003; Wojcik et al., 2000). Missense 
mutations in K1 or K10 result to the development of epidermolytic ichthyosis which is 
characterised at birth by the reddening of skin, thickening of skin and severe blistering. K1 
and K10 mutations commonly occur at the non-helical head domain (Fig. 1.2). K1 and K10 
mutations can also occur at the linker region L12 which will produce a milder form of the 
disease (Chamcheu et al., 2011).  
Heterozygous single point mutations along the 1A regions along the central helical rod 
domain (Fig. 2) of K1, such as N8T, and K10, such as N8H and Y14S (Arin et al., 1999; Arin 
et al., 1999), can cause the rare autosomal dominant disorder, epidermolytic hyperkeratosis. 
In addition, this disorder can arise from a few or a combination of the following mutations – 
two-point mutations in K1, one-point mutation in K10, two splice site mutations, two codon 
deletions and an insertion/deletion (indel) (Virtanen et al., 2003). The development of skin 
pathologies by keratin mutations is likely attributed to the dysregulation of dimerization 
between type I and type II keratins, whereas the complete absence of a keratin can be 





Figure 1.2. General protein structure of a keratin. -helical segments: 1A, 1B, 2A, 2B. Linker 
domains: L1, L12, L2. Green boxes: periphery domains.   
In addition to impacting keratinocyte proliferation and differentiation during epidermal 
stratification, deletions and mutations in keratin genes can also affect their role in wound 
repair. During injury, keratinocytes will exit terminal differentiation and induce the expression 
of a different set of keratins, K6, K16 and K17. K6-/- deletions in mice displayed a delay in re-
epithelisation, where a change in proliferation and migration was seen in keratinocytes in 
vivo but not in vitro (Wojcik et al., 2000). Like KRT6-/-, KRT17-/- mice also showed a delay in 
wound closure in embryonic skin wounds. In KRT6-/-/KRT6-/- mice, embryonic skin wounds 
were able to heal normally which was attributed to the increase in K5 expression (Mazzalupo 
et al., 2003). These results show K6 exhibits a degree of functional redundancy in embryonic 
skin wounds but an important functional role in mature keratinocytes of adult mice. Mutations 
in K6, K16 and K17 showed a more severe phenotype with the development of 
pachyonychia congenita types 1 and 2. Pachyonychia congenita belongs to the group of 
ectodermal dysplasias disorder which is observed to exhibit hypertrophic nail dystrophy, 
palmoplantar keratoderma, and hyponychial keratosis. Pachyonychia congenita can arise 
from heterozygous missense or small in-frame indel mutation in K6, K16 and K17. 
Pachyonychia congenita type 1 is characterised by follicular keratosis, palmoplantar 
keratoderma and oral leukokeratosis and occurs from K6 and K16 mutations. 
Pachyonychia congenita type 2 differs by the presence of pilosebaceous cysts, pili torti and 




1.1.2 The primary phases of wound healing 
Following injury, several intercellular and intracellular pathways involving inflammation, 
proliferation, differentiation and migration are activated to restore tissue integrity and 
homeostasis. The wound healing process in mammals follows three main phases: 
inflammation, proliferation and remodelling. These phases are executed by various cells, 
including keratinocytes, immune cells, fibroblasts and endothelial cells, to promote 
proliferation, migration and differentiation. The multiple underlying processes that executes 
repair and regeneration must be accurately coordinated and switched off at the appropriate 
time. Due to the complexity of wound healing, if the process is not tightly controlled it will 
result to uncontrolled and malignant phenotypes (Gurtner et al., 2008; Zhang et al., 2019). 
The first phase of wound healing, inflammation, acts to control the flow of blood and fluids to 
avoid loss, discard dead cells and prevent infection (Gurtner et al., 2008). Necrotic cells from 
the injury will release damage-associated molecular patterns (DAMPs) to be recognised by 
pattern recognition receptors on keratinocytes, leading to their activation. Activated 
keratinocytes will synthesise “alarmins”, including the S100 family of proteins, 
proinflammatory cytokines and antimicrobial peptides, to signal for the activation of immune 
cells (Zhang et al., 2019). Neutrophils and macrophages are the first immune cells to arrive 
at the wound site to activate keratinocytes surrounding the periphery of the wound. 
Additionally, macrophages phagocytose bacteria and debris, and release inflammatory 
cytokines, such as IL-1, IL-6 and TNF. IL-1 induces the proliferation of inflammatory and 
endothelial cells. Neutrophils will release the chemokine IL-8 to signal the movement of other 
circulating inflammatory cells to the site of injury. At the same moment, platelets are 
activated and recruited to the wound site to create clots. Additionally, platelets will secrete 
cytokines and growth factors, including transforming growth factor-, platelet-derived growth 
factor, vascular endothelial growth factor (Santoro and Gaudino, 2005; Qing, 2017). The 
inflammatory phase occurs over the first 2-3 days following injury (Gurtner et al., 2008). 
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Next, the proliferative stage involves keratinocytes increasing their proliferative capacity to 
undergo cell division to replace lesioned tissue and re-establish the epithelial barrier. This 
process is mediated by keratinocytes lining the margin of the wound, as well as various 
cytokines and growth factors to induce proliferation, migration and differentiation. Firstly, 
granulation tissue is formed to create new connective tissue and induce angiogenesis. The 
formation of blood vessels allows the transport of nutrients, oxygen, fluid, and immune cells 
into the wound bed. The formation of granulation tissue involves collagenous and elastic 
biosynthesis, fibroblastic proliferation, and synthesis of chemokines by fibroblasts. Newly 
formed endothelial cells and fibroblasts will increase their expression of integrin receptors to 
attach themselves to the wound bed. Fibroblasts will begin forming a new matrix, which is 
primarily composed of type III collagen (Gonzalez et al., 2016; Gurtner et al., 2008).  
In parallel, reepithelialisation occurs through keratinocytes located at the periphery of the 
lesion, which are activated through cytokines to proliferate. Proliferating keratinocytes will 
position their cell division axis towards the central site of the wound. These proliferating and 
migrating keratinocytes are committed progenitor cells that are programmed to undergo 
rapid proliferation and differentiation. Migrating cells undergo cellular- and subcellular 
changes including dismantling hemidesmosomal links to detach from the basement 
membrane of the epidermis, severing keratin filaments and intracellular tonofilaments to 
unanchor cells from desmosomes, and formation of cytoplasmic actin projections at the 
periphery of cells and focal contacts. As migrating cells approach the wound centre, there is 
an increased expression of genes encoding proteins involved in cell adhesion and ECM 
remodelling, such as integrin . Matrix metalloproteases mediate the dissolution and 
reorganisation of extracellular matrix proteins at the wound bed and help facilitate migration 
(Gonzalez et al., 2016; Rognoni and Watt, 2018; Santoro and Gaudino, 2005).  The cells at 
the periphery of the wound will also increase their expression of K6, K16 and K17. This 
keratin trio is classic of wound healing and hyperproliferative tissue, as they initiate cell 
growth, differentiation and migration (Pechter et al., 2012). Classic markers of terminal 
differentiation, K1/K10, are repressed by keratinocytes during wound healing as it inhibits 
10 
 
cell division. Expression of K1/K10 is restricted to undamaged cells in the epidermis 
(Bragulla and Homberger, 2009; Luo et al., 2011).  
The remodelling stage works towards degrading, synthesising and organising the 
extracellular matrix. This final stage will re-establish the normal structure of stratified 
epithelia and forming a less cellular and vascular scar tissue at the site of the lesion. 
Migration terminates after a single layer of keratinocytes is covering the area of the lesion. 
Additionally, inflammation at the site of wound begins to shut down with previously recruited 
and formed cells, such as macrophages and endothelial cells, signalled to undergo 
apoptosis or leave the wound site. Dermal fibroblast cells will reconstruct the extracellular 
matrix at the injury site. Fibroblasts will degrade type III collagen and synthesise type I 
collagen as its replacement (Gonzalez et al., 2016; Gurtner et al., 2008; Rognoni and Watt, 
2018). When the wound bed has been replaced with a new layer of epithelial cells, the 
expression of various keratins returns to normal levels, such as increasing the expression of 
K1/K10 in suprabasal cells and a decrease in K6, K16 and K17 in the stratified epidermis 
(Patel et al., 2006; Pechter et al., 2012).  
1.1.3 Changes in keratin expression during wound healing  
As described in the development of the stratified epidermis, keratins can also be used to 
distinguish various phenotypes observed during wound healing. Following injury, suprabasal 
keratinocytes in-close proximity to the wound will halt terminal differentiation and lower their 
expression of desmosome to become untethered. Once untethered, cells will alter their cell 
size and shape, adhesion to other cells and matrix, and protein translation. Suprabasal cells 
will migrate towards the wound bed and adopt a more basal cell phenotype with a reduction 
in K1/K10 expression and rise in K5 expression to prepare for proliferation. Alongside basal 
cells, suprabasal keratinocytes will undergo cell division (Pastar et al., 2014; Patel et al., 
2006). Keratinocytes surrounding the wound bed and other skin appendages, such as sweat 
ducts and hair follicles, will coordinate re-epithelisation during wound healing. The process of 
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re-epithelisation will occur through the following processes – mitosis, migration, 
differentiation, retraction, hypertrophy, and closure (Patel et al., 2006; Zhang et al., 2019). 
Activated basal and suprabasal cells from the normal, unaffected stratified epidermis will 
exhibit low migratory potential and increase their rate of migration as they progress towards 
the site of injury. As they approach the wound centre, there is an increased expression of 
genes encoding proteins involved in cell adhesion and ECM remodelling, such as integrin 
 (Rognoni and Watt, 2018). Keratinocytes lining the wound edge are a mixture of cells 
proliferating and migrating into the wound bed. This cell population is divided into the 
proliferative zone and the migratory zone. In the proliferative zone, basal cells expressing 
K5/K14 and the proliferation marker Ki67 will divide to produce a daughter cell that will 
remain in the proliferative zone, and the other daughter cells will orient its division axis 
towards the migratory zone. A small number of suprabasal cells will also contribute to cell 
division (Patel et al., 2006; Rognoni and Watt, 2018) 
The proximity of cells to the wound centre influences keratin expression. For example, 
suprabasal keratinocytes located at the intact, unaffected epidermis will continue to express 
K1 and K10. Suprabasal cells surrounding and in the wound centre will express K10 and 
K6/K16/K17, respectively (Park et al., 2017; Patel et al., 2006). Type II keratin isoforms K6 
and K6 forms a complex with type I keratins K16 and K17. Under normal conditions, the 
keratin trio K6/K16/K17 is not expressed by keratinocytes in the stratified epithelium, 
however, is commonly seen in skin appendages (Zhang et al., 2019). K16 expression is 
characteristic of cells in the transition stage between basal and suprabasal cells. K16 will 
partner with K6 to promote hyperproliferation, the formation of an extracellular matrix and 
migration. Similarly, K17 will also contribute to hyperproliferation. K10 expression in 
suprabasal cells at the wound edge is not high as this terminal differentiation marker inhibits 
cell division. When K6, K16 and K17 expression increases, subsequently, K1/K10 
expression is lowered (Bragulla and Homberger, 2009; Patel et al., 2006; Zhang et al., 
2019). However, a study using a bilayered skin construct that is engineered to share high 
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similarities of injured skin in vivo, K1 was observed in migrating suprabasal cells at the 
wound’s periphery. Conversely, its partner K10 was not detected at the wound’s edge (Luo 
et al., 2011). These observations suggest K10 is not present in suprabasal keratinocytes or 
according to Patel et al., (2006) is detected at low levels. In suprabasal cells, K16 and K17 
will show the opposite pattern seen in K10 expression between distal and proximal 
keratinocytes. K16 and K17 expression is elevated when keratinocytes are located at or near 
the site of injury, however, will begin to decrease at cells located away from the wound area 
and approaches the normal epidermis (Patel et al., 2006).  
During day 2 post-wounding, basal cells and other keratinocytes adjacent the wound edge 
will express K5. These basal cells will increase K14 expression once they have committed to 
differentiation (Bragulla and Homberger, 2009; Patel et al., 2006). During day 4 post-
wounding, migrating keratinocytes at the wound bed are beginning to develop a scab. 
Suprabasal cells along the wound edge have been observed to express type II K5 and type I 
K10. K10 was not detected in suprabasal keratinocytes in the wound centre. Instead K17 
was expressed by keratinocytes covering the layer of cells covering the wound bed and its 
periphery. K16 was also found along the periphery of the wound bed. The upper and lower 
layer of basal cells surrounding K17-positive keratinocytes at the wound bed showed high 
K5 expression (Patel et al., 2006; Safferling et al., 2013). By day 6 post-wounding, the newly 
developing epidermis over the wound bed is 3-4 cells thick. Suprabasal keratinocytes at the 
wound edge and the upper cell layer of the wound centre expresses K16, however K16-
positive cells above the wound centre displayed a weaker K16 expression. During day 8 
post-wounding, a parakeratotic corneous layer had formed along with the scab tissue still 
present. The new epidermis over the wound centre developed to be 8-10 cells thick. Basal 
and suprabasal keratinocytes lining the wound edge were the remaining cells expressing K5. 
Additionally, suprabasal cells at the wound edge and upper layer of the healing wound 
centre expressed K16, however, the suprabasal cells displayed an inconsistent K16 
expression with small groups of cells expressing K16 across the area. K17 expression also 
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persisted at these areas but at a higher level relative to K16. K17 expression was the highest 
at the lower suprabasal layer of the wound centre (Pastar et al., 2014; Patel et al., 2006). 
These in vivo wound healing studies have shown a dynamic pattern of keratins are 
expressed during re-epithelisation in wound healing, with the primary keratins being K6, K16 
and K17. The expression of terminal differentiation markers, K1 and K10, appear not to 
contribute to re-epithelisation during wound healing, therefore, are not abundantly seen 
during wound healing in vivo. The expression of K1 and K10 may differ in in vitro wound 
healing models, where it played a key functional role in barrier formation (Roth et al., 2012).  
1.1.4 In vitro cell models for keratinocytes during differentiation, 
wound healing and inflammatory skin diseases 
Keratinocyte differentiation can be induced through several different methods. In vitro 
studies have typically altered the calcium concentration to control the transition from basal 
cells to terminally differentiated cells. When keratinocytes are cultured with calcium 
concentrations >0.1 mM will stimulate cells to differentiate. Keratinocytes will undergo 
morphological changes with the formation of cell-cell contacts which is typical of the 
differentiation process (Bikle et al., 2012). In contrast to cell lines, primary cultures of 
keratinocytes can be difficult to maintain in vitro with additional supplementary growth factors 
required for their survival and continued proliferation in culture. Furthermore, primary 
keratinocyte cultures have a short lifespan where once they’ve been stimulated to 
differentiate, they will shortly die afterwards. This short lifespan poses challenges for long-
term examinations of keratinocyte differentiation. Furthermore, primary cell cultures provided 
by donors will vary between donors with different growth characteristics, plating efficiencies 
in relation to cell densities, responses to the in vitro environment and accumulating variation 
in proliferation and differentiation as their number of passages increases (Colombo et al., 
2017). This variation will prove difficult in testing consistent biological replicates during 
experiments. The human keratinocyte cell line HaCaT is often used to examine various 
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cellular functions of keratinocytes, such as proliferation and differentiation. HaCaTs exhibit 
the same primary surface markers and functional characteristics such as differentiation and 
form a stratified epidermis at high calcium concentrations (1.4 mM) (Boukamp et al., 1988; 
Colombo et al., 2017) like primary keratinocyte cultures. Like primary cultures of 
keratinocytes, the initiation of differentiation in HaCaTs is affected by cell density. However, 
HaCaTs show a delay in expression of K1, K10 and involucrin compared to primary 
keratinocyte cultures when grown in low and high calcium concentrations (Micallef et al., 
2009). Based on these results, the expression of K1, K10 and involucrin markers may be 
delayed in other cellular contexts such as wound healing. An advantage over primary 
cultures, HaCaTs can be manipulated to exhibit cellular plasticity through the switches 
between the basal and differentiated phenotype by changes in calcium concentration 
(Colombo et al., 2017). Overall, HaCaTs is a reliable substitute for studying keratinocyte 
cellular function in vitro.  
A commonly used in vitro method to examine re-epithelisation during wound healing is to 
culture keratinocytes until they are confluent and introduce an artificial wound by scatching 
the cells via a pipette tip. Keratinocytes are microscopically recorded over the course of re-
epithelisation, recording cells migrating to close the wound gap (Pastar et al., 2014). Other 
methods to introduce artificial scratches in in vitro monolayer wound healing assays includes 
in addition to mechanical damage through an apparatus (e.g., pipette tip) to remove cells, 
thermal or chemical damage can be applied. However, the diverse methods used to simulate 
physical damage in in vitro wound healing assays introduces challenges in standardising 
and comparing observations between different studies. It is important to keep the number of 
scratches and wound sizes consistent, and to remove cellular debris within the gap 
(Jonkman et al., 2014). Generally, in vitro wound healing assays are utilised to examine cells 
in a monolayer migrating into the gaps caused by artificial damage in a tissue plate (Liang et 
al., 2007). 
Like wound healing, the autoimmune, inflammatory skin disorder, psoriasis, is marked by 
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elevated levels of K6, K16 and K17 in its psoriatic skin lesions. During wound healing, K6, 
K16 and K17 were involved in promoting hyperproliferation, cell migration and formation of 
extracellular matrix. These cellular processes are dysregulated in psoriasis, which is marked 
by hyperproliferation in the suprabasal layer, abhorrent keratinocyte differentiation and 
infiltration of immune cells (Chandra et al., 2018; Fischer et al., 2016; Pechter et al., 2012; 
Zhang et al., 2019). Imiquimod (IMQ) is a Toll-like receptor (TLR)-7/8 ligand which can be 
used as a potent immune activator to trigger or treat psoriasis. The prolonged treatment of 
IMQ on skin in vivo results to scaling, skin thickening and plaques characteristic of psoriasis, 
which is mediated through dendritic cells (Fits et al., 2009). Additionally, IMQ functions as an 
adenosine receptor antagonist. Adenosine receptors have shown the ability to control cell 
growth in two opposing outcomes – inducing proliferation or apoptosis. The differing roles of 
adenosine receptor has been attributed to the concentrations of adenosine receptors or 
utilising adenosine antagonists results to the induction of keratinocyte proliferation (Andrés 
et al., 2017). These results suggest at a higher concentration of adenosine receptors, 
apoptosis may occur instead. An in vitro IMQ-induced psoriasis cell model involves 
incubating HaCaT cells with >0.1 mM of calcium chloride (CaCl2) to induce differentiation. 
Finally, HaCaTs are given IMQ (e.g., 100 M) to trigger an inflammatory-like phenotype in 
differentiated HaCaTs that’s characteristic of psoriasis (Varma et al., 2017). In vitro IMQ-
induced psoriasis skin models are useful for testing the effect of anti-psoriatic drugs and 
cellular processes during psoriasis, such as keratinocyte activation and crosstalk between 
immune cells and keratinocytes (Sumida et al., 2014; Varma et al., 2017).  
1.2 Regulatory elements 
The different patterns of gene expression during keratinocyte differentiation, wound healing 
and skin inflammatory diseases are coordinated by cis-acting DNA regulatory elements. The 
different patterns of gene expression are controlled in a specific spatial and temporal manner 
by the following cis-regulatory elements: promoters, enhancers, insulators, silencers, and 
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locus control regions (LCRs) (Chen et al., 2018). Enhancers are key cis-regulatory element 
that coordinates gene activation during development, cell identity and many other cellular 
processes, independent of their position and location (Cheng et al., 2018; Pennacchio et al., 
2013). Enhancers are more abundantly found in the genome than genes, amounting to 
approximately hundreds of thousands of enhancers in each cell and approximately a million 
active enhancers in all human cells (Schoenfelder and Fraser, 2019). They are localised in 
non-coding regions either downstream or upstream of promoters, termed intergenic 
enhancers, or at the introns of gene bodies, referred to as intragenic enhancers. The 
intragenic enhancers do not necessarily have to regulate the gene in which they are located 
at and can associate with unrelated genes further away (Hnisz et al., 2013; Schoenfelder 
and Fraser, 2019). Enhancers are made up of DNA-recognition motifs for transcription 
factors, allowing them to coordinate gene expression upon binding to transcription start site 
(TSS) via chromatin looping (Rhie et al., 2014). During transcription, enhancer sequences 
will bind with transcription factors, recruiting co-activators or co-repressors, to create a stable 
complex to increase the rate of transcription (Chen et al., 2017; Shlyueva et al., 2014). Many 
genes can be expressed in multiple cell types where their expression is mediated in a 
specific spatial and temporal pattern by separate regulatory elements in each cell type (Li et 
al., 2018).  
Enhancer elements can be located tens to hundreds of thousands base pairs away from 
their target promoter (Lu et al., 2018). Long-range communication between enhancers and 
promoters have been hypothesised through two primary models: “tracking” and “looping”. 
Tracking involves enhancers searching for RNAPII along intervening DNA until it tracks its 
target promoter and activates transcription. Alternatively, looping entails cofactors facilitating 
long-range interactions between a target promoter and enhancer by looping over intervening 
DNA regions. Between these two models, looping is generally more accepted with the 
assistance of several recently developed techniques that examine chromatin structure, such 
as chromosome conformation capture (3C) and its more comprehensive alternatives 4C, 5C 
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and Hi-C (Sati and Cavalli, 2017). The interactions between cis-acting DNA regulatory 
elements and their target genes can be affected by genome rearrangements and enhancer 
DNA sequence variants, resulting in an increased disease susceptibility and occurrence of 
developmental malformations (Schoenfelder and Fraser, 2019). 
The significant advances in sequencing technologies has allowed a detailed examinations of 
protein interactions with DNA on a genome-wide level. Chromatin immunoprecipitation 
(ChIP) is a well-established method used to map for genome-wide locations of histone 
modifications, transcription factor binding and occupancy of protein complexes, such as RNA 
polymerase II (RNAPII). This technique employs the use of antibodies specific for a given 
histone modification and precipitates the chromatin, thus isolating the targeted protein-DNA 
complex. Next generation DNA sequencing is used to sequence the recovered DNA (ChIP-
seq) (Spicuglia and Vanhille, 2012). Other derivatives of this technology include ChIP-on-
chip which merges the techniques of ChIP and DNA-microarray technique (chip). Like ChIP-
seq, this method can search for genome-wide protein-DNA interactions, including histone 
modifications and transcription factor bindings (Barski et al., 2007; Ho et al., 2011).  
RNA polymerases transcribe DNA into various types of RNA, such as messenger RNA 
(mRNA), non-coding DNA, and structural RNAs. RNAPI and RNAPIII mediate transcription 
at non-coding RNA to produce transfer RNA (tRNA) and ribosomal RNA (rRNA). RNA pol II 
(RNAPII) transcribes coding and non-coding genes to produce mRNA and ncRNA species, 
respectively (Koch et al., 2008). Promoter regions bind tissue-specific and/or general 
transcription factors that are cofactors for RNA polymerase II (RNAPII) to direct the 
orientation and proper timing of transcriptional initiation (Schoenfelder and Fraser, 2019). 
When an enhancer element associates with the Mediator complex to loop over and interact 
with its target promoter, it will help recruit RNAPII to the promoter (Ong and Corces, 2011). 
For example, an RNAPII ChIP-seq analysis showed RNAPII occupancy at terminal 
differentiation marker KRT10 in keratinocytes undergoing early stages of differentiating 
(Kouwenhoven et al., 2015). This suggests RNAPII can be a marker of poised promoters 
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that are waiting for activation (Barski et al., 2007). Like promoters, RNAPII binding is also 
observed at active enhancers to transcribe non-coding enhancer RNAs (eRNAs). These 
eRNAs can be long, unidirectional, polyadenylated or short, bi-directional and non-
polyadenylated transcripts. The functional significance of these eRNAs are not well-
understood (Calo and Wysocka, 2013).  
Keratinocyte proliferation and differentiation is tightly controlled by cis-regulatory elements 
coordinating spatiotemporal changes in the gene expression of keratin type I and II loci 
(Cavazza et al., 2016). Cap Analysis of Gene Expression (CAGE) is used to map TSS 
located at the 5’ end of RNA molecules, which is used to determine the gene expression at 
the given promoter that generated the RNA transcript. CAGE is a high-throughput 
technology that generates gene expression profiles for condition-, cell-, and tissue-specific 
TSS (Takahashi et al., 2012). A CAGE analysis of promoters in progenitor and differentiated 
keratinocytes showed over 90% of identified promoters overlapped between these cell 
states, with less than 1% specific to either cell states. Although there was a high overlap of 
active promoters found in progenitor and differentiated cells, varying levels of quantitative 
changes in gene expression were observed. These observations suggest differences in the 
activity of regulatory elements (Botchkarev, 2015; Cavazza et al., 2016). In an in vitro 
keratinocyte differentiation model, RNAPII ChIP-seq analysis identified expression patterns 
of epidermal markers KRT5, KRT14, KRT1, KRT10, involucrin and loricrin. Furthermore, the 
RNA-seq analysis of these epidermal marker showed a positive correlation with the master 
regulator of skin keratinocytes, TP63. As the master regulator of skin keratinocytes, TP63 
plays a key role in proliferation and differentiation in the epidermis. Specifically, the RNA-seq 
showed a strong correlation with the shorter encoded isoform of TP63, Np63. Furthermore, 
p63 ChIP-seq experiments showing the binding of this transcription factor. The p63 ChIP-
seq experiment showed binding signals to be enriched at promoter regions and within 25 kb 
distance of genes of the epidermal markers and others involved in keratinocyte 
differentiation (Kouwenhoven et al., 2015). An RNA-seq analysis on primary cultures of 
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keratinocytes also displayed distinct patterns in the transcriptome of differentiated 
keratinocytes, and in addition, progenitor cells. A gene ontology analysis on the RNA-seq 
data showed changes in expression of genes involved in epithelium morphogenesis and 
proliferation were inclined towards the progenitor cells. In contrast, differentiated 
keratinocytes were associated with epidermal differentiation, cell migration and apoptosis 
(Cavazza et al., 2016). Collectively, these studies show evidence transcriptional activity 
during keratinocyte proliferation and differentiation are controlled by regulatory elements. 
The specific patterns of gene expression in progenitor and differentiated cells mediated by 
regulatory elements can be measured with high through-put sequencing technologies, such 
as RNA-seq, ChIP-seq and CAGE.  
CCCTC-binding factor (CTCF) is a transcription factor that can occupy many different DNA 
motifs, such as enhancers and promoters, and associate with multiple regulatory proteins. 
CTCF can function as transcriptional repressor, activator or insulator. Additionally, CTCF can 
coordinate the binding of transcriptional activators and repressor, protein complexes such as 
RNAPII and mediate chromatin looping which plays an important role in the communication 
between enhancers and promoters (Arzate-Mejía et al., 2018; Holwerda and de Laat, 2013). 
During epidermal differentiation, CTCF ChIP-seq has observed CTCF binding to localise at 
the same DNA regions as SMC1A, a cohesin subunit that stabilises chromatin looping 
between distal enhancers and their target genes. During epidermal differentiation, SMC1A 
associates with active enhancers marked by H3K27ac (DeMare et al., 2013; Rubin et al., 
2017). Collectively, these studies suggest CTCF cooperates with SMC1A to mediate contact 
between active enhancers and their target promoters during epidermal differentiation. 
Genomic DNA is assembled into chromatin which are repeating units called nucleosomes. 
Each nucleosome is an octamer of histones containing duplicates of the core histones – 
H2A, H2B, H3 and H4 (Klose, 2010; Rohlf et al., 2012). Each nucleosome is structured as a 
core histone octamer containing two H2A-H2B dimers and one (H3-H4)2 tetramer 
surrounded by 147 bp of DNA. Each of these histone cores are connected via the histone 
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protein H1 which includes an additional 20 bp wrapped around the histones (Dobersch et al., 
2019; Golbabapour et al., 2013). Chromatin is defined as the combination of DNA and 
histones and other proteins and is present in two forms: heterochromatin and euchromatin. 
Heterochromatin is the tightly packaged form of chromatin where it is inaccessible to most 
transcription factors. Conversely, euchromatin is the transcriptionally active configuration of 
chromatin where it is loosely packed (Murakami, 2013). The configuration of chromatin can 
be determined at a given region by the presence and absence of histone modifications. 
These histone modifications confer active or repressive marks along chromatins, which also 
determines the active status of regulatory elements in a cell type- and condition-specific 
manner, such as progenitor cells and the initiation of terminal differentiation Botchkarev, 
2015). 
Large chromatin associated complexes catalyse covalent attachments of methyl and acetyl 
groups – to establish the configuration of chromatin to control the activity of transcriptional 
machinery (Han and Garcia, 2013). The organisation of nucleosomes and the specific type 
and combination of post-translational modifications are important for distinguishing between 
regulatory elements – such as enhancers, promoters, silencers and several others (Rhie et 
al., 2014). Histone acetylation is a post-translational modification that unpacks chromatin, 
inducing its transition from heterochromatin to euchromatin. Histone acetylation is a highly 
dynamic post-translational modification that is a reversible process, regulated by two 
enzyme families – histone acetyltransferases (HATs) and histone deacetylases (HDACs). 
Active chromatin will commonly be hyper-acetylated at histone H3 lysine 9 (K9) and 27 (K27) 
(Bannister and Kouzarides, 2011; Murakami, 2013; Verdone et al., 2006). Histone H3 lysine 
27 (K27) acetylation (H3K27ac) is a commonly known as an active marker of chromatin, 
often observed at enhancer elements (Rhie et al., 2014). A H3K27ac ChIP-seq analysis on 
an in vitro keratinocyte differentiation model showed H3K27ac occupancy across the 
genome had and overlap of >50% with p63 binding sites during the early-, mid- and late-
differentiation stages. Additionally, RNAPII occupancy at epidermal marker genes, such as 
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K5, K14, K1, K10 and many others, correlated with H3K27ac binding signals (Kouwenhoven 
et al., 2015).  
 
 
Figure 1.3. Illustration of the histone modifications present at active promoter and enhancer 
regions.  
Histone methylation is another key epigenetic mechanism, which can be a marker of active 
or inactive transcriptional activity. This epigenetic modification is a reversible process where 
a group of methyltransferases and demethylases controls the addition and removal of methyl 
groups (Greer and Shi, 2012). Histone methylation occurs along basic residues – arginines, 
histidines and lysines (Herceg and Murr, 2011). Lysine residues are commonly methylated 
on the N-terminal tail of histones, where one (me1), two (me2) or three (me3) amine groups 
can be added (Blackledge and Klose, 2010). The number of methyl groups covalently 
bonded reflects different information and biological contexts (Kim and Kim, 2012). For 
example, regulatory elements marked by only H3K4me1 and H3K4me2 are characteristic of 
poised enhancers (Ong and Corces, 2011). Poised enhancers are marked by active, 
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H3K4me1, and repressive, H3K27me3, histone marks (Klein et al., 2017) (Example of 
histone marks provided in Fig. 1.3). Regions marked by an active and repressive histone 
modifications are called bivalent chromatin. This bivalent nature allows for quick and flexible 
changes in transcription factor binding, such as switching cell states during differentiation 
and development. Once the appropriate transcription factors and histone marks are present, 
it will initiate transcriptional changes to shape a cell’s identity and influence other cellular 
processes (Avramova, 2011; Nurminen et al., 2019).  
Active enhancer elements are marked by H3K27ac, H3K4me1 and H3K4me2 (Calo and 
Wysocka, 2013), whereas, the histone marks H3K4me3 and H3K27ac correlate with actively 
transcribed promoters (Cheng et al., 2018). Epigenetic modifications, including those found 
at enhancers and promoters, are integral to maintaining cellular functions, such as 
controlling phenotypic plasticity between cells in a population (Botchkarev, 2015). In 
keratinocyte differentiation, dynamic epigenetic changes occur along regulatory elements. A 
ChIP-seq analysis of differentiation in a primary culture of keratinocytes showed the markers 
for enhancers and promoters, H3K4me1, H3K4me3 and H3K27ac, occupied regulatory 
regions between proliferating and differentiating keratinocytes. Furthermore, a marker of 
gene repression, H3K27me3, was found at promoters in differentiating keratinocytes that 
were actively transcribed in proliferating keratinocytes. A distinct class of enhancer, super-
enhancers, which regulate genes important for defining cell identity are also observed in 
proliferating and differentiating cells. Each cell state displayed their own unique collection of 
super-enhancers. The group of genes regulated by super-enhancers exhibit a higher level of 
expression in comparison to the other typical enhancers identified. Many of these genes are 
key regulators of skin development and stem cell biology, including TP53, TP63, RUNX1, 
MYC and many others (Cavazza et al., 2016). Overall, the epigenetic landscape during 
keratinocyte proliferation and differentiation is complex and is regulated by an assortment of 




1.3 DNA methylation 
DNA methylation is an important epigenetic modification for mammalian development, 
responsible for changes in transcription factor binding and chromatin structure (Bergman 
and Cedar, 2013). In normal cells, DNA methylation is involved in genomic imprinting and X-
chromosome inactivation. DNA methylation at the fifth carbon of cytosine nucleotides (5mC) 
was a mechanism developed in bacteria and the first eukaryote (Bird, 2002; Greenberg and 
Bourc’his, 2019). Mammalian genomes are highly methylated at CpG regions, amounting for 
70-80% methylated DNA. DNA methylation functions as a type of DNA annotation where it 
can initiate gene activation or repression. This DNA annotation is predominantly mediated 
through the DNA methyltransferases (DNMT) – DNMT1, -3a, and -3b (Dukatz et al., 2019; 
Edwards et al., 2017; Greenberg and Bourc’his, 2019). These DNMT will add methyl groups 
to cytosine bases at the 5’ position to supress gene expression (Xu et al., 2016). In 
mammals, methylation usually occurs most often at CpG rich sites, termed CpG islands, and 
located at or near approximately 50% of human promoters. CpG islands extend over 200 bp 
with over 50% GC content. CpG islands at promoters are typically resistant to DNA 
methylation and will be free of methylation regardless if the gene is active or silent (Bird, 
2002; Oberley and Farnham, 2003; Xu et al., 2016). DNA methylation does not occur 
frequently at CpG-rich promoters, which are generally occupied by H3K4me3 histone marks 
(Greenberg and Bourc’his, 2019). These reports suggest the occupancy of histone marks 
can affect the level of DNA methylation present at the same region.  
There is crosstalk between histone modifications and DNA methylation, where both 
epigenetics processes can be used to differentiate active enhancers and promoters. The 
promoter histone mark, H3K4me3, has been observed to be marked by low levels of DNA 
methylation. Conversely, the enhancer histone marks H3K4me1 and H3K27ac were found to 
have higher levels of DNA methylation relative to H3K4me3 with intermediate DNA 
methylation levels (Sharifi-Zarchi et al., 2017). Hypomethylated promoters are also observed 
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in the embryonic genome where H3K4me3 will frequently bind to promoters with low levels 
of DNA methylation. In addition, H3K4me3 occupied promoters will not be occupied by the 
repressive histone marks H3K9me3 and H3K27me3. When zygotes are entering their first 
developmental stage, midblastula transition, the epigenetic landscape is altered with 
hypomethylated promoters becoming increasing enriched with H3K4me3 (Andersen et al., 
2012). During disease, healthy and disease-affected tissues show distinct DNA methylation 
profiles with healthy tissue generally exhibiting hypomethylated regions, on the other hand, 
disease-affected tissue depict an increasing number of hypermethylated regions (Song et 
al., 2018). Like histone methylation and acetylation, there are varying levels of DNA 
methylation at varying cellular contexts and conditions. Although, there is an increasing 
number of studies on the relationship between histone modifications and DNA methylation, 
further research into how these epigenetic mechanisms communicate with one another 
when controlling gene expression is not well understood.  
DNA methylation plays a significant role during development, such as silencing germline-
specific genes and transposons, and when deficient, can result to developmental 
abnormalities. For example, when DNA methylation patterns are perturbed, it contributes to 
the development of diseases such as cancer. Dysregulation in DNA methylation is an 
occurrence seen in all cancer types (Bird, 2002; Greenberg and Bourc’his, 2019). For 
example, a gene ontology analysis of hypermethylated areas in cutaneous melanoma 
showed an increase at genes encoding proteins involved in cell polarity and cell-contact 
adhesion. Conversely, hypomethylated regions were enriched at genes involved in the 
inflammatory process and immune system (Wouters et al., 2017). Differential DNA 
methylation patterns are also observed during re-epithelisation in wound healing. In an in 
vitro wound healing assay in human corneal endothelial (HCEC) cell line, the global DNA 
methylation showed a significant increase during the first 12 h post-scratch. Global DNA 
methylation levels reached their peak at 48 h post-scratch and began to decrease until DNA 
methylation levels dropped back to the basal levels, marked by the controls, at 96 h post-
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wounding. A Western blot and qPCR analysis showed DNA methyltransferases, DNMT1, 
DNMT3A and DNMT3B, exhibited a rise at 48 h post-wounding (Luo et al., 2019). Changing 
patterns of DNA methylation also occurs during keratinocyte differentiation. This was 
observed in a HaCaT in vitro differentiation model where lower levels of DNA methylation is 
observed at K10 and at a genome-wide level (Pucci et al., 2013). A genome-wide DNA 
methylation analysis in murine keratinocytes and primary dermal fibroblasts showed 
hypomethylation was primarily enriched at intergenic regions and introns (Chatterjee et al., 
2014). Alongside histone modifications, varying levels of DNA methylation occur during 
keratinocyte proliferation and differentiation (Perdigoto et al., 2014; Rishi et al., 2010).  
Alongside keratinocyte proliferation and differentiation, differential DNA methylation levels 
are observed in inflammatory skin disease. Skin lesions from psoriasis patients showed 
global hypermethylation and high, abnormal levels of DNMT1, suggesting perturbed DNA 
methylation patterns (Chandra et al., 2018). Similar observations are seen at enhancer 
regions in psoriatic skin lesions which displayed differentiation DNA methylation (Gu et al., 
2015). Conversely, other pathologies can exhibit different DNA methylation patterns. For 
example, the development of autoimmune diseases, including scleroderma and systemic 
lupus erythematosus, are marked hypomethylation (Back et al., 2012). Differentially 
methylated genes occurred at genes encoding for anti-microbial, adhesion and scaffold 
proteins such as S100A9, KAZN, and CARD14. A gene ontology analysis of all the 
differential DNA methylation sites showed hypermethylated regions overlapped with 
promoters important for cell adhesion and motility, cell development, differentiation and 
cytoskeletal organisation. Whereas, hypomethylated regions occurred at promoters involved 









1.4 Genetic variants 
The genetic basis of cutaneous disorders in different populations is characterised by multiple 
genes working in concert. Genome-wide association studies (GWAS) are a valuable 
research technique in identifying genetic variants specifically linked to polygenic diseases 
and traits. GWAS searches for single nucleotide polymorphisms (SNPs) commonly found 
across the human genome and compare the distribution of these polymorphisms across 
different population groups. These SNPs are usually found in haplotype blocks. Haplotype 
blocks are groups of alleles that tend to collectively occur together on the same chromosome 
more often than is expected by random chance. Haplotype blocks reflect the presence of 
linkage disequilibrium (LD) which is a pairwise measure of association between two alleles in 
a population. GWAS have taken advantage of the occurrence of haplotype blocks by using a 
GWAS reported SNP to determine which variant it is in LD with. The variant in LD with the 
reported SNP is the causal SNP associated with a trait or disease. Most haplotype blocks 
localise at intergenic and intronic regions (Bartonicek et al., 2017; Tsoi et al., 2018; Wall and 
Pritchard, 2003). Next, the disease susceptibility of causal SNPs is calculated to determine 
risk factors of an individual or population carrying the given casual SNP. A genome-wide 
significant threshold of P < 5x10-8 is a standard utilised. This threshold accounts for P-values 
giving false positives by random chance (Tsoi et al., 2018; Zhang, 2012). 
Complex diseases are not explained by typical Mendelian genetics, but by the interplay 
between genetics and environmental factors. The development of these complex diseases is 
contributed by a network of SNPs found at multiple genes, each contributing a small effect 
with disease risk (1.1-1.5-fold), which are imposed by environmental factors. Each SNP will 
contribute to a small portion of heritability which is the degree of phenotypic variation in a 
population that is due to the collective genetic variation. Many traits and diseases are 
controlled by multiple genes (“polygenic”) (Bartonicek et al., 2017; Manolio et al., 2009; 
Zhang, 2012). The development of psoriasis is strongly correlated with genetic factors 
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associated with the immune system and epidermis. There are more than 40 disease 
susceptibility loci of psoriasis that have been identified through GWAS (Tsoi et al., 2012; Yin 
et al., 2014). For example, a GWAS psoriasis study conducted on Caucasian subjects found 
genetic variants correlating to psoriasis susceptibility loci were at genes involved in innate 
immunity. Additionally, these psoriasis susceptibility loci overlapped with other disease loci, 
such as Crohn’s disease, rheumatoid arthritis and celiac disease (Tsoi et al., 2012). Genetic 
variants along keratin genes have been found to associate with disease risk in various 
inflammatory-related and skin diseases, including psoriasis, systemic sclerosis (SSc) and 
systemic lupus erythematosus (SLE). A study on a Chinese Han population found a SNP 
and indel polymorphism mapping to KRT1 was associated with the autoimmune diseases 
SSc and SLE. The SNPs rs14024 and rs267607656 are located at exon 9 of KRT1, which 
encodes the carboxy tail end domain (Luo et al., 2017). The gene expression signatures in 
KRT1-/- mice resemble the inflammatory gene expression patterns seen in another 
inflammatory skin disorder, atopic eczema (Roth et al., 2012). The amino head and carboxy 
tail end domains have been previously identified to be a site in keratins subject to post-
translational modifications (Wang et al., 2016). The DNA regions with these KRT1 genetic 
variants might undergo different post-translational modifications to partly explain for 
phenotypic and gene expression variations in SSc and SLE.  
Changes in DNA methylation and histone modifications have been linked to genetic variants. 
Excluding imprinted genes and regions targeted for X-inactivation in females, CpG DNA 
methylation is often observed to exhibit stable patterns of methylation between alleles in 
diploid cells with both nucleotides either methylated or unmethylated (Shoemaker et al., 
2010). However, the human genome can also exhibit dynamic levels of DNA methylation 
with imbalanced DNA methylation at an allele in diploid cells. This phenomenon is referred to 
as allele-specific methylation (ASM). Single nucleotide variants (SNVs) at protein-coding 
regions can be associated with a higher disease susceptibility. Similarly, SNVs at non-coding 
regions can create an imbalance of DNA methylation between two alleles, causing disease 
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risk (Wang et al., 2019). ASM at a single allele can also result to allele-specific gene 
expression with a single nucleotide change causing a disruption at a CpG methylation site. 
The change in DNA methylation status will alter the gene expression patterns (Shoemaker et 
al., 2010). The presence of DNA methylation prevents the binding of transcription factors, 
therefore, is classically correlated to gene repression (Botchkarev et al., 2012). ASM regions 
have been found to increase variation in gene expression by influencing the frequency of 
transcription factor binding and gene expression based on the presence of an allele or 
genetic variant (Wang et al., 2019). An analysis of whole blood eQTL data from a Chinese 
cohort found a SNP expressing the T allele associated with a hypomethylated promoter at 
VSTM1, a gene involved in immune cell activation and differentiation, correlated with an 
allele-specific gene expression increase at SIRL-1, a gene encoding a protein that inhibits 
monocyte-derived pro-inflammatory reactions (Kumar et al., 2017). Monocytes exhibit 
variations in SIRL-1 expression, and Kumar et al., (2017) propose this gene expression 
variation is due to the VSTM1-associated SNP (rs612529). When this SNP is expressing the 
alternative C allele, it exhibits a genetic risk for skin inflammation in atopic dermatitis (Kumar 
et al., 2017). These allele-specific changes in gene expression and DNA methylation are 
also observed in cancer (Chen et al., 2008; Milani et al., 2009). However, there is a lack of 














1.5 Hypothesis and aims 
In this thesis, we hypothesise that changes in KRT1 expression during wound healing 
correlates to differential DNA methylation at regulatory elements along the KRT1 locus. The 
changes in gene expression and DNA methylation are due to phenotypic variations in cell 
lines and are condition-dependent during re-epithelialisation, a process marked by changes 
in keratin expression in vivo. Moreover, variation in DNA methylation and by extension gene 
expression are also influenced by single nucleotide variants in the sequence of regulatory 
elements. To test the changes in gene expression during wound healing, an in vitro wound 
healing assay using HaCaTs cells was designed. Additionally, to further examine the gene 
expression changes, single cells were isolated from an original HaCaT cell population and 
tested for changes in gene expression during wound healing. A bioinformatics analysis of 
H3K27ac, H3K4me1, RNAPII and CTCF ChIP-seq and DNA methylation data was utilised to 
identify regions exhibiting transcriptional activity and potential regulatory functions in 
proliferating and differentiating keratinocytes. A Methylation Sensitive Restriction Enzyme 
(MSRE)-qPCR was designed to test for changes in DNA methylation at regulatory elements. 
Finally, the identified putative regulatory regions were sequenced using Nanopore 




Chapter 2: Cell model 
 
2.1 Introduction 
Recent studies have reported cultured cell lines exhibiting phenotypic and molecular 
heterogeneity through genetic variation and epigenetic modifications and can therefore be 
considered as heterogeneous populations of cells (Ben-David et al., 2018; Martín-Pardillos 
et al., 2019). Following on from this, it is hypothesised that clonal cell lines can be generated 
from these heterogeneous cell populations, with different clonal cell lines showing variation 
in phenotype that reflects genetic and epigenetic variation. 
The genetic and epigenetic variability may be linked to the response of a cell to a specific 
environmental stimulus. The primary role of skin is to act as a barrier against infection and 
protect against mechanical stress. Several GWAS of inflammatory skin diseases, such as 
psoriasis, have identified genetic variants linked to differences in barrier formation and repair 
(Kim et al., 2015; Liu et al., 2008; Zhang, 2012). In this study, we are interested in studying 
the changes in gene expression of keratinocytes undergoing wound healing and how keratin 
expression changes over time. To assess the transcriptional changes during wound healing 
in keratinocytes, an in vitro wound healing assay paired with an inflammatory stimulus was 
designed to test changes in gene expression encoding antimicrobial factors, keratins, 
cytokines and transcription factors involved in keratinocyte proliferation and differentiation in 
HaCaT cells. The expression of genes was also assessed during the first 24, 48 and 72 h 
post-scratch in the in vitro wound healing assay. In addition, single HaCaT cells were 
isolated from an original multi-clonal population (referred to as the “parental” cell line) and 




2.2 Materials and Methods 
2.2.1 Cell culturing 
HaCaT cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco 
Australia), with 10% heat inactivated foetal bovine serum (FBS) (Gibco Australia) and 1% 
Penicillin-streptomycin (Gibco Australia) at 37°C with 5% CO2. To create clonal populations, 
cells were seeded at one cell per 200 L on a 96-well plate (Fig. 2.1). Cells were also 
seeded at ten cells per 200 L to increase the likelihood of seeding cells into a well. Wells 
with single cells were left to grow for 2 weeks and then passaged onto a 24-well plate. Once 
reaching 50% confluency, cells were transferred into T25 flasks.  
 
Figure 2.1. Workflow of establishing and selecting clones for wound healing analysis.  
2.2.2 Inflammatory-wound healing assay in HaCaT parental cell line 
A wound healing assay paired with the inflammatory stimulus IMQ (Fits et al., 2009) was 
designed to induce an inflammatory response during wound healing in the parental cell line. 
Cells were plated at a density of 2.5x105 cells/mL in DMEM media and 10% FBS 
supplemented with 1 g/mL or 10 g/mL of imiquimod (IMQ) (Sigma Australia) and left to 
grow for 4 days to reach 80-90% confluency. Single or two parallel scratches were made 
with a 4-toothed comb. Each well was washed with phosphate-buffered saline (PBS) (Gibco 
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Australia) and replaced with DMEM/10% FBS supplemented with 1 or 10 g/mL of IMQ. 
Cells are left to recover from the artificial scratch and isolated at days 3 or days 1-3 post-
scratch.  
2.2.3 Wound healing assay between HaCaT cell lines 
Clones were screened based on differences in the rate of wound closure. To do this, each 
clonal cell line was plated at a density of 1.25x105 cells/mL on a 12-well plate and grown 
until they were 80-90% confluent. To test the rate of wound closure for each clone, the 
media was changed to test each of the following conditions: 1% FBS, 10% FBS, 10% FBS 
with 10 g/mL of IMQ and cells were scratched vertically with a 4-toothed comb to produce 4 
evenly spread scratches. Each well was washed with PBS and cells were left for 24 h in 1% 
FBS, 10% FBS or 10% FBS with 10 g/mL of IMQ. The top, middle and bottom sections of 
wells were imaged with a Leica MC120 HD microscope to quantify the overall distribution of 
each scratch.  
Stocks of all cell lines, including the original multi-clonal cell population (termed ‘parental’ cell 
line) and clonal cell lines, used in this study were stored in liquid nitrogen as single vials. The 
single vials of each cell line were thawed, passaged three times in cultures and plated in 
DMEM media with 10% FBS. This was done to control for passage-dependent variations in 
gene expression between cell lines. Cells were plated at a density of 2.5x105 cells/mL and 
left to grow for 4 days to reach 80-90% confluency. Two parallel scratches were made with a 
4-toothed comb. Cells were isolated on days 1 and 3 post-scratch. Workflow of wound 





Figure 2.2. Workflow of wound healing assay and names of samples isolated 24, 48 and 72 h 
post-scratch with or without IMQ treatments. Abbreviations: Scr = scratch; NT = non-treated; 
HIMQ = high IMQ concentration (10 g/mL of IMQ); LIMQ = low IMQ concentration (1 g/mL of IMQ).  
2.2.4 Measurement of Wound Closure 
The rate of wound closure was quantitatively measured with ImageJ macros. Images were 
first converted to 8-bit file, and then the threshold colour was reset with ‘Dark background’ 
enabled. Next, an FFT Bandpass Filter was added with the following settings: - 
• Filter large structures down to 40 pixels 
• Filter small structures up to 3 pixels 
• Suppress stripes: None 
• Tolerance of direction: 5% 
• Enable ‘Autoscale after filtering’ 
• Enable ‘Saturate image when autoscaling’ 
• Disable ‘Display filter’ 
Afterwards, the threshold colour feature was activated with default settings. Using the 
paintbrush tool, the borders of the scratch were outlined (Fig. 2.3). The outlined scratch area 
was measured with the wand tracing tool. The measured area of the scratch is then 
converted to a percentage relative to the overall size of the image (e.g., dimensions; length x 




Figure 2.3. Example image of measuring gap caused by a scratch using ImageJ macros. Left: 
original image. Right: image processed using ImageJ macros.  
2.2.5 RNA isolation 
Cells were washed with PBS, then collected and lysed in RNA lysis buffer from the ISOLATE 
II RNA Mini Kit (Bioline). Purification of total RNA was done according to the manufacturer’s 
instructions with the following modification: after washing, columns were dried by 
centrifuging twice for 2 min at 11,000 x g and ensured complete removal of any residual 
wash buffer. RNA concentration was measured on a NanoDrop 2000c Spectrophotmeter 
(Thermo Fisher Scientific). 
2.2.6 Reverse transcription (RT) reaction and Quantitative 
polymerase chain reaction (qPCR) 
Reactions were done in a final volume of 20 L and included 200 ng of total RNA, using the 
SensiFAST cDNA Synthesis Kit (Bioline) as per the manufacturer’s instructions. The 
amplification conditions were 25°C for 10 min, 42°C for 15 min and 85°C for 5 min. The gene 
expression of the samples was analysed using the 7500 Fast Real-Time PCR (Applied 
Biosystems). After cDNA synthesis, 30 L of RNase free water were added to each reaction. 
Next, master mixes were prepared using the SensiFAST SYBR Lo-ROX Kit (Bioline), with a 
final reaction volume of 10 L consisting of 1x SYBR Lo-ROX, 2 L of a forward and reverse 
primer mix (each at a final concentration of 0.1 M), and 2 L of diluted cDNA. The qPCR 
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conditions were: 95°C for 20 sec, followed by 40 cycles of 95°C for 3 sec, 60°C for 30 sec, 
95°C for 15 sec, 60°C for 1 min, 95°C for 15 sec and 60°C for 15 sec.  
2.2.7 Gene expression analysis 
The fold expression of each gene was obtained by normalising cycle threshold numbers (Ct) 
to the NFYB reference gene Ct for each sample and then relative to a no-treatment control 
(Ct), with a fold change determined using the formula 2-ct. To measure the differences in 
fold change between samples in each gene, the calculated fold changes in expression were 
transformed based on the Euclidean distance normalisation method. This normalisation 
method normalises the fold gene change between conditions in a gene, therefore showing 
the direction of change relative to each condition. Although, the Euclidean distance 
normalisation method is useful to show the direction of change between conditions restricted 
to a single gene, it is unable to show the changes in expression relative to other genes. Due 
to this, the calculated fold changes without the Euclidean distance normalisation was also 
examined in conjunction to compare genes against each other to show which genes had the 
highest fold change the in vitro wound healing assays.  
2.3 Results 
2.3.1 Previous exposure of IMQ induces a potent response after 





Figure 2.4. Inflammatory-wound healing assay of parental HaCaT cells treated with low or high 
IMQ concentrations (1 g/mL or 10 g/mL) paired with four scratches (n = 1). Plated HaCaT cells 
were cultured to passage 5 and RNA isolated 72 h post-scratch when all wounds were closed. Genes 
encoding proteins involved in the innate immune response in epithelial cells, keratinocyte proliferation 
and differentiation, migration and wound repair were tested. (A) Heatmap of fold gene expression 
(CT) values are scaled based on the Euclidean distance normalisation method. CT values are 
scaled to show relative gene expression changes between conditions in each gene. (B) Heatmap of 
fold gene expression (CT) values scaled to show relative gene expression changes between all 
conditions and genes. Abbreviations: Scr = scratch; NT = non-treated.  
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First, the inflammatory response during wound healing was examined in our original HaCaT 
cell population, termed the parental cell line. Imiquimod (IMQ) is a common treatment used 
in psoriasis patients which elicits an immune response by inducing the production of pro-
inflammatory cytokines. Alternatively, IMQ has also been used to simulate a psoriasis-like 
phenotype in vitro. IMQ shows characteristics of an adenosine receptor antagonist in 
keratinocytes (Schön et al., 2006). 
Adenosine receptors show contradicting roles for cell growth, where they can enhance 
proliferation or promote apoptosis. It has been shown that low concentrations of adenosine 
receptor antagonists promote keratinocyte proliferation (Andrés et al., 2017), which suggest 
concentration-dependent differences in the effect of IMQ. 
Based on these previous observations, we hypothesised that including a long-term treatment 
of IMQ in the 7-day wound healing assay, keratinocytes will be induced to heal at a faster 
rate. First, by pre-treating keratinocytes with IMQ during the first 4 days of growth, as they 
proliferate to reach 80-90% confluency before physical damage will prime keratinocytes to 
re-epithelialize at a faster rate during wound healing. Additionally, the continued treatment of 
IMQ following the 3 days after physical damage and the period of recovery will stimulate a 
higher proliferative potential in keratinocytes. To account for the differing roles of adenosine-
receptors in keratinocytes when treated with IMQ, cells were treated with either a low or high 
concentration of IMQ (1 g/mL or 10 g/mL of IMQ) prior and following to wounding (scratch) 
of confluent HaCaT monolayer cultures. Different concentrations of IMQ were applied to 
compare if keratinocytes required low or high concentrations of IMQ to be primed for faster 
rates of wound closure. These were compared to samples without the addition of a scratch 
or IMQ to assess the responses independent of each stimulus.  
Parental HaCaTs were cultured and plated at passage 5, and isolated 72 h post-scratch 
when the wounds for all conditions had healed. Although K1 and K10 dimerise to form 
intermediate filaments for keratinocytes (Moll et al., 2008), the expression of genes encoding 
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these proteins varies between the conditions (Fig. 2.4). An increased KRT1 expression was 
observed for all conditions relative to the NT_72h cells (Fig. 2.4A). The highest changes in 
KRT1 expression was seen in keratinocytes treated with 10 g/mL of IMQ (HIMQ_72h, 
HIMQ_Scr_72h) (Fig. 2.4A). When keratinocytes are treated only with 10 g/mL of IMQ 
(HIMQ_72h), KRT1 expression increases by a 5-fold change (Fig. 2.4B). The addition of 
scratches with 10 g/mL of IMQ further increased KRT1 expression to over a 9-fold change, 
showing a combined rise in expression (Fig. 2.4B). The 5-fold and 3-fold changes in gene 
expression of Scr_72h and HIMQ_72h as separate conditions does not add up to the 9-fold 
change when both stimuli are combined in HIMQ_Scr_72h (Fig. 2.4B). This result suggests 
a synergistic effect between the two stimuli to induce a stronger potent response to cause 
the higher KRT1 expression. LIMQ_72h, LIMQ_Scr_72h and Scr_72h cells exhibited the 
same increased KRT1 expression (Fig. 2.4B). Between conditions, KRT10 expression was 
at its highest in Scr_72h cells with the other conditions displaying similar KRT10 expression 
to the basal level marked by NT_72h (Fig. 2.4B). However, the fold change of KRT10 gene 
expression was overall not high and was closer to the basal level, with Scr_72h cells 
showing a minor increase (Fig. 2.4B).  
The basal cell marker, KRT14, responded positively to low concentrations of IMQ with the 
highest KRT14 expression seen in LIMQ_Scr_72h cells (Fig. 2.4A), amounting to over a 2-
fold increase relative to its NT control (Fig. 2.4B). KRT14 expression was also seen to 
increase when both stimuli were separated in LIMQ_72h and Scr_72h cells (Fig. 2.4A). 
MACF1 encodes for a cytoskeleton protein that plays an important role in cell migration 
during wound healing (Hu et al., 2017). The highest expression of MACF1 was observed in 
HIMQ_Scr_72h, LIMQ_Scr_72h and Scr_72h cells (Fig. 2.4A). The conditions showing high 
MACF1 expression were all exposed to a scratch which identifies this as a potent stimulus 
owing to the rise in gene expression of MACF1 and KRT1 between conditions (Fig. 2.4A). 
During wound healing, K16 works alongside K6 and K17 to promote cell growth, 
differentiation and migration (Pechter et al., 2012). KRT16 expression was at its highest with 
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HIMQ_72h cells, following this with the next highest KRT16 expression was HIMQ_Scr_72h 
(Fig. 2.4A), both exhibiting over a 2-fold change (Fig. 2.4B). LIMQ_72h cells showed an 
opposite effect with the scratch stimulus compared to the high IMQ concentrations, where 
the addition of a scratched in LIMQ_Scr_72h cells caused a higher KRT16 expression than 
LIMQ_72h cells (Fig. 2.4A). LIMQ_72h cells were at a 1.4-fold change and the addition of a 
scratched resulted to LIMQ_Scr_72h exhibiting a 1.9-fold change (Fig. 2.4B). KRT16 
expression in Scr_72h resembled a similar level of expression as LIMQ_72h with 
approximately a 1.4-1.6-fold change (Fig. 2.4A and 2.4B). The pattern of varying KRT16 
gene expression between conditions inversely reflects the gene expression pattern seen in 
KRT14, with KRT16 and KRT14 expression increasing in high and low IMQ concentrations, 
respectively (Fig. 2.4A). As observed with MACF1 and KRT1, the addition of scratches 
induces a potent stimulus in the incremental increases in expression (Fig. 2.4A). 
Keratinocytes treated with only scratches also showed an increase of KRT14 and KRT16 
expression compared to the NT cells (Fig. 2.4A). Comparatively to KRT1, KRT14 and 
KRT16 expression did not exhibit any conditions that reached a maximum fold change that 
was similar to the levels of fold change seen in KRT1 in the conditions tested here (Fig. 
2.4B).  
The TP63 gene is the master regulator of epithelial cells, which play a key role in epithelial 
development. TP63 encodes two primary isoforms, Np63 and TAp63, which show differing 
gene expressions during epithelial development. Np63 has predominately showed to be the 
primary isoform active in keratinocytes during development and differentiation (Romano et 
al., 2012; Yang et al., 2011) (Fig. 2.4A). Here, Np63 reflects these previous studies which 
was highly expressed relative to TAp63 expression. Relative to the other conditions, TAp63 
expression was at its highest in cells exposed to scratches (Fig. 2.4A), however, the overall 
fold change was close to NT cells (Fig. 2.4B). This shows TAp63 shows minimal expression 
when treated with high or low concentrations of IMQ and physical damage in this in vitro 
HaCaT inflammatory-wound healing assay. In contrast, HIMQ_72h, LIMQ_72h and 
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LIMQ_Scr_72h showed closed to double the fold expression change of Np63 in 
comparison to its NT control (Fig. 2.4B). Scr_72h cells only showed a minor increase in 
Np63 expression, but still resembled the basal level of expression (Fig. 2.4B).  
Interferon Lambda Receptor 1 (IFNLR1) is part of a heterodimeric receptor complex with 
IFNAR for the cytokines IL-29, IL-28A and IL-28B. IFNLR1 is typically expressed in epithelial 
cells and mediates antiviral functions with IL-29. IL-29 has been observed to be highly 
expressed in psoriasis (Lazear et al., 2015). IFNLR1 positively reacted to the pro-
inflammatory stimuli and scratches (Fig. 2.4A). LIMQ_72h and LIMQ_Scr_72h displayed 
double the fold expression change seen in NT cells (Fig. 2.4A and 2.4B). When the IMQ 
concentration was increased by 10-fold in HIMQ_72h and HIMQ_Scr_72h cells, it showed a 
more potent response with a 3-fold increase in IFNLR1 expression compared to the NT cells 
(Fig. 2.4B). When scratches were included with LIMQ_72h and HIMQ_72h cells, minimal 
changes in gene expression are seen with the addition of physical damage (Fig. 2.4A). 
However, cells treated solely with a scratch, Scr_72h, showed the highest change in 
expression over the IMQ conditions (Fig. 2.4A). Scr_72h cells showed over a 3-fold increase 
in IFNLR1 expression than cells treated with IMQ (Fig. 2.4B).  
The anti-microbial peptides, DEFB4 and S100A8 displayed little to no expression when 
exposed to IMQ or physical damage (Fig. 2.4B). IL-22R1 is the functional subunit of the IL-
22 receptor (IL-22R) which functions as a receptor for the pro-inflammatory cytokines IL-20, 
IL-22 and IL-24. These cytokines have been observed to promote wound healing in diabetic 
mice (Kolumam et al., 2017). Under inflammatory conditions such as psoriasis, IL-22 
induces keratinocytes to produce S100A8/A9 (Kerkhoff et al., 2012). LIMQ_72h and 




Figure 2.5. Inflammatory-wound healing assay of parental HaCaT cells treated with low or high 
IMQ concentrations (1 g/mL or 10 g/mL) paired with four scratches (n = 1). Plated HaCaT cells 
were cultured to passage 6 and RNA isolated at 72 h post-scratch when all wounds were closed. 
Genes encoding proteins involved in the innate immunity, inflammatory response in epithelial cells, 
keratinocyte proliferation and differentiation, migration and wound repair were tested. (A) Heatmap of 
fold gene expression (CT) values are scaled based on the Euclidean distance normalisation 
method. CT values are scaled to show relative gene expression changes between conditions in 
each gene. (B) Heatmap of fold gene expression (CT) values scaled to show relative gene 






When the IMQ concentration was increased to 10 g/mL, the gene expression of this 
receptor increased to levels comparable to that seen in LIMQ_72h and LIMQ_Scr_72h cells 
(Fig. 2.4A). However, in HIMQ_Scr_72h cells, IL22RA1 expression dropped to the basal 
level of gene expression seen in NT cells (Fig. 2.4A). Although, collectively, IL22RA1 
expression between conditions reflected a similar level as NT cells (Fig. 2.4B), depicting very 
little change in this in vitro inflammatory-wound healing assay. 
The in vitro HaCaT inflammatory-wound healing assay was repeated with another sample of 
HaCaT parental cells that were cultured and plated at passage 6, and isolated at day 3 post-
scratch. As previously seen in parental cells at passage 5 (Fig. 2.4), KRT1 exhibited an 
increase in expression (Fig. 2.5A). As previously observed at passage 5 (Fig. 2.5), 
HIMQ_Scr_72h cells showed the highest KRT1 expression (Fig. 2.5A). When the IMQ 
concentration was decreased by 10-fold with scratches still present (LIMQ_Scr_72h), KRT1 
was still highly expressed (Fig. 2.5A) with over a 4-fold change (Fig. 2.5B). These results 
differ from HaCaTs at passage 5 that showed the condition with the second highest KRT1 
expression was HIMQ_72h cells and LIMQ_Scr_72h cells following afterwards as the next 
condition with high KRT1 expression (Fig. 2.4A). HIMQ_72 and LIMQ_72 cells showed 
similar levels of KRT1 expression with fold changes of 3 Fig. 2.5B). Keratinocytes exposed 
to physical damage for all the genes tested showed minimal or low levels of expression in 
HaCaTs at passage 6 (Fig. 2.5A). The other genes, including IL-8, S100A8, MACF1, 
GRHL3, DEFB4 and IL1RL1, showed expression levels below the basal level (Fig. 2.5B). 
The change in passages between experiments shows variations between gene expression. 
Despite the effect of cell passages on gene expression, the marker for terminal 
differentiation, KRT1, was consistently found to be highly expressed in keratinocytes 
undergoing wound healing. This suggests a potential role for KRT1 in this in vitro 





2.3.2 Differences in gene expression over 3-days of wound healing 
During re-epithelisation from day 1 to 8 post-wounding in primary cultures of keratinocytes, 
keratins are expressed at different levels throughout the repair process (Patel et al., 2006). 
Based on this, we hypothesised that the expression of antimicrobial peptides, keratins and 
other proteins important for keratinocyte differentiation and migration will not remain static 
over the 3 days of wound healing. Furthermore, the little change in gene expression 
observed in the previous inflammatory-wound healing experiments (Fig. 2.4 and 2.5) could 
be attributed to genes showing their maximal scratch-induce increase in gene expression 
has passed. Due to this, cells cultured up to passage 3 were isolated at days 1 (24 h), 2 (48 
h) and 3 (72 h) post-wounding. Cells were only pre-treated with 10 g/mL of IMQ prior and 
after the scratch. In parental cells at passages 5 and 6 in the previous inflammatory-wound 
healing assays, 10 g/mL of IMQ showed a more potent response than 1 g/mL of IMQ in 
KRT1 expression (Fig. 2.4 and 2.5). Additionally, most of the other genes tested in HaCaTs 
at passage 5 reacted positively with increased levels of expression with 10 g/mL of IMQ 
(Fig. 2.4). Shown in Fig. 2.4 and 2.5, the addition of scratches displayed a potent response 
in the HaCaTs in the absence or presence of a low and high IMQ concentration. Due to 
these observations, the number of scratches was doubled from 4 to 8 scratches to maximise 
the number of keratinocytes responding to wounding. To quantify the change in gene 
expression from day 1 to day 3 post-scratch, genes were normalised to day 1 NT cells to 





















Figure 2.6. Inflammatory-wound healing assay of parental HaCaT cells treated with a high IMQ 
concentrations (10 g/mL) paired with eight scratches (n = 1). HaCaT cells were passaged 3 
times and then used for the wound healing assay, with RNA isolated at days 1 (24 h), 2 (48 h) and 3 
(72 h) post-scratch. Genes encoding proteins involved in the innate immune response in epithelial 
cells, keratinocyte proliferation and differentiation, migration and wound repair were tested. (A) 
Heatmap of fold gene expression (CT) values are scaled based on the Euclidean distance 
normalisation method. CT values are scaled to show relative gene expression changes between 
conditions for each gene. (B) Heatmap of fold gene expression (CT) values scaled to show relative 
gene expression changes between all conditions and genes. (C) Bar chart showing KRT1 gene 
expression from days 1 (24 h), 2 (48 h) and 3 (72 h) post-scratch, grouped for each condition. 
Abbreviations: Scr = scratch; NT = non-treated.  
KRT1 expression of parental cells in passage 3 in the inflammatory-wound healing assay 
(Fig. 2.6) agrees with experiments shown in Figs. 2.4 and 2.5. Although, the KRT1 
expression does not reach the same level of fold change seen in these previous 
experiments, which suggests passage-induced variations in gene expression between the 
inflammatory-wound healing experiments. Between 24 h and 72 h post-scratch showed a 
steady increase of KRT1 expression with KRT1 reaching its peak expression by day 3 (Fig. 
2.6C). The highest expression was seen in NT_72 cells (Fig. 2.6A), reaching a 6-fold change 
in expression with an initial basal level of expression during 24-48 h post-scratch (Fig. 2.6B). 
Similar to NT_72h cells, Scr_72h cells also display a 6-fold change in KRT1 expression (Fig. 
2.6B). Between 24-48 h post scratch, KRT1 expression was higher in scratched cells than 
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NT cells (Fig. 2.6C). However, NT_72h cells exceeded Scr_72h cells by a small difference of 
0.5 (Fig. 2.6C). The effect of IMQ in KRT1 does not induce the same potent response seen 
in the parental cells at passages 5 and 6 of the previous inflammatory-wound healing 
experiments (Fig. 2.4 and 2.5). Instead the addition of double the amount of scratches 
induces the highest KRT1 expression (Fig. 5A). Collectively, these results show the effect of 
passage-induced variations in gene expression between experiments (Figs. 2.4-2.6).  
Reflecting the previous inflammatory-wound healing experiments (Fig. 2.4 and 2.5), the 
antimicrobial peptides, S100A8 and DEFB4, across most conditions showed minimal 
expression in this inflammatory-wound healing assay (Fig. 2.6A). All the conditions showed a 
decrease in DEFB4 expression relative to the NT cells (Fig. 2.6B). Scr_48h cells showed an 
elevated expression of S100A8 past the basal level (Fig. 2.6A), with almost a 2-fold change 
in expression (Fig. 2.6B). Collectively, S100A8 expression in most of the conditions from 24-
72 h displayed a basal level of expression, which agrees with the previous experiments (Fig. 
2.4 and 2.5). This shows the effect of passage-induced variation in gene expression does 
not occur for all genes.  
Interleukin 1 receptor like 1 (IL1RL1, also referred to as ST2) can be found in two spliced 
variant forms – its soluble form (sST2) and its active membrane-bound form (ST2). The 
membrane-bound form ST2 will bind to its ligand IL-33 released by keratinocytes, stromal 
and endothelial cells to activate the MyD88, NF-B signalling pathway to increase the 
function of immune cells during injury and mechanical stress (Griesenauer and Paczesny, 
2017). IL1RL1 expression (Fig. 2.6A) mirrors the previous inflammatory-wound healing 
assay (Fig. 2.4 and 2.5), where cytokines and their receptors remain inactive when HaCaTs 
are treated with IMQ or wounded. NFKBIZ contains two promoter regions which undergo 
alternative splicing to generate two major isoforms – the long isoform (IBL) and a short, N-
terminal truncated isoform (IBS). IB has been observed to be overexpressed in psoriatic 
lesions to induce pro-inflammatory signalling in keratinocytes, with the long isoform IBL 
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found to be predominantly translated than IBS (Müller et al., 2018). The keratinocytes in 
the inflammatory-wound healing assay shows the shorter isoform (labelled as NFKBIZ_S) 
has a higher expression than the longer isoform (labelled as NFKBIZ_L) (Fig. 2.6A). The 
highest expression of NFKBIZ_S was seen in HIMQ_72h cells (Fig. 2.6A), amounting to 
almost a 4-fold change in gene expression, and Scr_72h cells reached close to a 3-fold 
change (Fig. 2.6B). Despite the potent response these stimuli induced separately on 
HaCaTs, the combination of these stimuli did not result to a combined increased of 
NFKBIZ_S (Fig. 2.6A). Instead, a basal level of NFKBIZ_S was observed in HIMQ_Scr_72h 
cells (Fig. 2.6B). The other conditions showed a basal level or lower level of NFKBIZ_S 
expression (Fig. 2.6B). A single condition of NFKBIZ_L showed a 1.5-fold increase in 
expression in NT_48h cells (Fig. 2.6B). The other conditions showed similar levels of 
NFKBIZ_L expression in NT_24h cells or lower than the basal level (Fig. 2.6B), showing 
NFKBIZ_L expression is not induced pro-inflammatory and wound healing conditions in this 
in vitro inflammatory-wound healing assay.  
MACF1 expression between conditions and between 24-72 h post-scratch does not show 
large differences. HIMQ_24h and HIMQ_48h cells shows a small increase in MACF1 
expression but drops past the basal level in HIMQ_72h cells (Fig. 2.6A). The other 
conditions resemble similar levels of MACF1 expression, below the basal level (Fig. 2.6B). 
Similarly, KRT16 expression did not increase past the basal level of expression, instead, 
exhibited a similar or lower level of KRT16 expression (Fig. 2.6A). These results differ from 
the previous inflammatory-wound healing experiment (Fig. 2.4) which showed over a 2-fold 
increase in KRT16 expression in HIMQ_72h cells (Fig. 2.4B). The inflammatory-wound 
healing assay in parental cells at passage 6 showed a low level of expression among most 
genes (Fig. 2.5B, S100A8, DEFB4, GRHL3, IL1RL1, IL-8, MACF1). This indicates that 
higher passages in culture does not always equate to higher changes in gene expression. 
Although the proteins involved in keratinocyte migration and wound healing, K16 and Macf1, 
appears to not be frequently transcribed during 24-72 h of wound healing in cells exposed to 
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physical damage and inflammatory conditions. However, other proteins involved in 
keratinocyte migration and wound healing may still be active in this in vitro inflammatory-
wound healing assay, such as GRHL3. When keratinocytes have been physically damaged, 
GRHL3 expression remains below the basal level at 24 h post-scratch (Fig. 2.6A) but 
increases between 48-72 h post-scratch with close to a two-fold change (Fig. 2.6B).  
The gene expression of S100A8, DEFB4, GRHL3, NFKBIZ short and long isoforms, KRT1 
and KRT16 were assessed in another inflammatory-wound healing experiment. This 
experiment included parental cells at passage 2 and isolated at days 1 (24 h), 2 (48 h) and 3 
(72 h) post-scratch. Consistent with the previous experiments (Figs 2.4-2.6), KRT1 showed 
the highest expression out of the entire gene set (Fig. 2.7B). Like the HaCaTs at passage 3 
(Fig. 2.6), each condition, excluding cells treated with only 10 g/mL of IMQ, displayed a 
progressive increase of KRT1 expression (Fig. 2.7C). Additionally, as seen with HaCaTs at 
passage 3 (Fig. 2.6B), the NT_72h cells showed the highest KRT1 gene expression 
amounting to over a 40-fold change in expression compared to NT_24h cells (Fig. 2.7B). 
The second highest KRT1 expression was observed in Scr_72h cells which exhibited a 24-






















Figure 2.7. Inflammatory-wound healing assay of parental HaCaT cells treated with a high IMQ 
concentrations (10 g/mL) paired with eight scratches (n = 1). Plated HaCaT cells were cultured 
to passage 2 and isolated at days 1, 2 and 3 post-scratch. Genes encoding proteins involved in the 
innate immunity, inflammatory response in epithelial cells, keratinocyte proliferation and 
differentiation, migration and wound repair were tested. (A) Heatmap of fold gene expression (CT) 
values are scaled based on the Euclidean distance normalisation method. CT values are scaled to 
show relative gene expression changes between conditions in each gene. (B) Heatmap of fold gene 
expression (CT) values scaled to show relative gene expression changes between all conditions 
and genes. (C) Bar chart of KRT1 gene expression from days 1, 2 and 3 post-scratch, grouped for 
each condition. Abbreviations: Scr = scratch; NT = non-treated.  
The changes in KRT1 expression during 24-72 h post-scratch showed keratinocytes treated 
with 10 g/mL of IMQ had the lowest KRT1 expression relative to the NT and scratched cells 
(Fig. 2.7B). Keratinocytes treated with only 10 g/mL of IMQ did not show a progressive 
increase of KRT1 expression, instead it started with close to a 2.5-fold increase in 
HIMQ_24h cells (Fig. 2.7C). In HIMQ_48h cells, KRT1 expression dropped close to a 2-fold 
increase relative to the NT_24h cells, then KRT1 expression rose to a 3-fold change in 
expression in HIMQ_72h (Fig. 2.7C). Finally, HIMQ_48h and HIMQ_72h displayed a 2-fold 
and close to a 7-fold increase of KRT1 expression (Fig. 2.7C). HIMQ_24h cells showed a 




The expression between NFKBIZ isoforms reflects the results observed in HaCaTs at 
passage 3 with NFKBIZ_S found to be predominately expressed (Fig. 2.6A). However, 
NFKBIZ_L expression in NT_72h and Scr_72h cells displayed over a 2-fold increase (Fig. 
2.7A and 2.7B). Scr_48h cells also showed a NFKBIZ_L expression above the basal level 
outlined by NT_24h cells (Fig. 2.7A and 2.7B). The remaining conditions showed NFKBIZ_L 
expression dropped below the basal level of expression (Fig. 2.7B). Most conditions, 
including Scr_24h, HIMQ_24h, Scr_48h and all 72 h post-scratch cells, showed over a 2-fold 
increase of NFKBIZ_S expression (Fig. 2.7B). HIMQ_Scr_72h amounted to over a 5-fold 
change in NFKBIZ_S expression (Fig. 2.7B). In Scr_48h cells, S100A8 showed over a 2-fold 
change in gene expression relative to NT_24h cells (Fig. 2.7B). However, this expression 
level of S100A8 dropped during 72 h post-scratch, although Scr_72h cells was still higher 
than NT_24h cells (Fig. 2.7A). DEFB4 and GRHL3 expression remained at the same level 
as NT_24h cells or fell below the basal level (Fig. 2.7A).  
Overall, the collective results of these inflammatory-wound healing assays showed a more 
potent response is seen in keratinocytes exposed to physical damage than the IMQ 
treatments. Furthermore, the results of keratinocytes undergoing wound healing showed 
KRT1 frequently exhibiting the greatest change in gene expression. Furthermore, KRT1 
expression during wound healing agrees with the hypothesis that the expression of keratins 
dynamically change during re-epithelisation. In vivo keratinocytes undergoing re-
epithelisation during wound healing will predominantly express other keratins, such as 
KRT16 (Patel et al., 2006). However, the in vitro wound healing assay in this study exhibited 
KRT1 to be consistently highly expressed over the hyperproliferative marker KRT16, basal 






2.3.3 Variation in KRT1 gene expression between HaCaT passages 
in culture 
Table 2.1. Collective KRT1 CT (Ct KRT1 – Ct NFYB) values of inflammatory-wound healing 
assays of parental HaCaT cells from qPCR experiments detailed in Figs. 3-6 (n = 4), with 
HaCaT passages 2, 3, 5 and 6. HaCaT cells cultured to passages 5 and 6 were isolated at day 3 
post-scratch. HaCaT cells cultured to passages 3 and 2 were isolated at days 1-3 post-scratch.  
4 scratches 
 Passage 5  Passage 6 
Day 3 - NT 7.44 5.92 
Day 3 - Scr 5.61* 5.81* 
Day 3 - 10 g/mL IMQ 5.01 7.69 
Day 3 - 10 g/mL IMQ + Scr 4.19 8.60 
Day 3 - 1 g/mL IMQ 6.27 7.57 
Day 3 - 1 g/mL IMQ + Scr 5.76 8.07 
8 scratches 
 Passage 2 Passage 3 
Day 1 – NT 8.07 5.90 
Day 1 – Scr 7.81* 7.81* 
Day 1 – 10 g/mL IMQ 6.79 8.23 
Day 1 – 10 g/mL IMQ + Scr 7.54 8.59 
Day 2 – NT 3.79 5.43 
Day 2 – Scr 4.88* 4.25* 
Day 2 – 10 g/mL IMQ 7.14* 6.91* 
Day 2 – 10 g/mL IMQ + Scr 6.99* 6.87* 
Day 3 – NT 2.69* 3.20* 
Day 3 – Scr 3.49* 3.31* 
Day 3 – 10 g/mL  6.44 4.50 
Day 3 – 10 g/mL + Scr 5.29* 5.70* 
*KRT1 CT values showing <1 CT difference to its alternate passage.  
The in vitro inflammatory-wound healing assay outlined KRT1 to show a consistent increase 
in expression to the inflammatory and wounding stimuli in independent experiments. 
However, the fold change in expression between HaCaT passages was not consistent with 
one another, exhibiting variations in KRT1 expression. In Table 2.1, HaCaTs at passages 5 
and 6 showed a consistent increase of CT from passage 5 to 6. Although, in comparison to 
HaCaTs at passages 2 and 3, a higher KRT1 expression was seen in lower passages. Table 
2.1 shows less variation in KRT1 CT values between HaCaT passages at 2 and 3. 
However, an increase in KRT1 CT value was observed from passage 2 to 3 in several 
conditions, such as HIMQ_24h and HIMQ_Scr_24h cells, NT_48h, NT_72h and 
HIMQ_Scr_72h cells. The remaining conditions showed higher KRT1 CT values for 
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passage 2. Collectively, these results show inherent variations in gene expression of the 
HaCaT population, and the importance of applying passage controls between experiments. 
Generally, the increasing number of times a cell population is passaged, the health of the 
cell continues to deteriorate. Due to this, many researchers will not utilise higher passaged 
cells and restrict experiments conducted with lower passages (Kwist et al., 2016). Based on 
the common practice of utilising lower passaged cells, passages 2 or 3 of HaCaTs can be 
used for the next wound healing experiments. HaCaTs at passage 3 will be selected over 
passage 2 as it singled out KRT1 as the major gene showing a potent response during 
wound healing. In contrast, the parental cells of passage 2 showed additional changes in the 
expression of other genes, along with KRT1.  
2.3.4 Clonal selection shows variation in rate of wound closure 
As shown in the gene expression analyses of the inflammatory-wound healing assay (Fig. 
2.4 and 2.5), KRT1 is positively reacting to physical damage and time in culture. Following 
on from this, we next tested the phenotypic variations of the HaCaT parental cell line. This 
was accomplished by isolating single cells from the original multi-clonal cell line (“parental” 
cell line) and grown as separate clonal populations. Six clonal cell lines were plated at 
passage 3 in culture and subjected to a scratch with or without IMQ in 10% FBS. This 
inflammatory-wound healing assay was designed to select for clones exhibiting differences 




















Figure 2.8. Clonal selection of clones 1-6 in DMEM media supplemented with 1% FBS and 
given four scratches. Images of the responses of clonal cell lines were taken 24 h post-wounding 
with scratch sizes quantified and represented as percentages. (A) Bar chart of the average scratch 
sizes of clones 1-6 (n = 2). All error bars represent ±SD. Images of scratch size measurements for 
each clone are shown in (B) – (G). Yellow outline: border of scratch. White outline: areas of missing 
cells. Confluency of cell images are given at the bottom left corner with images showing a 90-100% 
confluency is labelled as ‘100%’. Images with white outlines are labelled as ‘<90%’ confluent. (B) 




Each clonal cell line was scratched, and the results expressed relative to cells grown in 1% 
FBS to slow down the regrowth. Scratches observed in each clonal cell line were imaged 24 
h post-scratch, with images taken at the top, middle and bottom sections of the scratches. 
For each clone and condition, two images were used in ImageJ to borders of the scratch, 
excluding areas across wells that were missing cells due to a lower confluence. The areas of 
the outlined scratches were measured using ImageJ, and the percentage of these areas 
relative to the total size of each image was calculated. The results of each measurement 
with their accompanying images are shown in Fig. 2.8. From the results, three primary clonal 
types were selected which include a slow-, moderate- and fast-healing clone. We 
hypothesise the phenotypic variations observed in these primary clonal types will reflect 
differential KRT1 expression between cell lines 
When cells were treated with 1% FBS, clones 3 and 4 were unaffected by the low FBS 
concentration and repaired the scratch faster than the other clones (Fig. 2.8D and 8E). 
Clone 4 was able to re-epithelialize at a faster rate with a scratch size of 7.04 ± 0.42% (Fig. 
2.8A). The scratch in clone 3 amounted to 12.05 ± 0.61% which suggests clone 4 may heal 
faster than clone 3. However, the difference in scratch size between clone 3 and 4 could be 
attributed to the difference in cell density, seen from the missing cells adjacent the scratch 
(Fig. 2.8D, image on the left). Clones 1, 2 and 6 appeared to be healing slower with larger 
sized scratches still present (Fig. 2.8B, 8C, and 8G) with percentages of 20.46 ± 1.37%, 
19.62 ± 5.96% and 20.86 ± 1.37%, respectively (Fig. 2.8A). Although, the slower healing 
rates of wound closure seen in clones 1, 2 and 6 may be attributed the lower confluency 
seen in these clones compared to clones 3 and 4 (Fig. 2.8B-E, 8G). Clones 1, 2 and 6 show 
areas adjacent the scratches that aren’t covered by cells which suggests the cell density can 
affect the rate of wound closure. However, this is not observed in clone 5 which has the 
same level of confluency as clones 3 and 4 but still has a scratch size similar to clones 1, 2 
and 6. Furthermore, clone 5’s scratch size equates to 16.52 ± 0.48% which resembles the 




















Figure 2.9. Clonal selection of clones 1-6 in DMEM media supplemented with 10% FBS and 
given four scratches. Images of the responses of clonal cell lines were taken 24 h post-wounding 
with scratch sizes quantified and represented as percentages. (A) Bar chart of the average scratch 
sizes of clones 1-6 (n = 2). All error bars represent ±SD. Images of scratch size measurements for 
each clone are shown in (B) – (G). Yellow outline: border of scratch. White outline: areas of missing 
cells. Confluency of cell images are given at the bottom left corner with images showing a 90-100% 
confluency is labelled as ‘100%’. Images with white outlines are labelled as ‘<90%’ confluent. (B) 










This evidence shows regardless of cell density, clone 5 is inherently heals slower than 
clones 3 and 4. 
Next, when clones were grown in 10% FBS, clone 4 healed faster than clone 3 with less 
than 1% left of the scratch (Fig. 2.9A and 2.9E). The change to 10% FBS stimulated clones 
2, 5 and 6 to heal faster with scratch sizes of 14.29 ± 6.73%, 12.29 ± 0.11% and 11.99 ± 
1.53%, respectively (Fig. 2.9A). Clone 6 shows less than 90% confluency than clone 5 which 
is 100% confluent (Fig. 2.9F and 9G), however, the difference in cell density isn’t affecting 
the rate of wound closure as seen with their similar scratch sizes (Fig. 2.9A). Clone 2 is also 
not completely confluent like clone 5, with small patches of missing space not caused by the 
scratch (Fig. 2.9C). Clone 2 may be affected by cell density and the small decrease in 
scratch size could be attributed to the minor difference in cell density (Fig. 2.9A and 2.9C). In 
comparison to clones 2, 5 and 6, clone 3 exhibits a slower rate of wound closure with a 
higher scratch size of 16.04 ± 0.39% which is close to the size of clone 2 (Fig. 2.9C and 
2.9D). As seen in clone 2, clone 3 is not as confluent as clone 4 and 5 with missing patches 
of cells (Fig. 2.9D, image on the left). The rate of wound closure in clones 2 and 3 may be 
affected by cell density. Consistent with the results from 1% FBS (Fig. 2.9A and 2.9B), clone 
1 was the slowest clone to heal from the scratch with a scratch size of 26.83 ± 1.95% which 
was higher than its 1% FBS scratch size. Conversely, clones 2’s and 6’s wound closure rate 
improved with a higher FBS concentration which started with 19.62 ± 5.96% and 20.86 ± 
1.37% (Fig. 2.8A) and decreased to 14.29 ± 6.73% and 11.99 ± 1.53%, respectively (Fig. 
2.9A). In contrast to clone 3, clones 2, 4 and 6 reacted positively to the higher FBS 

























Figure 2.10. Clonal selection of clones 1-6 in DMEM media supplemented with 10% FBS and 10 
g/mL of IMQ with four scratches. Images of the responses of clonal cell lines were taken 24 h 
post-wounding with scratch sizes quantified and represented as percentages. (A) Bar chart of the 
average scratch sizes of clones 1-6 (n = 2). All error bars represent ±SD. Images of scratch size 
measurements for each clone are shown in (B) – (G). Yellow outline: border of scratch. White outline: 
areas of missing cells. Confluency of cell images are given at the bottom left corner with images 
showing a 90-100% confluency is labelled as ‘100%’. Images with white outlines are labelled as 




To test the clones’ response to an inflammatory stimulus during wound healing, 10 g/mL of 
IMQ was added with 10% FBS. Clones 2 and 5 reacted positively to IMQ with an initial 
scratch size of 14.29 ± 6.73% and 12.29 ± 0.11% in 10% FBS (Table 2.2) and they 
decreased to sizes of 5.75 ± 0.32% and 9.74 ± 2.65% (Table 2.2) with the treatment of IMQ, 
respectively. The addition of IMQ affected clone 4’s rate of wound closure where the 
absence of IMQ in 10% FBS produced an initial scratch size of 0.97 ± 0.22% (Table 2.2), but 
this size increased to 10.45 ± 2.75% when clone 4 was treated with IMQ for 24 h (Table 2.2). 
Although IMQ hindered the rate of wound closure in clone 4, when comparing the other 
clones’ scratches collectively with sizes between 11-27% in 1% and 10% FBS (Table 2.2), 
clone 4’s scratch size of 10.45% treated with IMQ is lower (Table 2.2). This supports clone 4 
is inherently a faster healing clone. Due to this, clone 4 was chosen as the fast-healing 
clone.  
The IMQ treatment did not greatly affect clone 3 which showed its wound size to be 16.04 ± 
0.39% in 10% FBS (Table 2.2) and when paired with IMQ, the size increased to 16.57 ± 
2.57% (Table 2.2). However, this small difference in scratch sizes could be attributed to a 
difference in cell density, with clone 3 cells treated with IMQ was completely confluent (Fig. 
2.10D) than cells treated with only 10% FBS which showed one of the measurements with a 
confluency of <90% (Fig. 2.9D). Although, the lower cell density in clone 3 did not appear to 
affect its rate of wound closure when grown in 1% FBS (Fig. 2.8A and 8D), potentially 
indicating the importance of FBS concentration in clone 3 cells. Clone 6 cells treated with 
IMQ reflected the same changes seen in clone 4 cells (Table 2.2), which displays an 
increased delay in wound closure as seen with the large scratches still present 24 h post-
wounding (Fig. 2.10E and 2.10G) compared to its 10% FBS-treated equivalent (Fig. 2.9E 
and 2.9G). Additionally, the wound size of clone 6 increased from 11.99 ± 1.53% in 10% 
FBS (Table 2.2) to 18.91 ± 7.23% with the addition of IMQ as a treatment (Table 2.2). The 
wound size of clone 6 cells treated with IMQ resembles the scratch from 1% FBS cells which 
had a size of 20.86 ± 1.37% (Table 2.2). Finally, the treatment of IMQ in clone 1 showed the 
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same hindrance in re-growth seen in clones 3, 4 and 6 (Table 2.2). IMQ-treated clone 1 cells 
showed a 2.51% increase in scratch size in comparison to the cells grown in 10% FBS 
(Table 2.2). In each condition, clone 1 has consistently proven to be the slowest to close its 
wound (Fig. 2.8-10). Due to this, clone 1 was chosen as the slow-healing clone. Between the 
various growth conditions and treatment of IMQ, the rate of wound closure in clone 2 
appeared to be constantly changing. Clone 2 showed to be a slow-, moderate- and fast-
healing clone when treated with 1% FBS, 10% FBS, and 10% FBS with IMQ, respectively. 
Due to this volatile change in its rate of wound closure, clone 2 was not considered as 
moderate-healing clone. Although clone 6 exhibited signs of a slow-healing clone in 1% FBS 
(Table 2.2), it showed potential signs of being a slow- or moderate-healing clone when it was 
grown in presence or absence of IMQ and 10% FBS, respectively (Table 2.2). Due to these 
differing observations, clone 1 was selected over clone 6 as the slow-healing clone. Like 
clones 2 and 6, clone 5 showed varying patterns of wound closure between conditions and 
was not selected for the moderate-healing clone. Although, clone 3 showed signs of 
potentially being a fast-healing clone when grown in 1% FBS (Table 2.2), its rate of wound 
closure in 10% FBS with or without IMQ showed a moderate rate of wound healing. Clone 3 
was often found to be between the slow-healing clone and fast-healing clone in 10% FBS 
media. These observations support clone 3’s candidature as the moderate-healing clone and 
was selected for this clonal type. 
Table 2.2. Summary table of average scratch sizes of clones 1-6 taken from two 
measurements. Scratch sizes are given as a percentage and taken from the clonal selection assays 
detailed in Figs. 7-9, with the following conditions 1% FBS, 10% FBS, or 10% FBS and 10 g/mL of 
IMQ.  
 
 1% FBS 10% FBS 10% FBS and 
10 g/mL of IMQ. 
Clone 1 20.46 ± 5.65% 26.83 ± 1.95% 29.34 ± 0.43% 
Clone 2 19.62 ± 5.96% 14.29 ± 6.73% 5.75 ± 0.32% 
Clone 3 12.05 ± 0.61% 16.04 ± 0.39% 16.57 ± 2.57% 
Clone 4 7.04 ± 0.42% 0.97 ± 0.22% 10.45 ± 2.75% 
Clone 5 16.52 ± 0.48% 12.29 ± 0.11% 9.74 ± 2.65% 





2.3.5 Differential gene expression between parental and clonal cell 
lines during day 1 and 3 
As shown from the inflammatory-wound healing assay (Figs. 2.4 and 2.5), the scratch 
stimulus induced a potent response in KRT1. Additionally, the wound healing experiments of 
HaCaT cells should not use cells of more than 3 passages. Due to these observations, the 
parental and selected clonal cell lines were run through the wound healing assay containing 
8 scratches. Additionally, the modified inflammatory-wound healing experiments that 
analysed gene expression during the 3 days of recovering after wounding provided evidence 
of dynamic changes in KRT1 expression. This dynamic change showed an incremental 
increase of KRT1 expression over the 3 days of wound healing (Fig. 2.6C and Fig. 2.7C). 
The greatest difference in expression was seen between 24h and 72 h post-wounding, due 
to this, cells were plated and isolated at these time points. Additionally, to control the 
variation inherent to different HaCaT cell populations, each cell line was cultured up to 
passage 3. Differences between the days were quantified by using day 1 NT cells as a 
control to normalise day 1 scratched cells and day 3 NT and scratched cells. This 
normalisation method was applied to show the progressive change in expression, from day 1 
to day 3 in NT and scratched cells.  
All cell lines, excluding clone 1, showed evidence of elevated KRT1 expression during day 3. 
Compared to clone 4 and the parental, clone 3 exhibited the lowest increase in KRT1 
expression with an increase by a factor of 1.5-2 in day 3 cells (Fig. 2.11B). The parental cells 
showed a 6-fold increase in NT_72h cells (Fig. 2.11B). Scr_72h cells of the parental cell line 
showed double the rise in KRT1 in comparison to the NT_72h cells. Like the parental cells, 
clone 4 showed a high increase in its NT_72h cells by a factor of 20, and its KRT1 
expression rose higher with the addition of physical damage (Fig. 2.11B). Both NT_72h and 
Scr_72h cells exhibited a higher KRT1 expression than the parental cell line (Fig. 2.11C). 
Previously seen in the inflammatory-wound healing assays (Fig. 2.6C and 2.7C), KRT1 
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again shows a dynamic change in expression with an increase, either small or large, 
between 24 h to 72 h in clone 3, clone 4 and parental cells (Fig. 2.11C). Conversely, clone 1 
displayed a minor drop in KRT1 expression, however, remaining relatively close to the basal 
level.  
KRT16 was previously not seen to be active in parental cells, in contrast, there are 
differential KRT16 expression between clones. The highest KRT16 expression was 
observed in clone 1’s day 3 cells (Fig. 2.11A). Following this, Scr_72h cells in clone 3 and 4 
exhibited a 2- and 3-fold (Fig. 2.11B). GRHL3 was primarily expressed in all conditions for 
clone 3 and Scr_72h cells in the parental cell line (Fig. 2.11A). The highest expression of 
clone 3 cells was observed in day 3 NT cells equating to a 2.5-fold increase (Fig. 2.11B). 
This increase remained relatively stable with day 3 cells still exhibiting this elevated GRHL3 
expression. The NT_72h cells of clone 3 also increased its GRHL3 expression by two-fold. 
In the parental HaCaTs, GRHL3 expression started below the basal level in NT_24h cells 
and rapidly accumulated to over a 3-fold change in NT_72h (Fig. 2.11B). Between NT cells, 
GRHL3 expression started at the basal level and decreased by day 3 (Fig. 2.11A). Clone 1 




















Figure 2.11. Wound healing assay of parental and clonal HaCaT cell lines. Eight scratches 
were given to the parental cell line and clones 1, 3 and 4. Each cell line was plated at passage 3 
in culture and isolated at day 1 (24 h) and 3 (72 h) post-wounding. Genes encoding proteins involved 
in the innate immunity, keratinocyte proliferation and differentiation, migration and wound repair were 
tested. (A) Heatmap of fold gene expression (CT) values are scaled based on the Euclidean 
distance normalisation method. CT values are scaled to show relative gene expression changes 
between conditions in each gene. (B) Heatmap of fold gene expression (CT) values scaled to show 
relative gene expression changes between all conditions and genes. (C) Bar chart of KRT1 gene 





Mirroring the previous gene expression experiments, DEFB4 is not expressed during wound 
healing, with most conditions in this HaCaT monolayer model showing an expression close 
to the basal level marked by NT_24h or lower (Fig. 2.11A). However, expression of 
antimicrobial peptides in this wound healing assay is not completely absent. S100A8 
expression was previously observed to increase above NT_24h cells in Scr_48h cells of the 
parental cell line (Fig. 2.6A). The parental cell line showed little activity of S100A8 
expression in this gene expression analysis, however, the clonal cell lines increased their 
expression in NT_72h and Scr_72h cells (Fig. 2.11A). Clone 1 and 4 showed over an eight-
fold increase in S100A8 expression in NT_72h cells (Fig. 2.11B). Scr_72h cells of clone 4 
showed a similar rise with over a seven-fold change in expression (Fig. 2.11B). This 
condition in clone 1 cells also displayed an increased S100A8 expression by a factor of five 
relative to the NT_24h cells (Fig. 2.11B). Clone 3 showed a similar pattern of S100A8 
expression on day 3 as clones 1 and 4, with the highest expression seen in NT cells and 
closely following are cells that have recovered from a scratch.  
The clonal cell lines showed a lower NFKBIZ_L expression in all the conditions with the 
NT_72h and Scr_72h cells of the parental cell line compared to the clones (Fig. 2.11A). 
However, the NT_72h and Scr_72h cells of the parental cell line showed a fold change of 
approximately to a 1.5-fold change which is relatively lower than its shorter isoform, 
NFKBIZ_S (Fig. 2.11B). The highest expression of NFKBIZ_S is seen in Scr_72h cells of the 
parental cell line (Fig. 2.11A). During day 1, NFKBIZ_S expression in the wounded parental 
cells was initially below the basal level but began to increase as cells continued to re-
epithelialize and amount to a 5-fold change by day 3 (Fig. 2.11B). Similarly, NT parental cells 
increased their expression of NFKBIZ_S which increased to a 3-fold change (Fig. 2.11B). 
This progressive change from day 1 to day 3 was also observed in clone 4 cells which had a 
basal level of expression NT_24h and Scr_24h cells (Fig. 2.11A). As clone 4 cells underwent 
wound closure, NFKBIZ_S expression increased by a fold change of 1.5 (Fig. 2.11B). The 
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NT cells in clone 4 doubled their expression of NFKBIZ_S by day 3 which shows dynamic 
gene expression changes is also present in undamaged cells (Fig. 2.11B). Clone 1 did not 
show a progressive change in NFKBIZ_S from day 1 to day 3 and remained the same (Fig. 
2.11A). However, in comparison to the basal level of expression marked by NT_24h cells, it 
was able to maintain its 3-fold change in expression for 3 days post-wounding (Fig. 2.11B). 
Clone 3 displayed minimal changes in NFKBIZ_S expression, which overall remained close 
to the basal level of expression (Fig. 2.11A). 
 
2.4 Conclusion 
The initial HaCaT cell model with the inflammatory stimulus, IMQ, showed evidence of a 
synergistic effect with physical damage to further increase KRT1 expression oppose to when 
keratinocytes were treated with each stimulus separately (Fig. 2.4-2.7). However, 
comparisons of IMQ-treated cells in the presence and absence of scratches exhibited the 
introduction of physical damage was responsible for inducing the potent response in KRT1 
expression. Furthermore, when tracking KRT1 expression during the three days of recovery 
from scratches displayed further dynamic changes in KRT1 expression. In contrast, IMQ 
presented inconsistent patterns of phenotypic variation when selecting clonal cell lines (Fig. 
9), therefore was removed as a treatment for testing wound healing in keratinocytes. The 
other conditions for clonal selection, growth medium with 1% or 10% FBS, supported the 
presence of phenotypic variations between clones with the varying rates of wound closure.  
After modifying the wound healing assay by removing the additional variable of inflammation 
and primarily focusing on physical damage, HaCaT parental and clonal cell lines were tested 
with this newly modified wound healing assay. The first four inflammatory-wound healing 
experiments of parental cells showed passage-induced variations within the HaCaT 
population. These experiments showed cells should be analysed at earlier passages. Due to 
this, the final gene expression analysis of parental cell line and clones utilised cells at 
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passage 3.  
The in vitro wound healing assay showed a rise in KRT1 expression of clones 3, 4 and 
parental cells by day 3, with differing degrees of increases between these HaCaT cell lines. 
In addition to the phenotypic variations seen between clones, the differential KRT1 
expression between parental and clonal cell lines further distinguishes these four separate 
cell lines. A strong correlation between wound closure and KRT1 expression was seen 
between cell lines, with clone 4 marked as the fast-healing clone exhibited the highest KRT1 
expression. In contrast, the other clonal cell lines that showed a slower rate of wound 
closure had a lower KRT1 expression. This observation suggests KRT1 has a potential role 





Chapter 3: Bioinformatics 
 
3.1 Introduction 
After screening the expression of genes important for keratinocyte innate immunity, 
differentiation, proliferation and inflammation, KRT1 was determined to exhibit significant 
changes in gene expression between the parental and clonal cell lines during wound healing 
(Chapter 2, Fig. 2.11). The phenotypic variations and changes in KRT1 expression could be 
attributed to epigenetic variation at potential regulatory elements along the KRT1 locus. 
Therefore, potential regulatory regions associated with KRT1 gene expression were 
determined by utilising several computational analyses to construct a map across the KRT1 
locus of histone modifications, DNA methylation, RNAPII activity and CTCF binding.   
3.2 Methods 
3.2.1 Data gathering and analysis 
3.2.1.1 ChIP-seq 
RNAPII, CTCF, H3K27ac, H3K4me1 and H3K4me3 data were accessed via the ENCODE 
project and 9 publicly available ChIP-seq datasets in human primary keratinocytes from 
Gene Expression Ominibus (Table 3.1). From the ENCODE project, Binary Alignment Map 
(BAM) and narrow peak files were used. From the GEO datasets, publicly available ChIP-
seq data from previous studies were taken as FASTQ files. These raw sequencing reads 
were mapped to a reference human genome assembly GFCh37 (hg19) using Bowtie2 v2.3.4 
to produce a Sequence Alignment Map (SAM) files. Next, Samtools was used to convert 
SAM files to its binary format, Binary Alignment Map (BAM). Using Samtools, these BAM 
files were sorted by chromosomal position. Finally, MACS2 was used to normalise the data 
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by eliminating background signal. This process produces peaks of signal enrichment of 












Figure 3.1. Pipeline of processing FASTQ files from publicly available databases. 
 
Table 3.1. Description of ChIP-seq data.  
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GSE29611 N/A N/A N/A No 
GEO 
repository 
GSE84662 Proliferating 1.2 mM 
CaCl2 














Day 6 No 
Note: N/A represents details not provided from given study. Datasets without replicates may be 
unreliable 
To locate enriched regions that include statistically significant peaks between conditions, the 
R package, DiffBind (Ross-Innes et al., 2012), was applied. DiffBind determines differentially 
bound sites between ChIP-seq experiments. Results may not be reliable for studies that did 
not conduct replicates, therefore, were not processed in DiffBind.  
3.2.1.2 DNA methylation 
DNA methylation data was gathered from whole genome bisulfite sequencing (WGBS) and 
reduced representation bisulfite sequencing (RRBS) experiments that have already been 
processed and analysed from the source it was acquired from. The WGBS data was 
conducted by Vandiver et al., (2015) and deposited to the DNA methylation database, 
MethBase (Song et al., 2013). The RRBS data was accessed from the Encyclopedia of DNA 





3.2.2 Quality control 
After the sequenced data were run through the ChIP-seq data analysis pipeline, the quality 
of the sorted BAM files were assessed with FastQC 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Results from FASTQC are 
provided in Appendix 2.3. Before acquiring differentially bound sites from DiffBind, ChIP-seq 
data with replicates were examined for shared consensus peaks between replicates. 
Replicates that did not share 50% or above of their peaks were not analysed with DiffBind.  
3.2.3 Visualisation and Statistical analysis 
For data visualisation, sorted BAM files normalised to their respective controls were 
converted into a BIGWIG format through the bamCompare tool on Deeptools (Ramírez et 
al., 2014). These files were then uploaded to the UCSC Genome browser to view (Kent et 
al., 2002). Along with these bigwig files, sites found to be significantly enriched by DiffBind in 
histone modifications and important transcriptional complexes were written into a bed file 
and uploaded onto UCSC Genome browser.  
3.3 Results 
It was previously shown (Chapter 2) that KRT1 expression varied between parental and 
clonal HaCaT cell lines with a time-dependent increase was seen in all cell lines, excluding 
clone 1, with the greatest increase in the parental cell line and clone 4 (Chapter 2, Fig. 2.11).  
The variation in expression of KRT1 might be correlated to differing patterns of DNA 
methylation and genetic variants along the KRT1 locus between cell lines. This chapter will 
be utilising bioinformatics to identify regions bound by H3K27ac, H3K4me1, H3K4me3, 
CTCF, RNAPII, and subject to DNA methylation across the KRT1 locus. H3K4me1 and 
H3K4me3 binding will be used to identify enhancer and promoter regions, with H3K27ac to 
active enhancers and promoters from poised (Calo and Wysocka, 2013; Cheng et al., 2018). 
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RNAPII binding will be assessed if the enhancer and promoter regions are transcriptionally 
active (Schoenfelder and Fraser, 2019). CTCF binding was used to review its interaction 
with DNA methylation as it has been previously cited to disrupt DNA methylation (Wang et 
al., 2012).  
ChIP-seq experiments identify sites across the genome through the recovery of short DNA 
fragments. Sites that are enriched for ChIP-seq fragments relative to a control are defined as 
peaks and the strength of the binding of a target to a given site is reflected in the sequencing 
read depth. Given that a ChIP-seq experiment involves multiple steps that can each 
introduce experimental variability, a minimum of two, and where possible three, replicates for 
each sample is seen as good practice. Replicate samples are important to identify significant 
ChIP-seq peaks for a given conditions (Yang et al., 2014).  
 Table 3.2. Quality control of ChIP-seq data replicates used for DiffBind. Consensus peaks 
shared between replicates are given as a percentage. 
 
In the data sets used here, peaks called from MACS2 for each replicate were compared 
against each other to calculate the number of similar peaks between replicates and peaks 
unique to a replicate. Replicates are determined to be valuable if they show >50% peak 
similarity (Yang et al., 2014). Similar peaks between replicates are considered consensus 
peaks and are represented as percentage (see Table 3.2). The results of this quality check 
H3K27ac 












ENCSR000ALK N/A 21521 26386 45139 48.51% 
GSE84662 Day 0  68984 43641 130 0.11% 
GSE84662 Day 3 73635 57268 187 0.14% 
GSE84662 Day 6 88344 42901 192 0.15% 
GSE68075 12 h 42802 42010 275 0.32% 
H3K4me1 
GSE68075 12 h 100891 101556 480 0.24% 
H3K4me3 
GSE68075 12 h 27197 30504 134 0.23% 
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of consensus peaks showed all ChIP-seq data fell below the 50% threshold. Differences 
between replicates could be attributed to noise generated during the multiple steps of library 
preparation and sequencing during the ChIP experiment. Additionally, noise can be 
generated by biological differences between individual samples (Yang et al., 2014).  
Due to the low quality of ChIP-seq data, they were not analysed with DiffBind to identify 
statistically significant binding sites. Although, the absence of differential analysis prevents a 
robust statistical analysis of the ChIP-seq data, the ChIP-seq peaks normalised to their given 
controls were still utilised. The ChIP-seq peaks will be used to survey the overall level of 
H3K27ac, H3K4me1, H3K4me3 and RNAPII binding across the KRT1 locus to identify 
regions subject to these histone modifications and exhibiting potential transcriptional activity. 
H3K27ac ChIP-seq data will be gathered from various independent studies and compared to 
identify shared peaks during different stages of keratinocyte differentiation. Peaks of 
H3K27ac, H3K4me1, H3K4me3, RNAPII and CTCF will be paired with the search for regions 
with DNA methylation. The combination of these computational analyses will be used to 
identify putative regulatory regions and provide evidence for their regulatory function to 




Figure 3.2 UCSC genome browser display of normalised H3K27ac ChIP-seq data from multiple 
independent studies. Beginning at the top of the figure, shown are H3K27ac peaks from primary 
adult keratinocytes from ENCODE; next are ChIP-seq results from Rubin et al., (2017) using neonatal 
foreskin keratinocytes induced to differentiate through the addition of 1.2 mM CaCl2, and analysed at 
days 0, 3 and 6 in two replicates (Rep 1 and Rep 2); next is shown results Kouwenhoven et al., 
(2015) using keratinocytes taken from skin biopsies of the abdomen and differentiated for 0, 2, 4 and 
7 days (no replicates), the final data set is taken from Klein et al., (2017) investigating the response of 
keratinocytes induced to differentiate through the addition of 1.8 mM CaCl2, and analysed 24 h (no 
replicates); and the response of keratinocytes 12 h after damage in two replicates (Rep 1 and Rep 2) 
as assessed using a scratch assay. The bottom of the figure shows the location of the genes KRT2, 
KRT1, and KRT77, as well as the “GeneHancer” track in the UCSC genome browser that displays 
interactions between regulatory elements and target genes. Green box: broad H3K27ac peak. 
H3K27ac peaks: 1-4.  
Active regulatory regions are flanked by H3K27ac (Ong and Corces, 2011). To identify active 
DNA regulatory elements in differentiating keratinocytes, the location of H3K27ac peaks 
were mapped across the KRT1 locus (Klein et al., 2017; Kouwenhoven et al., 2015; Rubin et 
al., 2017). In Rubin et al., (2017), primary keratinocytes were analysed at the 
undifferentiated, progenitor cell state (day 0), early differentiation (day 3) and late 
differentiation (day 6). A region downstream from the 3’ end of KRT1 contains two common 
H3K27ac peaks at days 3 and 6 (Fig. 3.2, Day 3, Rep 1; Day 6, Rep 1 and 2 tracks: 
H3K27ac peaks 1 and 2). Similarly, the region downstream of the 3’ end of KRT77 is marked 
by a third H3K27ac peak seen during days 3 and 6 in the same dataset. The presence of 
this third peak suggests this region is commonly acetylated when keratinocytes are 
undergoing differentiation (Fig. 3.2, Day 3, Rep 1; Day 6, Rep 1 and 2 tracks: H3K27ac peak 
3). Similarly, the regions marked by H3K27ac peaks 1 and 2 appear to be commonly 
acetylated during keratinocyte differentiation. At day 3 keratinocytes show conflicting results 
between its replicates, with replicate 1 displaying the presence of three H3K27ac peaks, 
whereas, these H3K27ac peaks are not visible in replicate 2 (Fig. 3.2, Day 3, Rep 1 and Rep 
2 tracks: H3K27ac peaks 1, 2 and 3). 
The H3K27ac ChIP-seq data set generated by Kouwenhoven et al., (2015) was compared to 
the ChIP-seq data by Rubin et al., (2017). The ChIP-seq experiment by Kouwenhoven and 
colleagues (2015) generated differentiating keratinocytes using a different protocol to that 
described by Rubin et al., (2017) and analysed cells at Day 0, representing proliferating 
cells, and also at days 2, 4 and 7 that represent early, mid and late differentiation stages, 
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respectively. In agreement with Rubin et al., (2017), similar histone acetylation signatures 
were found 3’ to KRT1 and KRT77 (Fig. 3.2, Day 2; Day 4; Day 7 tracks: H3K27ac peaks 1, 
2 and 3). The final H3K27ac ChIP-seq data provides two separate conditions – normal 
human epidermal keratinocytes (NHEK) that were induced to differentiate and isolated 24 h 
later (Fig 3.2, Day 1), and damaged cells harvested 12 h post-scratch (Fig. 3.2, scratched, 
Klein et al., (2017)). Klein et al., (2017) originally conducted the H3K27ac ChIP-seq 
experiment of day 1 cells with two biological replicates (Fig. 3.2, Day 1 – track – single 
replicate provided by Klein et al., (2017)). However, Klein and colleagues (2017) performed 
their own quality check of these biological replicates by using a Pearson correlation 
coefficients test to determine the level of similarity between replicates. Day 1 keratinocytes 
displayed the same H3K27ac peak at the region between KRT1 and KRT77 seen in the 
previous H3K27ac ChIP-seq data from Rubin et al., (2017) and Kouwenhoven et al., (2015) 
(Fig. 3.2, Day 1; Day 3, Rep 1; Day 6, Rep 1 and 2; Day 0; Day 2; Day 4; Day 7 tracks: 
H3K27ac peak3). In day 1 cells, there is an additional H3K27ac peak at the 3’ end of KRT77 
which is an area that loops over to associate with the 5’ end of KRT1 (Fig. 3.2, Day 1 track: 
H3K27ac peak 4), and a broad H3K27ac peak between KRT2 and KRT1 (Fig. 3.2, Day 1 
track: green box outlining broad H3K27ac peak). The H3K27ac peaks seen during 
proliferation and differentiation are lost during wound healing.  
Taken together, the H3K27ac ChIP-seq data from these independent experiments supports 
the presence of regions of regulatory activity 3’ to KRT1 and KRT77. These regions of 
H3K27ac were next compared to the “GeneHancer” track that maps interactions between 
regulatory elements and genes (Fig. 3.2, bottom, Fishilevich et al., 2017). This track shows 
interactions between the 5’ end of KRT1 with a region downstream of KRT1 that is close to 
H3K27ac peak 1 (Fig. 3.2, top Day 0, 3, 6, peaks 1 and 2), and a second interaction 
between the 5’ end of KRT1 and the 3’ end of KRT77 that maps closest to H3K27ac peak 4 
in Day 1 differentiating keratinocytes (Fig. 3.2). This suggests contact between the 5’ end of 
KRT1 with regions 3’ to KRT1 and KRT77 to or near sites of elevated H3K27ac binding in 
76 
 
differentiating keratinocytes.  
As mentioned previously, promoters are flanked by H3K4me3 and poised enhancers 
awaiting activation are identified by H3K4me1. Active promoters and enhancers identified by 
peaks of H3K27ac (Creyghton et al., 2010; Heintzman et al., 2007). Histone marks 
H3K4me1 and H3K4me3 will be reviewed in day 1 and scratched cells from the same study 
conducted by Klein and colleagues (2017), and proliferating cells from ENCODE. DNase-seq 
data from ENCODE was also included to look for active regulatory elements. DNase-seq 
data will identify regions sensitive to cleavage by DNase I when the chromatin is in its open, 
accessible configuration. This open state is a marker of active cis-regulatory regions and 
often used to identify enhancers and other regulatory elements. These sites cleaved by 
DNase I are referred to as DNase I hypersensitive sites (DHS) and can be flanked by other 
histone modifications, such as H3K4me3 or H3K4me1 which is a common marker of 
promoters and poised enhancers, respectively (Chen et al., 2018). Proliferating cells and 
damaged keratinocytes show an absence in H3K4me1 peaks (Fig. 3.3A, H3K4me1 





Figure 3.3. UCSC genome browser display of normalised H3K4me1 and H3K4me3 ChIP-seq 
and DHS data from Klein et al., (2017) and ENCODE. (A) – (B) Beginning at the top of these 
figures, shown are H3K4me1 or H3K4me3 peaks of proliferating keratinocytes from ENCODE; next is 
shown results from Klein et al., (2017) using keratinocytes induced to differentiate through the 
addition of 1.8 mM CaCl2 and analysed at 24 h (no replicates); and the response of keratinocytes 12 h 
after damage in two replicates (Rep 1 and Rep 2) as assessed using a scratch assay. The bottom of 
the figure shows the location of the genes KRT2, KRT1, and KRT77, as well as the “GeneHancer” 
track in the UCSC genome browser that displays interactions between regulatory elements and target 
genes. Blue highlights: locations of H3K27ac peaks from Fig. 3.2. (A) H3K4me1 ChIP-seq and 
addition DHS tracks from ENCODE. (B) H3K4me3.  
 
In contrast, day 1 keratinocytes undergoing early differentiation showed five H3K4me1 
peaks across the KRT1 locus (Fig. 3.3A, Day 1 track: H3K4me1 peaks 1, 2, 3, 4 and 5). 
H3K4me1 peak 5 in day 1 differentiating cells (Fig. 3.3A, Day 1 track: H3K4me1 peak 5) 
overlaps with the region looping over to associate with KRT1. H3K4me1 peak 4 in day 1 
cells also overlaps with DHS in proliferating cells (Fig. 3.3A, ENCODE track: DHS peak 3; 
Day 1 track: H3K4me1 peak 4) and with H3K27ac peak 3 (Fig. 3.3A, blue highlight at 
ENCODE track: DHS peak 3; Day 1 track: H3K4me1 peak 4). Two additional DHS peaks in 
proliferating cells (Fig. 3.3A, ENCODE track: DHS peaks 1 and 2) are at a region 
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downstream of KRT1 marked by H3K27ac peak 2 (Fig. 3.3A, blue highlight at ENCODE 
track: DHS peak 1 and 2). H3K4me1 peaks 2 and 3 overlap with H3K27ac peaks, 
corresponding to the H3K27ac peaks boxed in green and peak 1 in Fig. 3.2) with H3K4me1 
peak 1 mapping to an intragenic region of KRT2 (Fig. 3.3A, Day 1 track: H3K4me1 peaks 1).  
The histone mark associated with promoters, H3K4me3, showed similar patterns to 
H3K4me1. H3K4me3 peak 1 observed in day 1 cells (Fig. 3.3B, Day 1 track: H3K4me3 peak 
1) overlapped with a H3K27ac peak 4 (Fig. 3.3B, blue highlight at Day 1 track, see also Fig. 
3.2) and H3K4me1 peak 5 in day 1 (Fig. 3.3A, Day 1 track: H3K4me1 peak 5). Due to the 
limited conditions available for H3K4me1 and H3K4me3 ChIP-seq data, it is unclear if these 
histone marks change during different cellular processes, such as proliferation or later 
stages of differentiation. Although, replicate 1 of scratched cells undergoing wound healing 
shows the same H3K4me3 peak as day 1, but at a lower read depth (Fig. 3.3B, Scratched, 
Rep 1 track: H3K4me3 peak 1; Day 1 track: H3K4me3 peak 1). Despite this, H3K4me3 peak 
1 suggests potential activity as a promoter during wound healing.  
To determine when the KRT1 locus is actively transcribed during differentiation, ChIP-seq 
data of RNAPII binding from Kouwenhoven et al., (2015) was examined. The KRT1 gene 
body outlined two RNAPII peaks that indicates transcription during early differentiation 
between days 2-4 (Fig. 3.4, Day 2; Day 4 tracks: RNAPII peaks 1 and 2). RNAPII occupancy 
at KRT1 is expected, due to KRT1 labelled as a terminal marker of differentiation for post-
mitotic keratinocytes (Fischer et al., 2016). RNAPII shows high occupancy across the entire 
KRT1 gene body, including exonic and intronic regions. Unexpectedly, the area between 
KRT1 and KRT77 displays another two RNAPII peaks (Fig. 3.4, Day 2; Day 4 tracks: RNAPII 
peaks 3 and 4). RNAPII peaks 3 and 4 align and are flanked by H3K27ac peaks 3 and 4 
(Fig. 3.4, blue highlight at Day 2; Day 4 tracks: RNAPII peaks 3 and 4), showing that this 
area is transcriptionally active with proximal regulatory elements, indicated by the H3K27ac 
peaks, during early differentiation between days 2-6. Additionally, the presence of H3K4me1 
and DHS (Fig. 3.4, purple highlight at Day 4 tracks: RNAPII peaks 3 and 4) paired with 
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Figure 3.4. UCSC genome browser display of normalised RNAPII ChIP-seq. Beginning at the top 
of the figure, shown are RNAPII peaks from primary adult keratinocytes from ENCODE; next are 
ChIP-seq results from Kouwenhoven et al., (2015) using keratinocytes taken from skin biopsies of the 
abdomen and differentiated for 0, 2, 4 and 7 days (no replicates). The bottom of the figure shows the 
location of the genes KRT2, KRT1, and KRT77, as well as the “GeneHancer” track in the UCSC 
genome browser that displays interactions between regulatory elements and target genes. Highlights: 
Blue = location of H3K27ac peaks from Fig. 2; Red = location of H3K4me1 peaks from Fig. 3A; Yellow 
= location of DHS peaks from Fig. 3A; Purple = location of overlap of H3K4me1 and DHS; Green = 
location of overlap of H3K4me1 and H3K4me3 from Fig. 3. 
After using histone modifications to identify regulatory elements, the presence of DNA 
methylation at these regulatory elements was examined. Since changes in DNA methylation 
accompany changes in keratinocyte proliferation and differentiation (Pucci et al., 2013; Sen 
et al., 2010), we next assessed the level of DNA methylation across the KRT1 locus. To do 
this, DNA methylation data from a publicly available methylome database, MethBase (Song 
et al., 2013), was used. MethBase is a repository for DNA methylation experiments from 
multiple WGBS studies. A study was also used (Vandiver et al., 2015) that includes samples 
from the outer forearm or lateral epicanthus (denoted as sun exposed skin) and upper inner 
arm (denoted as sun protected skin) from Caucasian subjects between 61 to >90 years of 
age, and those younger in age were between 18-34 years. A plot of DNA methylation across 
the KRT1 locus showed hypomethylated regions (HMR) (Fig. 3.5, HMR 1, 2, 4, 5, 8 and 9), 
as well as regions of high methylation across all samples (Fig. 3.5, green boxes). However, 
there are also varying patterns of DNA methylation across the KRT1 locus observed in HMR 
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3 and 7 which are specific to certain skin conditions. HMR 8 correlates to the same area that 
showed H3K27ac peak 3 during days 2-7 of keratinocyte differentiation (Fig. 3.2, Day 2; Day 
4; Day 7 tracks: H3K27ac peak 3), H3K4me1 peak 4 during day 1 of keratinocyte 
differentiation, and DHS peaks in proliferating keratinocytes (Fig. 3.3A, Day 1 track: 
H3K4me1 peak 4; ENCODE track: DHS peak 3). Additionally, this area displayed RNAPII 
peaks (Fig. 3.5, grey highlight), further supporting this area to have transcriptional and 
regulatory activity. The presence of histone modifications and RNAPII binding indicates this 
area is normally active. The occupancy of histone modifications and RNAPII might be 
blocking DNA methylation, a marker typically associated with gene repression.  
 
 
Figure 3.5. Data of displaying DNA methylation and CTCF binding. (A) DNA methylation from 
WGBS experiment. DNA methylation data was processed by the MethBase database from the Smith 
Lab (Song et al., 2013), with original study conducted by Vandiver et al., (2015). Keratinocytes were 
provided from young and old skin that were exposed or protected from the sun. For pigmentation 
control, Caucasian subjects were chosen. Blue bars = hypomethylated regions (HMR) 1-9; Purple 
bars = allele specific methylated regions (AMR) 1-3. (B) CTCF binding of keratinocytes induced to 
differentiate through the addition of 1.2 mM CaCl2 and collected at days 0, 3 and 6 (Rubin et al., 
2017). “GeneHancer” track activated for in UCSC genome browser to display regulatory elements and 
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gene interactions. Highlights: Blue = location of H3K27ac peaks from Fig. 2; Red = location of 
H3K4me1 peaks from Fig. 3A; Yellow = location of DHS peaks from Fig. 3A; Purple = location of 
overlap of H3K4me1 and DHS; Green = location of overlap of H3K4me1 and H3K4me3 from Fig. 3. 
Similarly, this is HMR 9 (Fig. 3.5A) which is an area that co-localises with H3K4me1 and 
H3K4me3 peaks (Fig. 3.5A, green highlight). The low level of DNA methylation marked by 
HMR 9 can be attributed to the occupancy of H3K4me1 and H3K4me3. The correlation 
between the loss of DNA methylation and gain of histone marks is seen in the 
hypomethylated region marked by HMR 2 overlapping with a H3K4me1 peak (Fig. 3.5A, red 
highlight). In addition to H3K4me1, HMR2 overlaps with the location of the broad H3K27ac 
peak (Fig. 3.5A, blue highlight). HMR 2 is present across all skin conditions which indicates 
this DNA area is not methylated because of the presence of H3K4me1 and H3K27ac. 
Overall, these results support a relationship between DNA methylation, histone modifications 
and RNAPII occupancy.  
Areas marked by RNAPII binding during keratinocyte differentiation during days 2 and 4 (Fig. 
3.5A, dark grey highlight) are marked by an allele-specific methylated region (hereafter 
referred to as ‘AMR’) in the young sun-protected skin (Fig. 3.5A, Young sun protected track: 
AMR 2 and 3). One of the AMR is shared with old sun-exposed skin (Fig. 3.5A, Old sun 
exposed track: AMR 2). AMR 2 in young sun-protected and old sun-exposed skin co-
localises with a RNAPII peak (Fig. 3.5A, grey highlight at Young sun protected; Old sun 
exposed tracks: AMR 2). Finally, an AMR (Fig. 3.5, purple bar 1) unique to young sun 
exposed skin aligns with a hypomethylated area (Fig. 3.5A, HMR 5). When compared to 
CTCF occupancy during days 0, 3 and 6 (Rubin et al., 2017) (Fig. 3.5B), this AMR and 
hypomethylated area overlaps (Fig. 3.5A, AMR 1; HMR 5) with CTCF binding in proliferating 
and differentiating keratinocytes (Fig. 3.5B, ENCODE; Day 0; Day 3; Day 6 tracks: CTCF 
peak 1). CTCF is a transcription factor responsible for maintaining genomic architecture to 
activate, silence or act as an insulator during enhancer and promoter interactions (Kim et al., 
2015). CTCF peak 1 appears to be a stable CTCF binding across all conditions (Fig. 3.5B, 
ENCODE; Day 0; Day 3; Day 6 tracks: CTCF peak 1). Similarly, this region is typically 
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hypomethylated across all the skin conditions (Fig. 3.5A, Old sun exposed; Young sing 
exposed; Old sun protected; Young sun protected track: HMR 5), suggesting this is a 
common, stable mark of CTCF block DNA methylation at this region.  
In contrast to WGBS, RRBS primarily sequences CpG-rich regions with little focus on CpG-
poor intergenic regions. RRBS data assists in determining methylated regions at CpG-rich 
regions (Guo et al., 2015). This distinguishes RRBS from WGBS which is used to provide a 
genome-wide overview of regions marked by DNA methylation (Doherty and Couldrey, 
2014). To examine DNA methylation at CpG-rich areas in multiple epithelial cell types and 
conditions, RRBS data accessed from ENCODE was utilised to identify differential DNA 
methylation patterns at CpG rich regions. Human small airway epithelial cells (SAEC), 
adenocarcinomic human alveolar basal epithelial cells (A549), normal human mammary 
epithelial cell (HMEC), breast cancer cell line (MCF-7), normal human neonatal dermal 
fibroblasts (NHDF-neo), normal human fibroblast (BJ), human epidermal melanocytes 
(Melano), and normal human skin cell line (Skin BC) were examined. These other cell lines 
were used in conjunction to epidermal keratinocytes to identify DNA methylation marks 
common to all epithelial cells and those specific to a cell type. Cancer cell lines were 
included due to its shared cellular pathways to wound healing (Sundaram et al., 2018). The 
RRBS data includes denotes the degree of methylation as a gradient at a given region, with 
the colour scheme red, yellow and green representing complete DNA methylation (100%), 
partial methylation (50%) and unmethylated areas (0%), respectively. This data shows the 
region flanked by H3K27ac peaks (Fig. 3.6, blue box) contains high CG dinucleotides. 
Additionally, another region at the 3’ end of KRT1 which is flanked by RNAPII binding, 
H3K27ac peaks and DHS is rich in CG dinucleotides (Fig. 3.6, orange box). These regions 
show varying patterns in DNA methylation between cell types. In the first region (Fig. 3.6, 
blue box), SAEC, HMEC and MCF-7 cells shows full DNA methylation. During cancer, lung 
epithelial cells exhibits an absence of DNA methylation as seen in A549 cells. Indicating the 
region showing this aberrant DNA methylation is important in the pathogenesis of the A549 
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cells. When comparing HMEC to its cancer counterpart, MCF-7, appears to be fully 
methylated in both cell lines. This suggests this DNA methylation signature is stable across 
all mammary epithelial cells, regardless of condition. Conversely, progenitor and 
differentiated skin cells are marked by partial or a lack of DNA methylation at this region. 
Together, this shows this region is highly methylated in lung and mammary epithelial cells 
which indicating the putative regulatory element at region 1 is not active in these tissues. 
However, this putative regulatory element may exhibit a regulatory function in skin cells.  
The second region (Fig. 3.6, orange box) showed most cells with complete DNA methylation 
in lung and mammary epithelial cells, normal and cancerous, except for HMEC cells that 
exhibited partial methylation in between flanking 100% methylated areas. The NHDF-neo 
cells show a similar pattern of DNA methylation, including both full and partially DNA 
methylated areas. This partially methylated area in NHDF-neo cells appears to not be 
commonly methylated across the other skin epithelial cell types – fibroblasts, melanocytes 
and keratinocytes. This low DNA methylation signature may be stable across all skin cell 
types, and gains and loses this DNA methylation mark depending on the cell state and type. 
Although, the two replicates provided by melanocytes depict differing DNA methylation 
signatures and may be overall be fully methylated or unmethylated at the 3’ end of KRT1 
(Fig. 3.6, orange box). Replicates between the other skin cell types are consistent and show 
the partition between the presence of full DNA methylation and lack of DNA methylation. 
Overall, the DNA methylation at the 3’ end of KRT1 is frequently methylated regardless of 





Figure 3.6. UCSC genome browser display of DNA methylation acquired from ENCODE at 
SAEC, A549, HMEC, MCF-7, NHDF-neo, BJ, Melano, Skin BC. Replicates included for each cell 
line (denoted as “1” and “2”). “GeneHancer” track activated in UCSC genome browser to display 
regulatory elements and gene interactions. Methylation status: red = 100% methylated; yellow = 50% 
methylated; green = 0% methylated. Highlights: Blue = location of H3K27ac peaks from Fig. 2; Red = 
location of H3K4me1 peaks from Fig. 3A; Yellow = location of DHS peaks from Fig. 3A; Purple = 
location of overlap of H3K4me1 and DHS; Green = location of overlap of H3K4me1 and H3K4me3 
from Fig. 3. 
 
3.4 Conclusion 
The bioinformatics analysis of H3K27ac, H3K4me1, H3K4me3, RNAPII and CTCF binding 
with DNA methylation data highlight three primary sites with high regulatory and 
transcriptional potential. These regions are located downstream of KRT1 (chr12:53,055,002-
53,060,743 – region 1), at exon 8-9 at the 3’ end of KRT1 (chr12:53,068,099-53,069,709 – 




Chapter 4: The epigenetic and genetic 
profile of KRT1 locus 
 
4.1 Introduction 
In the previous chapter, putative regulatory regions defined by H3K27ac, H3K4me1 and 
H3K4me3 binding along the KRT1 locus suggested a potential functional role in controlling 
KRT1 gene expression. This chapter will investigate whether the phenotypic variations and 
differential KRT1 gene expression observed during wound healing and time in culture 
between the HaCaT cell lines is correlated with changes in DNA methylation at these 
putative regulatory regions. A methylation specific restriction endonuclease (MSRE)-qPCR 
was utilised to test for changes in DNA methylation between different HaCaT cell lines at 
these putative regulatory regions.  
The phenotypic variation can also be attributed to allele-specific expression, which is the 
relative expression of two alleles in diploid cells (Tian et al., 2018). The allele-specific 
variation in gene expression can often be correlated with allele-specific variation in DNA 
methylation (Wang et al., 2019). In conjunction with the MSRE-qPCR, the putative regulatory 
regions were also sequenced to identify heterozygous genetic variants. Any observed 
differential methylation between regulatory elements in different cell lines is hypothesised to 







4.2.1 Genomic DNA isolation 
Cells were washed with PBS and collected with a cell scraper. Cells were pelleted by 
centrifugation for 8 seconds at 12,000 x g. The supernatant was removed, and the cell pellet 
was processed for genomic DNA (gDNA) extraction using the ISOLATE II Genomic DNA Kit 
(Bioline) with the following modification: to achieve a higher recover of gDNA from the spin 
column at the final elution step, the column was incubated with elution buffer for 15 min 
instead of 1 min. The DNA concentration was measured on a NanoDrop 2000c 
Spectrophotometer (Thermo Fisher Scientific). 
 
4.2.2 Methylation Specific Restriction Endonuclease (MSRE) and 
Sequencing Primers 
MSRE and sequencing primers were designed using Primer3 (version 4.1.0). The MSRE 
assay is based on the digestion of gDNA with the methylation sensitive restriction 
endonuclease HpaII, which recognises and cuts the sequence CCGG only if the cytosine in 
the CpG dinucleotide is not methylated. A second digestion is done in parallel using the 
enzyme MspI that recognises and cuts the same DNA sequence but is not inhibited by DNA 
methylation (Shiratori et al., 2016). Therefore, MSRE primers were designed by first 
searching each regulatory region for the MspI/HpaII CCGG recognition sequence. Primers 
were designed to generate amplicons between 150-300 bp. Primer pairs identified by 
Primer3, were then tested using the UCSC In-Silico PCR tool (https://genome.ucsc.edu/cgi-
bin/hgPcr). In parallel with the design of MSRE primers, primers were also designed to 
generate 2000-4000 bp amplicons suitable for long-read Nanopore DNA sequencing. To 
design DNA sequencing primers, 2000-4000 bp amplicons were entered in Primer3 with the 
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melting temperatures setting altered to the following: 59°C (Min), 60°C (Opt), and 61°C 
(Max). Primer pairs were validated using the UCSC In-Silico PCR tool. Appendix 3.1 
provides additional information on primers.  
 
4.2.3 Primer efficiency 
To test the efficiency of MSRE primers to generate amplicons with the correct base pair 
sizes, digestions of gDNA were setup with five separate dilutions. gDNA (150 ng/L) were 
digested with MspI (5 U/L) (New England BioLabs) in a total volume of 15 L. A mock 
digestion without the addition of either enzyme was also prepared in parallel. Digestions 
were done at 37°C for 1 hr followed by 95°C for 15 min. To quantify product yield of 
amplicons from each of these three digestion conditions, a quantitative PCR was done with a 
final reaction volume of 10 L that included SensiFAST SYBR Lo-ROX (Bioline), forward 
and reverse primers (each at a concentration of 4 M/L), RNase-free water and gDNA with 
the following dilutions: 2.5 ng/L, 1.25 ng/L, 0.63 ng/L, 0.31 ng/L, 0.16 ng/L. The qPCR 
conditions were: 95°C for 5 min, followed by 40 cycles of 95°C for 10 sec, 63°C for 10 sec 
and 72°C for 30 sec using an ABI 7700 FAST. Each reaction was run in triplicates. The Ct 
values of each triplicate were averaged. Next, the log of each sample dilution was taken and 
plotted with the averaged Ct values as a linear regression. The slope of this linear regression 
was calculated and used as an input to generate the primer efficiency as a percentage, 
using the formula below: 
𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (%) = (
−1
10𝑠𝑙𝑜𝑝𝑒 − 1
) × 100 
Primers with efficiencies between 90-110% were utilised for the MSRE-qPCR assay. 
Additionally, the correlation coefficient (R2) of primers were also included for assessing 




4.2.4 MSRE-qPCR assay 
gDNA (35-680 ng/L) were digested with HpaII (5 U/L) (New England) or MspI (5 U/L) 
(New England) in a total volume of 15 L. A mock digestion without the addition of either 
enzyme was also prepared. Digestions were done at 37°C for 1 hr followed by 95°C for 15 
min using a Veriti 96 Well Thermal Cycler (Applied Biosystems). To quantify product yield of 
amplicons from each of these three digestion conditions, a qPCR was done with a final 
reaction volume of 10 L that included SensiFAST SYBR Lo-ROX (Bioline), forward and 
reverse primers (final concentration of 0.4 M), gDNA (2-45 ng/L) and RNase-free water to 
produce a final reaction volume of 10 L. The qPCR conditions were: 95°C for 5 min, 
followed by 40 cycles of 95°C for 10 sec, 63°C for 10 sec and 72°C for 30 sec using an ABI 
7700 FAST. Each reaction was run in triplicates.   
 
4.2.5 Optimisation of Nanopore sequencing primers 
Each reaction mixture included 10 L of 5x Q5 reaction buffer (New England), 1 L of 10 
mM dNTPs, 0.5 L of Q5 High-Fidelity DNA polymerase (New England) and nuclease-free 
water up to a final volume of 50 L. Specific conditions and reaction mixtures for each 
validated primer are provided in Table 1. The amplification conditions were 98°C for 2:10 
min, starting 10°C above the optimal annealing temperature for 10 sec, 72°C for the optimal 
extension time, 98°C for 10 sec, the optimal annealing temperature and extension time 
(Table 4.1), and 72°C for 2 min.  
Table 4.1. Optimal annealing temperature and extension time for each sequencing primer.  
 
 Annealing temperature and 
Extension time 
KRT1_seq1 68°C for 1:30 min 
KRT1_seq2 67°C for 1 min 
KRT1_seq3 64°C for 1:30 min 





4.2.6 Library preparation and sequencing 
Optimised sequencing primers generated amplicons from gDNA from each cell line’s NT 
sample. Amplicons, at a concentration of 500 ng/L, generated from each primer were 
combined to have a total of 2 g/L. The combined pool of amplicons from each primer 
constituted a separate library. Libraries were prepared for end repair/dA-tailing PCR. Each 
library at a concentration of 1 g/L was combined with NEBNext Ultra II End Prep Enzyme 
mix, NEBNext Ultra II End Prep Reaction buffer and RNAse-free water to create a total 
reaction volume of 60 L. The PCR conditions were: 20°C for 30 min, followed by 65°C for 
30 min using a Veriti 96 Well Thermal Cycler (Applied Biosystems). After the PCR reaction, 
each library was purified using the Monarch PCR & DNA Cleanup Kit (New England 
BioLabs).  
Libraries were then prepared for the ligation of barcode adaptors. Reactions were done in a 
final volume of 70 L and included 21 L of a single library, 14 L of Barcode adaptor and 
35 L of Blunt/TA Ligase Master Mix. Each component of this reaction was present at the 
following ratios relative to the final reaction volume: library (3:10), Barcode adaptor (2:10) 
and Blunt/TA Ligase Master Mix (1:2). These reactions were left for 10 min at room 
temperature. Before use, AMPure XP beads (Beckman Coulter) were vortexed to 
resuspend, and 40 L was added to each library-blunt/TA ligase reaction mixture and tubes 
were flicked to mix. This reaction mixture was incubated on a rotator mixer for 5 min at room 
temperature. Tubes were then briefly spun and placed on a magnetic rack to remove the 
supernatant. Beads were washed twice with 70% ethanol. Tubes were spun down briefly 
and any residual ethanol was removed. Tubes were dried by incubating them with lids open 
on a heating block at 37°C for 15 sec. The pellet in each tube were resuspended with 25 L 
of nuclease-free water and incubated for 2 min at room temperature. Tubes were placed on 
the magnetic rack to allow beads to migrate towards the side facing the magnet. Once all 
beads have migrated to the side adjacent the magnet, the remaining elute in each tube were 
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transferred into a clean 1.5 mL Eppendorf tube.  
Each library was diluted to a concentration of 10 ng/L and combined with unique PCR 
barcode numbers (barcodes 01-4) from the PCR barcoding expansion 1-12 kit (Oxford 
Nanopore Technologies, UK), 10 mM dNTPs, LongAmp Taq DNA polymerase (New 
England BioLabs), LongAmp Taq 2X Master mix and nuclease-free water to a final volume 
of 50 L. The Barcode PCR conditions were: 94°C for 2 min, followed by 15 cycles of 94°C 
for 15 sec, 62°C for 2:50 min and 62°C for 10 min using a Veriti 96 Well Thermal Cycler 
(Applied Biosystems). Barcoded DNA mixtures were then purified using Monarch PCR & 
DNA Cleanup Kit (New England BioLabs) and combined into a single mixture in a volume of 
50 L. This single mixture was combined with 3 L of NEBNext Ultra II End Prep Enzyme 
Mix and 7 L NEBNext Ultra II End Prep Reaction Buffer to create a final volume of 60 L. 
This reaction mixture will be processed in an end repair reaction with the following PCR 
conditions: 20°C for 30 min, followed by 65°C for 30 min using a Veriti 96 Well Thermal 
Cycler (Applied Biosystems).  
Next, the pooled libraries were prepared for adaptor ligation and clean-up. Before use, 
Adaptor Mix (AMX), NEBNext Quick T4 DNA Ligase, Ligation Buffer (LNB) and elution buffer 
(EB) from the Nanopore ligation kit (Oxford Nanopore Technologies, UK) were spun down 
and pipetted several times to mix each reagent. The 60 L of pooled libraries was combined 
with 25 L LNB, 10 L T4 DNA ligase and 5 L of AMX, and incubated at room temperature 
for 10 min. Before use, AMPure XP beads were vortexed to mix and resuspend beads. 40 
L of AMPure XP beads were added to the adaptor ligation mix and combined as a mixture 
by flicking the tube. This mixture was incubated for 5 min on a rotator mixer. Samples were 
spun down pelleted on the magnetic rack, with the supernatant removed. Off the magnetic 
rack, 250 L Short Fragment Buffer (SFB) was added to wash the beads. The tube was 
flicked to resuspend beads and placed on the magnetic rack to pellet the samples and 
remove the supernatant. This wash step was repeated. Samples were spun down and 
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placed on the magnet, and any remaining residual supernatant was removed. Additionally, 
samples were left for approximately 30 sec to dry. Sample pellets were removed from the 
magnetic rack and suspended with 15 L of EB. Samples were incubated for 10 min at room 
temperature. Samples were placed back on the magnetic rack to pellet the beads and isolate 
the eluate into a new 1.5 mL Eppendorf DNA tube. The concentration of the eluted sample 
was measured on a Quibit Fluorometer (Invitrogen by Life Technologies, US). The 
recommended sample load is 5-5 fmol.  
Connect the MinION sequencing device to a desktop computer or laptop (ensure charger is 
plugged) and setup a connection via MinKNOW GUI. On the selector box, click the flow cell 
type to verify the ”Available” box is present. Select the “New Experiment” icon at the bottom 
left of the GUI and select the following parameters: Fast and High accuracy (HAC). Before 
use, Sequencing Buffer (SQB) and Flush Buffer (FB) was vortexed and spun down to mix. 
Additionally, Flush Tether (FLT) tube was mixed by pipetting and spun down. Next, the 
nanopore sequencing device lid was opened to allow the flow cell to be loaded. Once 
properly loaded, the priming port should be open and visible to check any bubbles present 
under the cover. Remove a small volume (a few L) to remove any air bubbles. Using a 
p1000 pipette set to 200 L, insert the tip into the priming port and turn the wheel dial until it 
is set to 220-230 L. Next, to prepare the flow cell priming mix, combine 30 L of FLT into 
the tube with FB and mixing by pipetting. Load 800 L of this flow cell priming mix into the 
flow cell via the priming port and avoid forming air bubbles. Wait for 5 min to allow the 
priming mix to travel across the flow cell. Before use, mix the Loading Beads (LB) by 
pipetting. In a new 1.5 mL Eppendorf tube, prepare the sample library by combining the 
solutions in the following order: 37.5 L of SQB, 25.5 L of LB and 12 L of eluted DNA 
library. Lift the SpotON sample port cover and load 200 L of the priming mix via the priming 
port, be careful not to form air bubbles. Before loading the sample library, pipette up and 
down to mix and add 75 L of the sample library into the flow cell via the SpotON sample 
port in small drop doses until 75 L is loaded to avoid forming air bubbles. Ensure each drop 
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of sample flows into the port before adding the next. Gently close the SpotON sample port 
cover, ensuring the bung enters the SpotON port. Close the priming port and the MinION lid. 
On the computer, click “Start run”.  
 
4.2.7 MSRE-qPCR data analysis 
To analyse the MSRE results, triplicates of each digested DNA (HpaII, MspI, mock) were 
averaged. To classify regions as methylated or unmethylated, the difference in Ct between 
HpaII or MspI and mock (CT HpaII and CT MspI) was calculated. The distribution of CT 
MspI was plotted as a box plot and this defined the range of CT values for unmethylated 
DNA. A scatter plot of CT HpaII was plotted adjacent to the CT MspI values. Lower and 
upper outer fences were determined based on the distribution of CT MspI values, using the 
following formulas: 
𝐿𝑜𝑤𝑒𝑟 𝑜𝑢𝑡𝑒𝑟 𝑓𝑒𝑛𝑐𝑒 = 𝑄𝑢𝑎𝑟𝑡𝑖𝑙𝑒 1 (𝑄1) − 3 × 𝐼𝑛𝑡𝑒𝑟𝑞𝑢𝑎𝑟𝑡𝑖𝑙𝑒 𝑟𝑎𝑛𝑔𝑒 (𝐼𝑄𝑅) 
𝑈𝑝𝑝𝑒𝑟 𝑜𝑢𝑡𝑒𝑟 𝑓𝑒𝑛𝑐𝑒 = 𝑄𝑢𝑎𝑟𝑡𝑖𝑙𝑒 3 (𝑄3) − 3 × 𝐼𝑛𝑡𝑒𝑟𝑞𝑢𝑎𝑟𝑡𝑖𝑙𝑒 𝑟𝑎𝑛𝑔𝑒 (𝐼𝑄𝑅) 
  
The analysis of MSRE-qPCR results utilises CT MspI values as the control, as this enzyme 
is responsible for cleaving DNA regardless if it is methylated or unmethylated. Based on the 
distribution of CT MspI values, lower and upper outer fences were calculated using quartile 
1 and 3, and the interquartile range. The DNA methylation status of conditions was defined 
as CT HpaII values falling above the upper outer fences (not methylated) which are 
aligning closer to the distribution of CT MspI values, between the lower and upper outer 
fence (partially methylated), or below the lower outer fence (methylated). Example of 





















Figure 4.1. Example of interpreting MSRE-qPCR results with three levels of DNA methylation: 
not methylation, partially methylated and methylated. U: upper outer fence; L: lower outer 
fence.  




Figure 4.2. Pipeline for processing Nanopore sequencing data.  
 
4.2.9 Linkage disequilibrium analysis 
To examine the association of SNVs identified from Nanopore sequencing between each 
other and other genetic variants proximal to the putative regulatory elements, a linkage 
disequilibrium (LD) analysis was conducted by using the LD proxy tool 
(https://ldlink.nci.nih.gov/?tab=ldproxy) from the National Cancer Institute: Division of Cancer 
Epidemiology & Genetics. The LD proxy tool provides the correlation coefficient (R2) of a 
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group of SNPs in LD with each other.   
 
4.3 Results 
4.3.1 Variations in DNA methylation between HaCaT cell lines 
during wound healing 
 
 
Figure 4.3. UCSC genome browser display of DNA methylation from RRBS and WGBS data 
across the KRT1 locus. RRBS data acquired from ENCODE at human small airway epithelial cells 
(SAEC), adenocarcinoma human alveolar basal epithelial cells (A549), human mammary epithelial 
cells (HMEC), breast cancer cell line (MCF-7), normal human neonatal dermal fibroblasts (NHDF-
neo), normal human fibroblast (BJ), human epidermal melanocytes (Melano), normal human skin cell 
line (Skin BC). Replicates included for each cell line (denoted as “1” and “2”). Methylation status: red 
= 100% methylated; yellow = 50% methylated; green = 0% methylated. Processed WGBS data by the 
MethBase database (Song et al., 2013), with original study conducted by Vandiver et al., (2015). 
Keratinocytes were provided from young and old skin that were exposed or protected from the sun. 
For pigmentation control, Caucasian subjects were chosen. Blue bars = hypomethylated regions; 
Purple bars = allele specific methylated regions. Location of MSRE-qPCR primers: KRT1_msre1 
(chr12:53055839-53056023); KRT1_msre2 (chr12:53058368-53058530); KRT1_msre3 
(chr12:53059788-53059990); KRT1_msre4 (chr12:53060400-53060577); KRT1_msre5 
(chr12:53069291-53069485); KRT77_msre (chr12:53085153-53085321). “GeneHancer” track in 
UCSC genome browser that displays interactions between regulatory elements and target genes. 




Figure 4.4. Analysis of primer efficiencies for MSRE-qPCR primers. Mock digestions of genomic 
DNA at five serial dilutions (1:2) with a starting concentration of 2.5 ng (n = 3). Each dilution was set 
up in triplicates for a qPCR. Ct values acquired from qPCR are plotted as a scatterplot. Calculations 
of primer efficiencies for each primer are provided in a table. (A) Primer 1: KRT1_msre1. (B) Primer 2: 
KRT1_msre2. (C) Primer 4: KRT1_msre4. (D) Primer 5: KRT1_msre5.  
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It was previously shown (Chapter 3) that the KRT1 locus has putative regulatory elements 
that showed evidence of varying patterns of epigenetic modifications during keratinocyte 
proliferation and differentiation. In addition, it was previously shown (Chapter 2) that clone 4 
was the fastest healing cell line (Fig. 2.9A and 2.9E) which correlated with the highest KRT1 
expression in Scr_72h (Fig. 2.11C) between the HaCaT cell lines. Clone 1 in Scr_72h cells 
showed the opposite response with a decreased KRT1 expression correlated with slow 
wound closure rates (Fig. 2.8B, Clone 1; Fig. 2.10C).   
The difference in KRT1 expression in each cell line in response to scratching and/or time in 
culture led us test whether this was accompanied by changes in DNA methylation at one or 
more the previously identified putative regulatory elements.  
A MSRE-qPCR was utilised to assess this change in DNA methylation for the Scr_72h cells, 
that were grown for 4 days and then scratched and grown for a further 3 days, in each 
HaCaT cell line. The isolated gDNA from the Scr_72h cells of each HaCaT were treated with 
either MSREs which are used to differentiate between methylated or unmethylated DNA at 
CCGG sites. At each of the previously identified regulatory elements, amplicons containing 
the CCGG motifs were amplified from the digested and mock digested gDNA to assess the 
DNA methylation status between HaCaT cell lines.  
First, the primers designed for the MSRE-qPCR assay (Fig. 4.3) were experimentally 
validated by serially diluting (1:2) purified MSRE amplicons over a range of 2.5 to 0.16 
ng/L. Each dilution was run in triplicates and the cycle thresholds averaged. The dilution 
factor applied to each sample individually was log transformed. The Ct and log transformed 
values of sample quantities were utilised to plot a standard curve and the slope of the curve 
was determined (Fig. 4.4). Next, the amplification efficiency was assessed for each primer. 
The highest quality was seen for primer 2 (KRT1_msre2) with an efficiency of 97%. 
Additionally, a strong relationship between cycle threshold and sample concentration was 
observed with a high correlation coefficient (R2 = 0.79). Primers 1, 4 and 5 (KRT1_msre1, 4, 
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5) were 20% above the valid efficiency range (90-110%), however, these primers displayed 
a high correlation with the following correlation coefficients – primers 1 (R2 = 0.80), 4 (R2 = 
0.76) and 5 (R2 = 0.97). Due to this strong relationship between cycle thresholds and sample 
concentrations, these primers were selected for the MSRE-qPCR assay.  
Next, the MSRE-qPCR primers that passed the quality check were utilised to generate 
amplicons corresponding to each of the 4 MSRE sites (Fig. 4.3) were amplified from gDNA 
isolated NT_72h and Scr_72h cells from each HaCaT cell line. KRT1_msre1 maps to the 
first CpG region flanked by histone modifications (Fig. 4.3). Based on the RRBS data from 
ENCODE, KRT1_msre1 was not methylated. However, the WGBS data does suggest DNA 
methylation is not completely absent at this region.  
The presence of DNA methylation at this region in primary normal human epidermal 
keratinocytes correlated to DNA methylation observed in vitro in each of the HaCaT cells 
generated in our study (Fig. 4.3, location of KRT1_msre1, Fig 4.5A, DNA methylation status 
of KRT1_msre1). The KRT1_msre2 amplicon is located 9.99 kb towards KRT1 and was also 
identified as a possible regulatory region based on H3K27ac and H3K4me1 (Fig. 4.3). 
Similar to the KRT1_msre1 region, the RRBS experiments of human dermal fibroblasts and 
keratinocytes suggests an absence of DNA methylation in keratinocytes (Fig. 4.3, NHDF-neo 
track), whereas, WGBS indicates this regions is methylated across many different skin 
conditions in primary skin cultures (Fig. 4.3). The MSRE analysis of the KRT1_msre2 region 
showed most cell lines and both conditions as methylated, except for NT_72h cells of clone 




Figure 4.5. DNA methylation at intergenic regions downstream of KRT1 and 3’ end of KRT1 in 
HaCaT cell lines with day 3 post-scratch cells and their respective day 3 NT control. (A-D) 
Measurement of DNA methylation using the restrictions endonucleases MspI and HpaII. (A) 
KRT1_msre1. (B) KRT1_msre2. (C) KRT1_msre4. (D) KRT1_msre5. DNA methylation status is 
based on if normalised HpaII Ct values are above the upper outer fence (not methylated), between 




Clone 4 showed the highest KRT1 expression in Scr_72h cells (Chapter 2, Fig. 2.10B). 
KRT1_msre4 is located at the area of region 1 that interacts with the 5’ end of KRT1 and the 
3’ end of KRT77 (Fig. 4.3). MSRE analysis at KRT1_msre4 showed a variation in DNA 
methylation with only DNA from the NT_72h cells of the parental cell line being classified as 
methylated, with other cell lines and conditions classified as unmethylated or partially 
methylated (Fig. 4.5C). The region amplified by KRT1_msre5 is methylated in primary 
cultures and cell lines seen in RRBS and WGBS data (Fig. 4.3). The KRT1_msre5 amplicon 
showed a dynamic pattern of DNA methylation with most conditions, including all the 
NT_72h cells of the clonal cell lines with Scr_72h cells of clone 1, being partially methylated 
(Fig. 4.5D). 
4.3.2 Homozygous genetic variants found in KRT1 putative 
regulatory elements 
The presence of genetic variants at a region of DNA that is methylated can result to changes 
in DNA methylation, leading to allele-specific methylation (Wang et al., 2019). The change in 
DNA methylation can subsequently lead to changes in gene expression. To test for the 
presence of SNVs in HaCaTs at the identified putative regulatory elements, these regulatory 
elements were amplified as long DNA fragments and sequenced using Nanopore 
sequencing (Jain et al., 2016). Identified SNVs at the putative regulatory elements were 
assessed if they overlapped with MSRE-qPCR amplicons. First, sequencing primers were 
designed to generate amplicons at the regions showing potential regulatory function in the 
KRT1 locus (Fig. 4.6A). Generation of amplicons using these primers were optimised with 
specific extension times and annealing temperatures (Fig. 4.6B-D, KRT1_seq1, KRT1_seq2, 




Figure 4.6. Location and validation of nanopore sequencing primers. (A) UCSC genome browser 
display location of KRT1 sequencing primers and methylation primers. “GeneHancer” track activated 
in UCSC genome browser to display regulatory elements and gene interactions. (B-D) Validation 
results of sequencing primers. (B) KRT1_seq4 (2601 bp) and KRT1_seq1 (3061 bp). (C) KRT1_seq2 
(2027 bp). (D) KRT1_seq3 (2829 bp). 
 
Homozygous SNVs localised at bases within amplicons generated by KRT1_seq1, 
KRT1_seq2 and KRT1_seq3 were identified (Fig. 4.7). The intergenic variants, rs1994516 
(chr12:53,058,514), rs936955 (chr12:53,058,619) and rs1814640 (chr12:53,058,792), were 
found to be homozygous for the alternate alleles (rs1994516_GG, rs936955_CC and 
rs1814640_GG) in the HaCaT cell population (Fig. 4.7B, labelled as ‘1’ - rs1994516; ‘2’ - 
rs936955 and ‘3’ - rs1814640). These variants are also flanked by H3K27ac, H3K4me1 and 
DHS (Fig. 4.7A). rs1994516 co-localises with the KRT1_msre1 which was found to be 
methylated in all the HaCaT cell lines and conditions. To find potential TF-binding sites at 
these SNVs, the open-access database of transcription factor binding profiles, JASPAR 
2020 (http://jaspar.genereg.net/), was utilised. According to JASPAR, the alternative allele 
(C) of rs936955 is a predicted binding site of MEF2C, whereas, the reference allele (T) is a 
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predicted binding site of MEF2A, MEF2B, MEF2C and MEF2D. The transcription factors, 
MEF2A, MEF2B, MEF2C and MEF2D, belong to the MEF2 family of proteins. These 
proteins are involved in cell differentiation, proliferation, migration, shape, apoptosis and 
metabolism in immune, blood, vascular, muscle cardiac, skeletal and neural cells (Pon and 
Marra, 2015). 
Additionally, rs1994516 and rs936955 aligns with regions identified as evolutionary 
conserved among mammalians (Fig. 4.7B, Genomic Evolutionary Rate Profiling (GERP) 
track). Another intergenic variant was homozygous for the alternate allele, rs866135_T 
(chr12:53,058,971) in the HaCaT population and was found approximately 9.6 kb 
downstream of KRT1. rs866135 is surrounded by marks of H3K27ac, H3K4me1 and DHS, 
and located at an evolutionary conserved region (Fig. 4.7C, labelled as ‘4’). Three SNVs, 
rs14024_CC (chr12:53,069,014), rs936958_AA (chr12:53,070,145) and rs2010060_TT 
(chr12:53,070,502) were homozygous for the alternate alleles in KRT1 (Fig. 4.7D, labelled 
as ‘5’ - rs14024; ‘6’ - rs936958; ‘7’ - rs2010060). rs14024 is located at exon 9 of the 3’ end of 
KRT1, which is also near the KRT1_msre5 amplicon. rs936958 and rs2010060 are located 
at the exon 7 and at an intragenic region between exon 6-7 of KRT1, respectively. These 
SNVs are all evolutionary conserved and marked by H3K27ac, RNAPII-binding and DHS 
(Fig. 4.7D). Ensembl denotes rs14024 as a missense variant, with the G-allele a risk allele 
for systemic lupus erythematosus when it has mutated from a T to a G nucleotide (Luo et al., 
2017).  
Additionally, rs14024 was identified as a SNP associated with changes in migration rates 
during wound healing in an in vitro scratch assay using human epidermal keratinocytes (Tao 
et al., 2007). Tao et al., (2007) had measured the migration rate of 41 samples and most the 
fast migrating keratinocytes were heterozygous with the AG alleles and one of the fast 
migrating keratinocytes was homozygous for the GG alleles. SNPs rs936958 and rs2010060 
are listed as a synonymous variant and intron variant, respectively, in Ensembl. SNPs 
rs14024 and rs2010060 were previously identified to be part of a KRT1 haplotype block that 
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exhibited differential allelic expression in white blood cells (Tao et al., 2006).  
 
Figure 4.7. Homozygous SNV at KRT1 putative regulatory regions. (A) UCSC genome browser 
display location of validated KRT1 sequencing primers. Location of homozygous SNVs (rs1994516, 
rs936955, rs1814640, rs866135, rs14024, rs936958 and rs2010060) at amplicons generated by 
KRT1 sequencing primers. “GeneHancer” track in UCSC genome browser that displays interactions 
between regulatory elements and target genes. H3K27ac, H3K4me1, H3K4me3, RNAPII, DHS and 
CTCF tracks included. (B-D) KRT1 putative regulatory regions with SNVs previously identified from 
the 1000 Genomes Project. (B) KRT1_seq1 SNVs: 1 = rs1994516; 2 = rs936955; 3 = rs1814640. (C) 
KRT1_seq2 SNVs: 4 = rs866135. (D) KRT1_seq3 SNVs: 5 = rs14024; 6 = rs936958; 7 = rs2010060. 
Aligning SNV with H3K27ac, H3K4me1, RNAPII, DHS, JASPAR TF-binding or GERP. Green box: 
present. White box: absent.   
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Table 4.2. Heatmap of correlation co-efficient (R2) of identified HaCaT SNVs from LD analysis. 
  rs1994516 rs936955 rs1814640 rs14024 rs936958 rs2010060 
rs1994516 - 0.1471 0.1465 0.1664 0.5717 0.1932 
rs936955 0.1471 - 0.9989 0.7184 0.2229 0.6677 
rs1814640 0.1465 0.9989 - 0.7175 0.2223 0.6668 
rs14024 0.1664 0.7184 0.7175 - 0.2808 0.8532 
rs936958 0.5717 0.2229 0.2223 0.2808 - 0.3285 
rs2010060 0.1932 0.6677 0.6668 0.8532 0.3285 - 





Figure 4.8. UCSC genome browser display of KRT1 eQTL cluster overlapping with putative 
regulatory region 1 (defined by KRT1_seq1 and KRT1_seq2). Location of KRT1 MSRE-qPCR and 
Nanopore sequencing primers. “GeneHancer” track in UCSC genome browser that displays 
interactions between regulatory elements and target genes. “GTEx Tissue eQTL” track in UCSC 
genome browser displays genetic variants affecting proximal gene expression. Green highlight: KRT1 
eQTL cluster.   
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Table 4.3. Heatmap of correlation co-efficient (R2) of identified HaCaT SNVs and KRT1 eQTL 
cluster from LD analysis. Columns: HaCaT SNVS; Rows: KRT1 eQTLs.  
  rs1994516 rs936955 rs1814640 rs14024 rs936958 rs2010060 
rs10876315 0.1581 0.7806 0.7797 0.6074 0.2409 0.6416 
rs12302209 0.1586 0.7800 0.779 0.6067 0.2417 0.6407 
rs4258426 0.1573 0.7882 0.7873 0.6138 0.2409 0.6479 
rs1521342 0.1581 0.7882 0.7873 0.6138 0.2419 0.6479 
rs10783521 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs11170220 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs10783522 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs10783523 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs10783524 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs10876316 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs11170222 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs11542316 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs11170223 0.1419 0.8792 0.8782 0.6943 0.2169 0.5887 
rs11170224 0.1421 0.8803 0.8793 0.6952 0.2162 0.5894 
rs11613368 0.1421 0.8782 0.8772 0.6934 0.2171 0.5879 
rs11613399 0.1416 0.8791 0.8781 0.6943 0.2164 0.5888 
rs754644 0.1551 0.9361 0.9351 0.6678 0.2342 0.618 
rs2037433 0.1557 0.9427 0.9416 0.6712 0.2344 0.6211 
rs2037434 0.1559 0.9438 0.9427 0.6721 0.2346 0.6218 
rs2037435 0.1559 0.9438 0.9427 0.6721 0.2346 0.6218 
rs936952 0.148 0.9307 0.9296 0.6613 0.2263 0.6112 
rs11170226 0.1559 0.9438 0.9427 0.6721 0.2346 0.6218 
rs1521345 0.1559 0.9438 0.9427 0.6721 0.2346 0.6218 
rs10783526 0.1559 0.9438 0.9427 0.6721 0.2346 0.6218 
rs936954 0.2104 0.6994 0.6985 0.4713 0.282 0.5786 
rs10876318 0.1465 0.9989 0.9978 0.7175 0.2223 0.6668 
rs10876319 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs1402590 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs2200729 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs2200730 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs2220425 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs10783527 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs10876320 0.147 0.9989 0.9978 0.7175 0.2226 0.6669 
rs10876321 0.147 0.9967 0.9956 0.7157 0.2226 0.6652 
rs1488699 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs936955 0.1471 - 0.9989 0.7184 0.2229 0.6677 
rs936956 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs1814640 0.1465 0.9989 - 0.7175 0.2223 0.6668 
rs11170228 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs936957 0.1465 0.9989 0.9978 0.7175 0.2232 0.6668 
rs1873063 0.1456 0.9923 0.9912 0.712 0.2206 0.6615 
rs1873064 0.1471 1 0.9989 0.7184 0.2229 0.6677 
rs11170229 0.1473 0.9989 0.9978 0.7175 0.2232 0.6668 
Note: rs866135 was not found to be in LD with eQTL cluster. ‘ – ‘: same SNP.   
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To examine if the genetic variants at these putative regulatory elements are correlated, the 
LD of the identified SNVs were determined. The rs1994516 SNP was not highly correlated 
with the other SNVs (R2 = 0.1471 - 0.5717) (see Table 4.2). The genetic variants located at 
KRT1, rs14024 and rs2010060, exhibits a high correlation with each other (R2 = 0.8532) 
(Table 2). rs14024 was also highly correlated with downstream SNPs rs936955 (R2 = 
0.7184) and rs1814640 (R2 = 0.7175) (Table 4.2). rs936955 and rs1814640 are near a 
region that loops over to interact with KRT1 via the 5’ end (Fig. 4.7A). The SNV rs936958 
was not in LD with other SNPs at the KRT1_seq1 and KRT1_seq2 amplicons (Table 4.2). 
Similarly, rs2010060 was not found to share strong associations with variants at the 
KRT1_seq1 amplicon. SNP rs2010060 primarily showed a moderate level of association 
with rs936955 (R2 = 0.6677) and rs1814640 (R2 = 0.6668). In the KRT1_seq1 amplicon, 
rs936955 showed the highest correlation with rs1814640 (R2 = 0.9989).  
The putative regulatory region 1 overlaps with a nearby KRT1 eQTL cluster (Fig. 4.8, the 
combination of KRT1_seq1 and KRT1_seq2 constituting region 1; KRT1 eQTL cluster 
shown in green highlight). Due to this nearby collection of genetic variants, an LD analysis 
was performed with the 7 identified SNVs from the HaCaT population and the KRT1 eQTL 
cluster. The SNVs, rs936955 and rs1814640, that were found in the HaCaT population were 
found to be two of the KRT1 eQTLs from the nearby cluster (Table 4.3). Due to this, 
rs936955 and rs1814640 were found to be in high LD with the other KRT1 eQTLs. The 
HaCaT SNVs, rs1994516, rs936955 and rs2010060, showed a low correlation with the 
KRT1 eQTL cluster (Table 4.3). rs14024 was found to be associated with 18 of the KRT1 
eQTLs (R2 ≥ 0.712). The remaining 25 KRT1 eQTL cluster were not in high LD with rs14024. 
The difference in LD with the two groups of KRT1 eQTLs, sub-group 1 (25 KRT1 eQTLs in 
low LD) and sub-group 2 (18 KRT1 eQTLs in high LD), with rs14024 appears to be 
connected to the distance between these two sub-groups of KRT1 eQTLs. Relative to sub-
group 2, sub-group 1 is located further from rs14024. As the distance between the KRT1 






The DNA methylation status between HaCaT cell lines in NT_72h and Scr_72h cells were 
found to vary. However, stable patterns of DNA methylation were also observed between the 
parental cell line and clone 3; and at the two CCGG sites, KRT1_msre1, KRT1_msre2, 
between the HaCaT cell lines. Homozygous SNVs were also found within the HaCaT cell 
population, with the SNV rs14024 previously identified to be associated with differing 
migration rates in keratinocytes. Additionally, rs14024 was found to be in high LD with a 





Chapter 5: Discussion 
 
Skin is composed of the two major layers, one of which is the epidermis which is a stratified 
epithelium that functions as a barrier. This barrier is established through a coordinated 
pattern of expression of structural proteins at each layer of the epithelium. Keratins are the 
structural proteins that are abundantly expressed in skin and show a coordinated pattern of 
expression. There is also a specific coordinated pattern of expression in the response to 
wounding. Taken together, this argues for the existence of gene regulatory mechanisms that 
control expression of genes in response to cell differentiation and proliferation, and in 
response to tissue damage and healing. The inflammatory response of skin was also 
assessed through the use of IMQ treatments during wound healing. This study made use of 
the isolation of clonal HaCaT keratinocyte cell lines to examine the expression of a number 
of genes, with this approach identifying KRT1 as a gene that responds to cell growth and 
damage. In this study, the correlation between differential KRT1 gene expression and DNA 
methylation at regulatory elements, identified through bioinformatics analyses, was 
investigated. This was studied to better understand the underlying changes in gene 
expression that are reflected in phenotypic variations during wound healing. We showed the 
increased rate of wound healing was correlated with increased KRT1 expression. KRT1 
showed a consistent increase in expression across replicate wound healing experiments, 
which is a typical in vitro wound healing assay that is used to study keratinocyte migration 
(Liang et al., 2007). Of the four HaCaT cell lines examined in this study, clones 4 and 1 
exhibited the greatest difference in the rate of wound closure. The highest KRT1 expression 
was observed 3 days post-scratch (Scr_72h) of the fastest healing cell line (clone 4) while 
the lowest KRT1 expression was seen in the slowest healing cell line (clone 1) cells. These 
results indicated a relationship between KRT1 expression and the rate of wound healing.  
The gene expression analyses of genes encoding proteins involved in innate immunity, the 
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inflammatory response in epithelial cells, migration and wound repair did not show a 
consistent increase in expression during wound healing, with or without IMQ treatments in 
the parental cells. These genes include S100A8, DEFB4, TAp63, KRT10, KRT14, IL22RA1, 
Np63, KRT16, MACF1, IFNLR1, IL1RL1, GRHL3, IL8, NFKBIZ_S and NFKBIZ_L. Of those 
genes that showed an increase in expression, the most consistent change in expression was 
associated with passage number. For example, this is seen in KRT16 which is not 
expressed during earlier passages (2-3) but showed a 2-3-fold change in expression at 
passage 6. The effect of passages in culture on gene expression has been observed in 
primary cultures of rheumatoid arthritis synovial fibroblasts grown in vitro, where differential 
gene expression was observed between passages 1-8 (Neumann et al., 2010). For example, 
genes encoding cytokines and receptors exhibits low expression (passage 3) but increases 
at later passages (passages 5-8). Neumann et al., (2010) showed a consistent gene 
expression pattern between passages 2-4, such as gene encoding adhesion proteins which 
showed a high expression; but had started showing differential gene expression patterns at 
passages 5-8, with a decrease in expression of adhesion proteins. The changes in gene 
expression with increasing passage number of rheumatoid arthritis synovial fibroblasts was 
accompanied by phenotypic changes, such as a lower proliferative potential in later 
passages.  
This variation between passages has also been observed in bone marrow stromal cells, 
where late and early passages were marked by plasminogen activator tissue type (PLAT) 
and fibroblast growth factor receptor 2 (FGFR2) expression, respectively. Additionally, a 
principle component analysis of gene sets tested in passages 4 and 6 showed a higher 
correlation with each other than later passages, such as passages 9 and 10. Passages 9 
and 10 also depicted the same high correlation between each other than earlier passages 
(Liu et al., 2019). These previous reports reflect the gene expression results of the gene sets 
(S100A8, DEFB4, TAp63, KRT10, KRT14, IL22RA1, Np63, KRT16, MACF1, IFNLR1, 
IL1RL1, GRHL3, IL8, NFKBIZ_S and NFKBIZ_L) tested in this study with the in vitro wound 
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healing assay and IMQ treatments. Due to this passage-induced variation, the regulation of 
these genes during wound healing was not assessed. The in vitro wound healing experiment 
between the parental and clonal cell lines detected responses from genes encoding proteins 
involved in keratinocyte differentiation, inflammation and migration. S100A8 and NFKBIZ_S 
expression increased in the NT_72h and Scr_72h conditions between the parental and 
clonal cell lines showed similar patterns of expression. These results are similar to other 
reports of S100A8 expression and its heterodimer partner, S100A9, induced during wound 
healing in HaCaTs. During wound healing, S100A8/A9 expression is detected in 
differentiating suprabasal cells during the first 12-24h after injury (Thorey et al., 2001). In 
contrast to Thorey and colleagues (2001), the results reported here showed a delay in 
S100A8 expression with increased expression observed 72 h after injury and in NT cells, 
oppose to the first 24 h. The differences in time when S100A8 expression is induced might 
be attributed to different culture methods used between studies. Thorey et al., (2001) had 
stimulated their HaCaTs to differentiate prior to wounding. Additionally, different passages, 
not specified, were utilised by Thorey et al., (2001), which might differ to the passages of the 
in vitro wound healing assay of this study. Expression of NFKBIZ is typically observed in 
psoriatic lesions to promote a pro-inflammatory response in keratinocytes. In psoriasis, 
NFKBIZ will predominantly express NFKBIZ_L (Müller et al., 2018). However, in this study, 
NFKBIZ_S was found to be expressed over NFKBIZ_L. The absence in expression of 
cytokines and cytokine receptors indicates the rise in NFKBIZ_S expression is not 
inflammation-related, as seen with its long isoform equivalent. It remains unclear why 
S100A8 and NFKBIZ_S were observed to increase in NT_72h and Scr_72h between HaCaT 
cell lines. The similar pattern of expression between S100A8 and NFKBIZ_S does not reflect 
the same relationship between KRT1 expression and phenotypic variation therefore, S100A8 
and NFKBIZ_S is not related to different migratory rates. A future study can assess why 
S100A8 and NFKBIZ_S expression is found in this in vitro wound healing assay.  
The process of wound healing is typically associated with varying expressions of keratins 
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during re-epithelialisation. Keratin expression will dictate the proliferative, differentiative and 
migratory potential of a keratinocyte (Patel et al., 2006; Zhang et al., 2019). KRT16 
expression is usually found to be highly expressed with other wound healing-associated 
keratins, KRT6 and KRT17, during re-epithelisation in vivo (Patel et al., 2006); in the study 
described here, KRT16 expression increased in all IMQ and wounding conditions of the 
parentals in passage 5 of the in vitro wound healing assay. Similar increases in KRT16 
expression was also found in Scr_72h of all the clonal cell lines, with KRT16 expression 
undetected in the parental cell line at passage 3. The absence of KRT16 expression in 
parental cells at passage 3 mirrors the same results seen in the parental cell line at 
passages 2 and 6. During wound healing, KRT16 is highly expressed to induce cell 
migration and adhesion. In addition, KRT1 expression is lowered in keratinocytes adjacent to 
the wound site or those stimulated to migrate to the wound site (Zhang et al., 2019). This 
study unexpectedly showed KRT1 expression to positively correlate with the migratory 
activity of keratinocytes, with higher KRT1 expression associated with the cell line that 
exhibited the fastest rate of wound closure. The difference in KRT1 expression in this study 
to others could be attributed to different cell models used. Studies reporting increases in 
KRT6, KRT16 and KRT17 expression with decreases in KRT1 used primary cultures of 
keratinocytes from biopsies (Patel et al., 2006). KRT1 expression has been observed in a 
bilayered skin model, constituting a single layer of dermal fibroblasts overlayed with a layer 
of keratinocytes (Luo et al., 2011). This bilayered skin model was testing epiboly, a process 
involving migration of keratinocytes to envelope an entire surface with a single monolayer of 
cells, and wound healing. K1 expression was observed in migrating suprabasal cells during 
epiboly and wound healing. K6, K16 and K17 was also seen in migrating keratinocytes at the 
wound edge. This bilayered cell model is representative of in vitro and in vivo expression of 
keratins, with a K1, K6, K16 and K17 expressed. However, in in vivo wound healing of 
primary cultures of keratinocytes, K6, K16 and K17 are the most highly expressed keratins 
(Luo et al., 2011). Together, this suggests the in vitro monolayer wound healing assay lacks 
certain features of in vivo skin models during injury, such as the inflammatory components of 
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wound healing (Schneider et al., 2019). Additionally, due to the cell model used in this study 
is a monolayer, it is unable to recreate the same interactions that occur in a stratified skin 
structure. However, the in vitro monolayer wound healing assay in this study was able to 
capture KRT1 expression and its potential role in migration. A 2-3-fold increase of KRT16 
expression was observed in the NT_72h and Scr_72h conditions of all clonal cell lines, 
therefore, does display a typical wound healing-induced keratin. However, the results of 
KRT16 gene expression in this in vitro wound healing assay are unable to depict the same 
trend as KRT1 expression with varying rates in wound closure. The increased KRT16 
expression is associated with different stimuli, although, it is unclear which stimuli it is 
responding to. Additionally, KRT16 expression showed passage-induced variations with an 
absence in expression during the earlier passages but an increased expression in passage 5 
of parental cells. This supports the in vitro wound healing assay is able to measure KRT1 
expression during migration, independent of cell passage number, but not KRT16, which 
was only expressed in the parental cell line at passage 5 and clonal cell lines at passage 3. 
The expression between keratin heterodimer pairs might not exhibit an equal, 
complementary level of expression. For example, K10 is typically paired with K1 to form 
intermediate filaments in suprabasal cells during terminal differentiation (Luo et al., 2011), 
KRT10 expression did not match the increase in KRT1 expression in the parental cells at 
passage 5. The bilayered skin model designed by Luo et al., (2011) showed an absence of 
K10 expression in migrating suprabasal keratinocytes during wound healing, whereas, high 
K1 expression was present. Based on previous investigations and this study, the expression 
of heterodimer keratin pairs is not complementary. Additionally, the results presented in this 
thesis support the differential KRT1 expression observed between the parental and clonal 
cell lines is due to migratory rates, oppose to differentiation during wound healing. The 
unequal expression between KRT1 and KRT10 further supports previous reports of K10 as a 
functionally redundant keratin (Wallace et al., 2012). The model developed in this thesis can 
be applied to other keratin heterodimer pairs or complexes, such as wound healing-induced 
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keratins KRT6 and KRT17, to assess their complementary expression in migrating 
keratinocytes. In addition, this cell model can assess which keratin correlates to fast- or 
slow-healing keratinocytes by using the isolated clonal HaCaT cell lines.  
The qualitative analysis of H3K27ac, H3K4me1 and H3K4me3 ChIP-seq data (Klein et al., 
2017; Kouwenhoven et al., 2015; Rubin et al., 2017; ENCODE) identified three putative 
regulatory elements that were are downstream of KRT1 (chr12:53,055,002-53,060,743 – 
region 1), at exon 8-9 at the 3’ end of KRT1 (chr12:53,068,099-53,069,709 – region 2), and 
exons 8-10 at the 3’ end of KRT77 (chr12:53,082,959-53,086,433 – region 3). Correlating 
these results with the GeneHancer analysis showed that regions 1 and 3 were found to loop 
over and associate with the 5’ end of KRT1, thereby, interact with the 3’ end of KRT1. In 
addition, RNAPII ChIP-seq (Kouwenhoven et al., 2015) indicated potential transcription 
activity in keratinocytes undergoing early to mid-differentiation, which might be regulated by 
the identified putative regulatory elements. The regions flanking the putative regulatory 
elements are marked by different combinations of histone marks, including H3K27ac, 
H3K4me1 and H3K4me3 and DHS in proliferating and differentiating keratinocytes. 
However, the H3K4me1 and H3K4me3 ChIP-seq data used was limited to keratinocytes 
undergoing early differentiation and cells isolated 12 h post-wounding. Due to the lack of 
complementary conditions between H3K27ac with H3K4me1 and H3K4me3, it is unclear if 
the putative regulatory elements are active during mid to late differentiation. Similarly, the 
limited H3K27ac, H3K4me1 and H3K4me3 ChIP-seq data in keratinocytes undergoing 
wound healing restricts the predictions that can be made on these putative regulatory 
elements. Due to the variations of KRT1 gene expression between HaCaT cell lines, this is 
potentially established by the KRT1 regulatory elements identified in this thesis. Previous 
studies have not explored how keratin expression, including KRT1, is controlled through 
regulatory elements. This study has identified three potential KRT1 regulatory elements that 
suggest a regulatory function in KRT1 expression.  
When comparing H3K27ac, H3K4me1 and H3K4me3 ChIP-seq with WGBS and RRBS data, 
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it exhibited crosstalk between histone modifications and DNA methylation at a given region. 
The interplay between these epigenetic modifications can provide information about the level 
of gene expression at a given region (Rose and Klose, 2014). For example, the qualitative 
analysis of ChIP-seq and WGBS showed hypomethylated regions coincided with H3K27ac, 
H3K4me1, H3K4me3, DHS and CTCF peaks. The absence of DNA methylation and 
occupancy of markers associated with transcriptional and regulatory activity further 
supported the presence of active regulatory elements along the KRT1 locus. The interplay 
between DNA methylation and histone modifications has been observed with the changes in 
DNA methyltransferase activity. During terminal differentiation of embryonic stem cells, the 
absence of DNA methyltransferase activity, thereby a decrease in DNA methylation, in was 
found to colocalise with increased histone acetylation at a given region (Jackson et al., 
2004). The opposite can also occur with a higher enrichment of DNA methylation, 
consequently, causing histone acetylation and RNAPII binding to diminish (Lorincz et al., 
2004). The use of MSRE-qPCR at the regions 1 and 2 showed differential DNA methylation. 
The KRT1_msre1 and KRT1_msre2 amplicons at region 1 were predominantly methylated, 
while a KRT1_msre4 and KRT1_msre5 at regions 1 and region 2, respectively, were mostly 
unmethylated or partially methylated in the NT_72h and Scr_72h conditions between the 
parental and clones. Although, the previous bioinformatics analysis lacked H3K27ac, 
H3K4me1 and H3K4me3 ChIP-seq data during the later stages of re-epithelisation in wound 
healing, the MSRE-qPCR results can be used to speculate the absence of DNA methylation 
at regions 1 and 2 suggest these sites are occupied. Regions 1 and 2 might be occupied by 
the binding of H3K27ac, H3K4me1 and H3K4me3, therefore, blocking DNA methylation to 
allow regions 1 and 2 to mediate regulatory activity. This regulatory activity could be 
mediating differential KRT1 expression between cell lines (Fig 5.1, example of differential 






Figure 5.1. Example illustration of KRT1 regulatory elements regulating KRT1 expression to 
induce two different cellular pathways in keratinocytes: Differentiation or Inflammatory 
response.  
WGBS and MSRE-qPCR data shows evidence of dynamic and stable patterns of DNA 
methylation along the KRT1 locus. In the WGBS data, HMRs were found between all skin 
conditions, regardless of age and exposure to sunlight. The absence of DNA methylation 
may be a stable pattern of methylation in skin, but the patterns of histone modifications may 
differ to elicit different levels of KRT1 expression, thereby, potentially phenotypic variations. 
In intestinal tissue, constitutive expression of KRT1 was important to maintain this epithelial 
barrier. The loss of KRT1 resulted to the development of inflammatory bowel disease (Dong 
et al., 2017). Similarly, deletions of the entire KRT1 gene has shown perturbed skin 
formation (Roth et al., 2012). Based on these studies, KRT1 is likely to be constitutively 
active in the suprabasal epidermis along with other epithelial tissues, such as intestinal 
tissue. The non-specific HMR between all skin conditions supports the constitutive 
expression of KRT1 and its regulatory regions. This stable pattern of DNA methylation was 
seen in the CCGG sites covered by KRT1_msre1 and KRT1_msre2, which mostly showed 
methylated regions. KRT1 has also been found to regulate the inflammatory network in skin 
by regulating innate immunity and inducing the expression of pro-inflammatory genes (Roth 
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et al., 2012), which would require dynamic regulation along KRT1 to mediate different roles 
in the skin. Despite the WGBS and two MSRE-qPCR (KRT1_msre1, KRT1_msre2) sites 
depicting a stable pattern of DNA methylation, the locus might still exhibit a dynamic 
regulatory landscape. The KRT1 locus might be consistently active but the KRT1 expression 
might be contributing to differing cellular contexts, such as inducing terminal differentiation or 
controlling skin inflammatory responses (Fig. 5.1). In parallel, the KRT1_msre4 and 
KRT1_msre5 sites displayed the opposite DNA methylation patterns as KRT1_msre1 and 
KRT1_msre2, with a complete or partial absence of DNA methylation. The difference in DNA 
methylation at region 1, with two CCGG sites fully methylated and a third CCGG site that is 
mostly unmethylated supports this dynamic regulatory landscape along KRT1.  
The difference between high against partial or a complete absence of DNA methylation 
between the MSRE-qPCR CCGG sites might allude to region 1 and 2 constituting different 
types of regulatory elements. The MSRE-qPCR reported KRT1_msre1 and KRT1_msre2 
from region 1 to be mostly methylated with flanking peaks of H3K27ac and H3K4me1. This 
combination of DNA methylation, H3K27ac and H3K4me1 has been linked to the 
identification of enhancers (Sharifi-Zarchi et al., 2017). WGBS and RRBS data were 
previously assessed in putative enhancers identified in mouse tissues and cells, and showed 
sites occupied with H3K4me1 and H3K27ac coincided with regions with high DNA 
methylation (Sharifi-Zarchi et al., 2017). Additionally, Sharifi-Zarchi et al., (2017) noted 
promoters were marked by H3K4me3 and intermediate DNA methylation levels. This level of 
DNA methylation was seen KRT1_msre4 and KRT1_msre5 of regions 1 and 2, respectively. 
Although, the DNA of KRT1_msre4 and KRT1_msre5 were not occupied by H3K4me3, 
GeneHancer analysis showed they interacted with region 3, which exhibited H3K4me3 
binding. DNA methylation is associated with both gene repression and activation (Greenberg 
and Bourc’his, 2019), the higher level of DNA methylation found at KRT1_msre1 and 
KRT1_msre2 suggests these sites at region 1 are potentially primed enhancers. In contrast, 
the KRT1_msre4 site in region 1 and KRT1_msre5 site in region 2 that are marked by lower 
levels of DNA methylation function as a promoter element. It is unclear which of these 
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enhancer and promoter elements are responsible for differential KRT1 expression between 
cell lines and conditions, although, these observations further support the presence of 
regulatory elements along the KRT1 locus and their dynamic regulatory functions.  
When region 1 was sequenced, alleles of the KRT1 intergenic variants rs1994516, 
rs936955, rs1814640 and rs866135 were identified in the HaCaT population. These 
intergenic variants are homozygous variants in the HaCaT population and have not been 
previously studied. rs1994516 was found to co-localise with KRT1_msre2 which was 
completely methylated. However, rs1994516 exhibited low LD with the other SNPs found 
along region 1, rs936955, rs1814640 and rs866135. In contrast, rs936955 and rs1814640 
were found to be in high LD, with rs936955 predicted to be a binding site for MEF2C. 
MEF2C is involved in a variety of roles in neurons, blood, immune and skeletal cells, such as 
promoting apoptosis and differentiation. However, MEF2C has not been cited to be 
abundantly expressed in epithelial cells (Pon and Marra, 2015). Therefore, the predicted 
binding of MEF2C is unlikely to occur along the KRT1 locus of keratinocytes. Despite 
rs1994516 present as a homozygous SNV for the alternate allele (G) at the same DNA 
region as KRT1_msre2, the location of rs1994516 is not at the 5’ – CCGG – 3’ DNA 
methylation site of KRT1_msre2. Therefore, the HaCaT population does not contain allele-
specific DNA methylation along the KRT1 locus. The other SNPs identified at region 1 in the 
HaCaT population, rs936955, rs1814640 and rs866135, did not co-localise with a CpG 
dinucleotide of a KRT1_msre primer. Therefore, the alternate alleles of rs936955, rs1814640 
and rs866135 do not directly change the methylation of DNA. Collectively, rs1994516, 
rs936955, rs1814640 and rs866135 do not co-localise with a H3K27ac. Overall, the 
intergenic variants at region 1 do not indicate a correlation with changes in DNA methylation. 
When region 2 was sequenced, the three SNVs rs14024, rs936958 and rs2010060 were 
also identified as homozygous variants for their alternate alleles, with none located at the 5’ 
– CCGG – 3’ site of this study, KRT1_msre5. Collectively, the seven SNVs identified in the 
HaCaT population are not allele-specific DNA methylation sites. However, rs14024 and 
rs2010060 were found to be important SNVs in another context. A previous investigation had 
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found rs14024 with mutant allele G is associated with systemic lupus erythematosus and 
systemic sclerosis (Luo et al., 2017). Another study found rs14024 to be associated with 
migration rate in keratinocytes (Tao et al., 2007). rs14024 and rs2010060 were studied with 
other SNVs to assess allele-specific expression in KRT1 in white blood cells (Tao et al., 
2006). Tao et al., (2006) had also observed differential KRT1 expression in white blood cells, 
which reflected low- and high-expressing haplotype patterns. Additionally, Tao et al., (2006) 
had theorised as a topic for a future study that the differential KRT1 expression in white 
blood cells might influence different migratory rates in keratinocytes during wound healing. A 
cluster of KRT1 eQTLs (chr12:53,046,136-53,060,340) overlaps with SNVs rs1994516, 
rs936955, rs1814640 and rs866135 from region 1. The SNVs rs936955 and rs1814640 are 
part of cluster of SNPs as KRT1 eQTLs, and cited by GTEx 
(https://www.gtexportal.org/home/) to be expressed in testis and whole blood. The SNV 
rs14024 expressed in white blood cells was found to be in high LD with rs936955 (R2 = 0.72) 
and rs1814640 (R2 = 0.72), which are expressed in whole blood. An eQTL is a SNP that is 
correlated with gene expression or specific to a tissue type (Nariai et al., 2017). eQTLs have 
also been found to cluster at functional regulatory elements (Brown et al., 2013). Based on 
these reports, the eQTL cluster overlapping with region 1 might have a genetic basis of 
variability in KRT1 gene expression. Additionally, region 2 might be indirectly associated with 
the KRT1 eQTL cluster overlapping with region 1. The SNP rs14024 that mapped to region 2 
was in high LD with the cluster of KRT1 eQTLs (R2 ≥ 0.71). This is further supported with the 
GeneHancer analysis displaying potential interaction with region 1 and 2, via the 5’ end of 
KRT1. Genetic variants at promoters can result to changes in gene expression and 
transcriptome stability, subsequently, altering functional states and resulting to disease 
development (Li et al., 2017). As KRT1 gene variants were being sequenced in non-
pathological conditions, the absence of a risk allele related to a disease in the HaCaT 
population was expected. Overall, allele-specific DNA methylation was not found in the 
HaCaT population, however, a potential association between HaCaT SNVs and a KRT1 
eQTL cluster was determined. The HaCaT SNVs and KRT1 eQTL cluster may not be 
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This study has shown a correlation with different migratory rates in an in vitro wound healing 
assay result to differential KRT1 expression. The differential KRT1 expression is potentially a 
reflection of stable and dynamic changes of DNA methylation at KRT1 regulatory elements. 
Additionally, the differential KRT1 expression is possibly indirectly connected with 
homozygous SNVs that are associated with different migration rates in keratinocytes and 






Andersen, I.S., Reiner, A.H., Aanes, H., Aleström, P., and Collas, P. (2012). Developmental 
features of DNA methylation during activation of the embryonic zebrafish genome. Genome 
Biol 13, R65. 
Andrés, R.M., Terencio, M.C., Arasa, J., Payá, M., Valcuende-Cavero, F., Navalón, P., and 
Montesinos, M.C. (2017). Adenosine A2A and A2B Receptors Differentially Modulate 
Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis. Journal of 
Investigative Dermatology 137, 123–131. 
Arin, M.J., Longley, M.A., Küster, W., Huber, M., Hohl, D., Rothnagel, J.A., and Roop, D.R. 
(1999). An asparagine to threonine substitution in the 1A domain of keratin 1: a novel 
mutation that causes epidermolytic hyperkeratosis. Experimental Dermatology 8, 124–127. 
Arin, M.J., Longley, M.A., Anton-Lamprecht, I., Kurze, G., Huber, M., Hohl, D., Rothnagel, 
J.A., and Roop, D.R. (1999). A Novel Substitution in Keratin 10 in Epidermolytic 
Hyperkeratosis. Journal of Investigative Dermatology 112, 506–508. 
Arzate-Mejía, R.G., Recillas-Targa, F., and Corces, V.G. (2018). Developing in 3D: the role 
of CTCF in cell differentiation. Development 145. 
Bannister, A.J., and Kouzarides, T. (2011). Regulation of chromatin by histone modifications. 
Cell Res 21, 381–395. 
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, 
I., and Zhao, K. (2007). High-Resolution Profiling of Histone Methylations in the Human 
Genome. Cell 129, 823–837. 
Bartonicek, N., Clark, M.B., Quek, X.C., Torpy, J.R., Pritchard, A.L., Maag, J.L.V., Gloss, 
B.S., Crawford, J., Taft, R.J., Hayward, N.K., et al. (2017). Intergenic disease-associated 
regions are abundant in novel transcripts. Genome Biol 18. 
Bai, X.L., Zhang, Q., Ye, L.Y., Liang, F., Sun, X., Chen, Y., Hu, Q.D., Fu, Q.H., Su, W., 
Chen, Z., et al. (2015). Myocyte enhancer factor 2C regulation of hepatocellular carcinoma 
via vascular endothelial growth factor and Wnt/β-catenin signaling. Oncogene 34, 4089–
4097. 
Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C.A., 
Dempster, J., Lyons, N.J., Burns, R., et al. (2018). Genetic and transcriptional evolution 
alters cancer cell line drug response. Nature 560, 325–330. 
Bergman, Y., and Cedar, H. (2013). DNA methylation dynamics in health and disease. 
Nature Structural & Molecular Biology 20, 274–281.  
Bianconi, E., Piovesan, A., Facchin, F., Beraudi, A., Casadei, R., Frabetti, F., Vitale, L., 
Pelleri, M.C., Tassani, S., Piva, F., et al. (2013). An estimation of the number of cells in the 
human body. Annals of Human Biology 40, 463–471. 
Bikle, D.D., Xie, Z., and Tu, C.-L. (2012). Calcium regulation of keratinocyte differentiation. 
Expert Rev Endocrinol Metab 7, 461–472. 
120 
 
Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21. 
Blackledge, N.P., and Klose, R.J. (2010). Histone lysine methylation: an epigenetic 
modification? Epigenomics 2, 151–161. 
Blanpain, C., and Fuchs, E. (2006). Epidermal Stem Cells of the Skin. Annu Rev Cell Dev 
Biol 22, 339–373. 
Botchkarev, V.A. (2015). Integration of the Transcription Factor-Regulated and Epigenetic 
Mechanisms in the Control of Keratinocyte Differentiation. Journal of Investigative 
Dermatology Symposium Proceedings 17, 30–32. 
Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, 
N.E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human 
keratinocyte cell line. J. Cell Biol. 106, 761–771. 
Bragulla, H.H., and Homberger, D.G. (2009). Structure and functions of keratin proteins in 
simple, stratified, keratinized and cornified epithelia. J Anat 214, 516–559 
Brown, C.D., Mangravite, L.M., and Engelhardt, B.E. (2013). Integrative Modeling of eQTLs 
and Cis-Regulatory Elements Suggests Mechanisms Underlying Cell Type Specificity of 
eQTLs. PLOS Genetics 9, e1003649. 
Calo, E., and Wysocka, J. (2013). Modification of enhancer chromatin: what, how and why? 
Mol Cell 49. 
Cavazza, A., Miccio, A., Romano, O., Petiti, L., Malagoli Tagliazucchi, G., Peano, C., 
Severgnini, M., Rizzi, E., De Bellis, G., Bicciato, S., et al. (2016). Dynamic Transcriptional 
and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation. Stem Cell 
Reports 6, 618–632. 
Chamcheu, J.C., Siddiqui, I.A., Syed, D.N., Adhami, V.M., Liovic, M., and Mukhtar, H. 
(2011). Keratin Gene Mutations in Disorders of Human Skin and its Appendages. Arch 
Biochem Biophys 508, 123–137. 
Chandra, A., Senapati, S., Roy, S., Chatterjee, G., and Chatterjee, R. (2018). Epigenome-
wide DNA methylation regulates cardinal pathological features of psoriasis. Clin Epigenetics 
10. 
Chatterjee, R., He, X., Huang, D., FitzGerald, P., Smith, A., and Vinson, C. (2014). High-
resolution genome-wide DNA methylation maps of mouse primary female dermal fibroblasts 
and keratinocytes. Epigenetics & Chromatin 7, 35. 
Chen, A., Chen, D., and Chen, Y. (2018). Advances of DNase-seq for mapping active gene 
regulatory elements across the genome in animals. Gene 667, 83–94. 
Chen, H., Du, G., Song, X., and Li, L. (2017). Non-coding Transcripts from Enhancers: New 
Insights into Enhancer Activity and Gene Expression Regulation. Genomics Proteomics 
Bioinformatics 15, 201–207. 
Chen, X., Weaver, J., Bove, B.A., Vanderveer, L.A., Weil, S.C., Miron, A., Daly, M.B., and 
Godwin, A.K. (2008). Allelic imbalance in BRCA1 and BRCA2 gene expression is associated 
with an increased breast cancer risk. Hum Mol Genet 17, 1336–1348. 
Cheng, D., Cheng, T., Yang, X., Zhang, Q., Fu, J., Feng, T., Gong, J., and Xia, Q. (2018). 
121 
 
The genome-wide transcriptional regulatory landscape of ecdysone in the silkworm. 
Epigenetics Chromatin 11. 
Coulombe, P.A., Tong, X., Mazzalupo, S., Wang, Z., and Wong, P. (2004). Great promises 
yet to be fulfilled: Defining keratin intermediate filament function in vivo. European Journal of 
Cell Biology 83, 735–746. 
Colombo, I., Sangiovanni, E., Maggio, R., Mattozzi, C., Zava, S., Corbett, Y., Fumagalli, M., 
Carlino, C., Corsetto, P.A., Scaccabarozzi, D., et al. (2017). HaCaT Cells as a Reliable In 
Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human 
Keratinocytes. 
Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J., 
Hanna, J., Lodato, M.A., Frampton, G.M., Sharp, P.A., et al. (2010). Histone H3K27ac 
separates active from poised enhancers and predicts developmental state. Proc Natl Acad 
Sci U S A 107, 21931–21936. 
DeMare, L.E., Leng, J., Cotney, J., Reilly, S.K., Yin, J., Sarro, R., and Noonan, J.P. (2013). 
The genomic landscape of cohesin-associated chromatin interactions. Genome Res 23, 
1224–1234. 
Doherty, R., and Couldrey, C. (2014). Exploring genome wide bisulfite sequencing for DNA 
methylation analysis in livestock: a technical assessment. Front Genet 5. 
Dong, X., Liu, Z., Lan, D., Niu, J., Miao, J., Yang, G., Zhang, F., Sun, Y., Wang, K., and 
Miao, Y. (2017). Critical role of Keratin 1 in maintaining epithelial barrier and correlation of its 
down-regulation with the progression of inflammatory bowel disease. Gene 608, 13–19. 
Dukatz, M., Requena, C.E., Emperle, M., Hajkova, P., Sarkies, P., and Jeltsch, A. (2019). 
Mechanistic Insights into Cytosine-N3 Methylation by DNA Methyltransferase DNMT3A. 
Journal of Molecular Biology. 
Edwards, J.R., Yarychkivska, O., Boulard, M., and Bestor, T.H. (2017). DNA methylation and 
DNA methyltransferases. Epigenetics & Chromatin 10, 23. 
Fischer, H., Langbein, L., Reichelt, J., Buchberger, M., Tschachler, E., and Eckhart, L. 
(2016). Keratins K2 and K10 are essential for the epidermal integrity of plantar skin. Journal 
of Dermatological Science 81, 10–16. 
Fischer, H., Langbein, L., Reichelt, J., Praetzel-Wunder, S., Buchberger, M., Ghannadan, 
M., Tschachler, E., and Eckhart, L. (2014). Loss of Keratin K2 Expression Causes Aberrant 
Aggregation of K10, Hyperkeratosis, and Inflammation. Journal of Investigative Dermatology 
134, 2579–2588. 
Fishilevich, S., Nudel, R., Rappaport, N., Hadar, R., Plaschkes, I., Iny Stein, T., Rosen, N., 
Kohn, A., Twik, M., Safran, M., et al. (2017). GeneHancer: genome-wide integration of 
enhancers and target genes in GeneCards. Database (Oxford) 2017. 
Fits, L. van der, Mourits, S., Voerman, J.S.A., Kant, M., Boon, L., Laman, J.D., Cornelissen, 
F., Mus, A.-M., Florencia, E., Prens, E.P., et al. (2009). Imiquimod-Induced Psoriasis-Like 
Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis. The Journal of Immunology 
182, 5836–5845. 
Gniadecki, R. (1998). Regulation of Keratinocyte Proliferation. General Pharmacology: The 
Vascular System 30, 619–622. 
122 
 
Gonzalez, A.C. de O., Costa, T.F., Andrade, Z. de A., and Medrado, A.R.A.P. (2016). 
Wound healing - A literature review. An. Bras. Dermatol. 91, 614–620. 
Golbabapour, S., Majid, N.A., Hassandarvish, P., Hajrezaie, M., Abdulla, M.A., and Hadi, 
A.H.A. (2013). Gene Silencing and Polycomb Group Proteins: An Overview of their 
Structure, Mechanisms and Phylogenetics. OMICS 17, 283–296. 
Greer, E.L., and Shi, Y. (2012). Histone methylation: a dynamic mark in health, disease and 
inheritance. Nat Rev Genet 13, 343–357. 
Greenberg, M.V.C., and Bourc’his, D. (2019). The diverse roles of DNA methylation in 
mammalian development and disease. Nat Rev Mol Cell Biol. 
Griesenauer, B., and Paczesny, S. (2017). The ST2/IL-33 Axis in Immune Cells during 
Inflammatory Diseases. Front Immunol 8. 
Gu, X., Nylander, E., Coates, P.J., Fahraeus, R., and Nylander, K. (2015). Correlation 
between Reversal of DNA Methylation and Clinical Symptoms in Psoriatic Epidermis 
Following Narrow-Band UVB Phototherapy. J Invest Dermatol 135, 2077–2083. 
Guo, H., Zhu, P., Guo, F., Li, X., Wu, X., Fan, X., Wen, L., and Tang, F. (2015). Profiling 
DNA methylome landscapes of mammalian cells with single-cell reduced-representation 
bisulfite sequencing. Nat Protoc 10, 645–659. 
Gurtner, G.C., Werner, S., Barrandon, Y., and Longaker, M.T. (2008). Wound repair and 
regeneration. Nature 453, 314–321. 
Han, Y., and Garcia, B.A. (2013). Combining genomic and proteomic approaches for 
epigenetics research. Epigenomics; London 5, 439–452. 
Heintzman, N.D., Stuart, R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D., Barrera, L.O., 
Van Calcar, S., Qu, C., Ching, K.A., et al. (2007). Distinct and predictive chromatin 
signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39, 
311–318. 
Herceg, Z., and Murr, R. (2011). Chapter 3 - Mechanisms of Histone Modifications. In 
Handbook of Epigenetics, T. Tollefsbol, ed. (San Diego: Academic Press), pp. 25–45. 
Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-André, V., Sigova, A.A., Hoke, H., and 
Young, R.A. (2013). Transcriptional super-enhancers connected to cell identity and disease. 
Cell 155. 
Ho, J.W., Bishop, E., Karchenko, P.V., Nègre, N., White, K.P., and Park, P.J. (2011). ChIP-
chip versus ChIP-seq: Lessons for experimental design and data analysis. BMC Genomics 
12, 134. 
Holwerda, S.J.B., and de Laat, W. (2013). CTCF: the protein, the binding partners, the 
binding sites and their chromatin loops. Philos Trans R Soc Lond B Biol Sci 368. 
Hu, L., Xiao, Y., Xiong, Z., Zhao, F., Yin, C., Zhang, Y., Su, P., Li, D., Chen, Z., Ma, X., et al. 
(2017). MACF1, versatility in tissue-specific function and in human disease. Seminars in Cell 
& Developmental Biology 69, 3–8. 
Irvine, R.A., Lin, I.G., and Hsieh, C.-L. (2002). DNA Methylation Has a Local Effect on 
Transcription and Histone Acetylation. Molecular and Cellular Biology 22, 6689. 
123 
 
Jackson, M., Krassowska, A., Gilbert, N., Chevassut, T., Forrester, L., Ansell, J., and 
Ramsahoye, B. (2004). Severe Global DNA Hypomethylation Blocks Differentiation and 
Induces Histone Hyperacetylation in Embryonic Stem Cells. Mol Cell Biol 24, 8862–8871. 
Jain, M., Olsen, H.E., Paten, B., and Akeson, M. (2016). The Oxford Nanopore MinION: 
delivery of nanopore sequencing to the genomics community. Genome Biol 17, 239. 
Jonkman, J.E.N., Cathcart, J.A., Xu, F., Bartolini, M.E., Amon, J.E., Stevens, K.M., and 
Colarusso, P. (2014). An introduction to the wound healing assay using live-cell microscopy. 
Cell Adh Migr 8, 440–451. 
Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., and 
Haussler, and D. (2002). The Human Genome Browser at UCSC. Genome Res 12, 996–
1006. 
Kerkhoff, C., Voss, A., Scholzen, T.E., Averill, M.M., Zänker, K.S., and Bornfeldt, Karin.E. 
(2012). Novel Insights into the Role of S100A8/A9 in Skin Biology. Exp Dermatol 21, 822–
826. 
Kim, J., and Kim, H. (2012). Recruitment and Biological Consequences of Histone 
Modification of H3K27me3 and H3K9me3. ILAR J 53, 232–239. 
Kim, S., Yu, N.-K., and Kaang, B.-K. (2015). CTCF as a multifunctional protein in genome 
regulation and gene expression. Exp Mol Med 47, e166–e166. 
Kleftogiannis, D., Kalnis, P., and Bajic, V.B. (2016). Progress and challenges in 
bioinformatics approaches for enhancer identification. Brief Bioinform 17, 967–979. 
Klein, R.H., Lin, Z., Hopkin, A.S., Gordon, W., Tsoi, L.C., Liang, Y., Gudjonsson, J.E., and 
Andersen, B. (2017). GRHL3 binding and enhancers rearrange as epidermal keratinocytes 
transition between functional states. PLoS Genet 13. 
Koch, F., Jourquin, F., Ferrier, P., and Andrau, J.-C. (2008). Genome-wide RNA polymerase 
II: not genes only! Trends in Biochemical Sciences 33, 265–273. 
Koenecke, N., Johnston, J., He, Q., Meier, S., and Zeitlinger, J. (2017). Drosophila poised 
enhancers are generated during tissue patterning with the help of repression. Genome Res. 
27, 64–74. 
Koster, M.I. (2009). Making an epidermis. Ann N Y Acad Sci 1170, 7–10. 
Koster, M.I., and Roop, D.R. (2007). Mechanisms Regulating Epithelial Stratification. Annual 
Review of Cell and Developmental Biology 23, 93–113. 
Kouwenhoven, E.N., Oti, M., Niehues, H., van Heeringen, S.J., Schalkwijk, J., Stunnenberg, 
H.G., van Bokhoven, H., and Zhou, H. (2015). Transcription factor p63 bookmarks and 
regulates dynamic enhancers during epidermal differentiation. EMBO Rep 16, 863–878. 
Kumar, D., Puan, K.J., Andiappan, A.K., Lee, B., Westerlaken, G.H.A., Haase, D., Melchiotti, 
R., Li, Z., Yusof, N., Lum, J., et al. (2017). A functional SNP associated with atopic dermatitis 
controls cell type-specific methylation of the VSTM1 gene locus. Genome Medicine 9, 18. 
Kwist, K., Bridges, W.C., and Burg, K.J.L. (2016). The effect of cell passage number on 
osteogenic and adipogenic characteristics of D1 cells. Cytotechnology 68, 1661–1667. 
124 
 
Lamb, R., and Ambler, C.A. (2013). Keratinocytes Propagated in Serum-Free, Feeder-Free 
Culture Conditions Fail to Form Stratified Epidermis in a Reconstituted Skin Model. PLoS 
One 8. 
Lazear, H.M., Nice, T.J., and Diamond, M.S. (2015). Interferon-λ: immune functions at 
barrier surfaces and beyond. Immunity 43, 15–28. 
Li, Y., Bao, C., Gu, S., Ye, D., Jing, F., Fan, C., Jin, M., and Chen, K. (2017). Associations 
between novel genetic variants in the promoter region of MALAT1 and risk of colorectal 
cancer. Oncotarget 8, 92604–92614. 
Li, I.M.H., Liu, K., Neal, A., Clegg, P.D., De Val, S., and Bou-Gharios, G. (2018). Differential 
tissue specific, temporal and spatial expression patterns of the Aggrecan gene is modulated 
by independent enhancer elements. Sci Rep 8. 
Liang, C.-C., Park, A.Y., and Guan, J.-L. (2007). In vitro scratch assay: a convenient and 
inexpensive method for analysis of cell migration in vitro. Nature Protocols 2, 329–333. 
Liu, N., Nelson, B.R., Bezprozvannaya, S., Shelton, J.M., Richardson, J.A., Bassel-Duby, R., 
and Olson, E.N. (2014). Requirement of MEF2A, C, and D for skeletal muscle regeneration. 
Proc Natl Acad Sci U S A 111, 4109–4114. 
Liu, S., Stroncek, D.F., Zhao, Y., Chen, V., Shi, R., Chen, J., Ren, J., Liu, H., Bae, H.J., 
Highfill, S.L., et al. (2019). Single cell sequencing reveals gene expression signatures 
associated with bone marrow stromal cell subpopulations and time in culture. J Transl Med 
17, 23. 
Lu, Z., Ricci, W.A., Schmitz, R.J., and Zhang, X. (2018). Identification of cis-regulatory 
elements by chromatin structure. Current Opinion in Plant Biology 42, 90–94. 
Luo, G., Jing, X., Yang, S., Peng, D., Dong, J., Li, L., Reinach, P.S., and Yan, D. (2019). 
DNA Methylation Regulates Corneal Epithelial Wound Healing by Targeting miR-200a and 
CDKN2B. Invest. Ophthalmol. Vis. Sci. 60, 650–660. 
Luo, S., Yufit, T., Carson, P., Fiore, D., Falanga, J., Lin, X., Mamakos, L., and Falanga, V. 
(2011). DIFFERENTIAL KERATIN EXPRESSION DURING EPIBOLY IN A WOUND MODEL 
OF BIOENGINEERED SKIN AND IN HUMAN CHRONIC WOUNDS. Int J Low Extrem 
Wounds 10, 122–129. 
Luo, W., Zhou, B., Luo, Q., Fang, H., Zuo, X., and Zou, Y. (2017). Polymorphism of keratin 1 
associates with systemic lupus erythematosus and systemic sclerosis in a south Chinese 
population. PLoS One 12, e0186409–e0186409. 
Lorincz, M.C., Dickerson, D.R., Schmitt, M., and Groudine, M. (2004). Intragenic DNA 
methylation alters chromatin structure and elongation efficiency in mammalian cells. Nature 
Structural & Molecular Biology; New York 11, 1068–1075. 
Manolio, T.A., Collins, F.S., Cox, N.J., Goldstein, D.B., Hindorff, L.A., Hunter, D.J., 
McCarthy, M.I., Ramos, E.M., Cardon, L.R., Chakravarti, A., et al. (2009). Finding the 
missing heritability of complex diseases. Nature 461, 747–753. 
Martín-Pardillos, A., Valls Chiva, Á., Bande Vargas, G., Hurtado Blanco, P., Piñeiro Cid, R., 
Guijarro, P.J., Hümmer, S., Bejar Serrano, E., Rodriguez-Casanova, A., Diaz-Lagares, Á., et 
al. (2019). The role of clonal communication and heterogeneity in breast cancer. BMC 
Cancer 19, 666. 
125 
 
Masinde, G.L., Li, X., Gu, W., Davidson, H., Mohan, S., and Baylink, D.J. (2001). 
Identification of Wound Healing/Regeneration Quantitative Trait Loci (QTL) at Multiple Time 
Points that Explain Seventy Percent of Variance in (MRL/MpJ and SJL/J) Mice F2 
Population. Genome Res 11, 2027–2033. 
Micallef, L., Belaubre, F., Pinon, A., Jayat‐Vignoles, C., Delage, C., Charveron, M., and 
Simon, A. (2009). Effects of extracellular calcium on the growth-differentiation switch in 
immortalized keratinocyte HaCaT cells compared with normal human keratinocytes. 
Experimental Dermatology 18, 143–151. 
Milani, L., Lundmark, A., Nordlund, J., Kiialainen, A., Flaegstad, T., Jonmundsson, G., 
Kanerva, J., Schmiegelow, K., Gunderson, K.L., Lönnerholm, G., et al. (2009). Allele-specific 
gene expression patterns in primary leukemic cells reveal regulation of gene expression by 
CpG site methylation. Genome Res 19, 1–11. 
Moll, R., Divo, M., and Langbein, L. (2008). The human keratins: biology and pathology. 
Histochem Cell Biol 129, 705–733. 
Müller, A., Hennig, A., Lorscheid, S., Grondona, P., Schulze-Osthoff, K., Hailfinger, S., and 
Kramer, D. (2018). IκBζ is a key transcriptional regulator of IL-36–driven psoriasis-related 
gene expression in keratinocytes. PNAS 115, 10088–10093. 
Murakami, Y. (2013). Heterochromatin and Euchromatin. In Encyclopedia of Systems 
Biology, W. Dubitzky, O. Wolkenhauer, K.-H. Cho, and H. Yokota, eds. (New York, NY: 
Springer New York), pp. 881–884. 
Nariai, N., Greenwald, W.W., DeBoever, C., Li, H., and Frazer, K.A. (2017). Efficient 
Prioritization of Multiple Causal eQTL Variants via Sparse Polygenic Modeling. Genetics 
207, 1301–1312. 
Neumann, E., Riepl, B., Knedla, A., Lefèvre, S., Tarner, I.H., Grifka, J., Steinmeyer, J., 
Schölmerich, J., Gay, S., and Müller-Ladner, U. (2010). Cell culture and passaging alters 
gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. 
Arthritis Res Ther 12, R83. 
Oberley, M.J., and Farnham, P.J. (2003). Probing Chromatin Immunoprecipitates with CpG-
Island Microarrays to Identify Genomic Sites Occupied by DNA-Binding Proteins. In Methods 
in Enzymology, (Academic Press), pp. 577–596. 
Omary, M.B., Ku, N.-O., Tao, G.-Z., Toivola, D.M., and Liao, J. (2006). ‘Heads and tails’ of 
intermediate filament phosphorylation: multiple sites and functional insights. Trends in 
Biochemical Sciences 31, 383–394. 
Ong, C.-T., and Corces, V.G. (2011). Enhancer function: new insights into the regulation of 
tissue-specific gene expression. Nat Rev Genet 12, 283–293. 
Orioli, D., and Dellambra, E. (2018). Epigenetic Regulation of Skin Cells in Natural Aging 
and Premature Aging Diseases. Cells 7. 
Park, S., Gonzalez, D.G., Guirao, B., Boucher, J.D., Cockburn, K., Marsh, E.D., Mesa, K.R., 
Brown, S., Rompolas, P., Haberman, A.M., et al. (2017). Tissue-scale coordination of 
cellular behavior promotes epidermal wound repair in live mice. Nat Cell Biol 19, 155–163. 
Pastar, I., Stojadinovic, O., Yin, N.C., Ramirez, H., Nusbaum, A.G., Sawaya, A., Patel, S.B., 
Khalid, L., Isseroff, R.R., and Tomic-Canic, M. (2014). Epithelialization in Wound Healing: A 
126 
 
Comprehensive Review. Adv Wound Care (New Rochelle) 3, 445–464. 
Patel, G.K., Wilson, C.H., Harding, K.G., Finlay, A.Y., and Bowden, P.E. (2006). Numerous 
Keratinocyte Subtypes Involved in Wound Re-Epithelialization. Journal of Investigative 
Dermatology 126, 497–502. 
Pechter, P.M., Gil, J., Valdes, J., Tomic‐Canic, M., Pastar, I., Stojadinovic, O., Kirsner, R.S., 
and Davis, S.C. (2012). Keratin dressings speed epithelialization of deep partial-thickness 
wounds. Wound Repair and Regeneration 20, 236–242. 
Pennacchio, L.A., Bickmore, W., Dean, A., Nobrega, M.A., and Bejerano, G. (2013). 
Enhancers: five essential questions. Nat Rev Genet 14, 288–295. 
Perdigoto, C.N., Valdes, V.J., Bardot, E.S., and Ezhkova, E. (2014). Epigenetic Regulation 
of Epidermal Differentiation. Cold Spring Harb Perspect Med 4, a015263. 
Pon, J.R., and Marra, M.A. (2015). MEF2 transcription factors: developmental regulators and 
emerging cancer genes. Oncotarget 7, 2297–2312. 
Pucci, M., Rapino, C., Francesco, A.D., Dainese, E., D’Addario, C., and Maccarrone, M. 
(2013). Epigenetic control of skin differentiation genes by phytocannabinoids. British Journal 
of Pharmacology 170, 581–591. 
Qing, C. (2017). The molecular biology in wound healing & non-healing wound. Chin J 
Traumatol 20, 189–193. 
Qu, J., Tanis, S.E.J., Smits, J.P.H., Kouwenhoven, E.N., Oti, M., van den Bogaard, E.H., 
Logie, C., Stunnenberg, H.G., van Bokhoven, H., Mulder, K.W., et al. (2018). Mutant p63 
Affects Epidermal Cell Identity through Rewiring the Enhancer Landscape. Cell Reports 25, 
3490-3503.e4. 
Ramírez, F., Dündar, F., Diehl, S., Grüning, B.A., and Manke, T. (2014). deepTools: a 
flexible platform for exploring deep-sequencing data. Nucleic Acids Res 42, W187–W191. 
Ramms, L., Fabris, G., Windoffer, R., Schwarz, N., Springer, R., Zhou, C., Lazar, J., Stiefel, 
S., Hersch, N., Schnakenberg, U., et al. (2013). Keratins as the main component for the 
mechanical integrity of keratinocytes. Proc Natl Acad Sci U S A 110, 18513–18518. 
Reichelt, J., Büssow, H., Grund, C., and Magin, T.M. (2001). Formation of a Normal 
Epidermis Supported by Increased Stability of Keratins 5 and 14 in Keratin 10 Null Mice. 
MBoC 12, 1557–1568. 
Rhie, S.K., Hazelett, D.J., Coetzee, S.G., Yan, C., Noushmehr, H., and Coetzee, G.A. 
(2014). Nucleosome positioning and histone modifications define relationships between 
regulatory elements and nearby gene expression in breast epithelial cells. BMC Genomics 
15. 
Rishi, V., Bhattacharya, P., Chatterjee, R., Rozenberg, J., Zhao, J., Glass, K., Fitzgerald, P., 
and Vinson, C. (2010). CpG methylation of half-CRE sequences creates C/EBPα binding 
sites that activate some tissue-specific genes. Proc Natl Acad Sci U S A 107, 20311–20316. 
Rognoni, E., and Watt, F.M. (2018). Skin Cell Heterogeneity in Development, Wound 
Healing, and Cancer. Trends in Cell Biology 28, 709–722. 
Rohlf, T., Steiner, L., Przybilla, J., Prohaska, S., Binder, H., and Galle, J. (2012). Modeling 
127 
 
the dynamic epigenome: from histone modifications towards self-organizing chromatin. 
Epigenomics; London 4, 205–219. 
Romano, R.-A., Smalley, K., Magraw, C., Serna, V.A., Kurita, T., Raghavan, S., and Sinha, 
S. (2012). ΔNp63 knockout mice reveal its indispensable role as a master regulator of 
epithelial development and differentiation. Development 139, 772–782. 
Rose, N.R., and Klose, R.J. (2014). Understanding the relationship between DNA 
methylation and histone lysine methylation. Biochimica et Biophysica Acta (BBA) - Gene 
Regulatory Mechanisms 1839, 1362–1372. 
Ross-Innes, C.S., Stark, R., Teschendorff, A.E., Holmes, K.A., Ali, H.R., Dunning, M.J., 
Brown, G.D., Gojis, O., Ellis, I.O., Green, A.R., et al. (2012). Differential oestrogen receptor 
binding is associated with clinical outcome in breast cancer. Nature 481, 389–393. 
Roth, W., Kumar, V., Beer, H.-D., Richter, M., Wohlenberg, C., Reuter, U., Thiering, S., 
Staratschek-Jox, A., Hofmann, A., Kreusch, F., et al. (2012). Keratin 1 maintains skin 
integrity and participates in an inflammatory network in skin through interleukin-18. J Cell Sci 
125, 5269–5279. 
Rubin, A.J., Barajas, B.C., Furlan-Magaril, M., Lopez-Pajares, V., Mumbach, M.R., Howard, 
I., Kim, D.S., Boxer, L.D., Cairns, J., Spivakov, M., et al. (2017). Lineage-specific dynamic 
and pre-established enhancer–promoter contacts cooperate in terminal differentiation. Nat 
Genet 49, 1522–1528. 
Ruissen, F.V., Jongh, G.J.D., Zeeuwen, P.L.J.M., Erp, P.E.J.V., Madsen, P., and Schalkwijk, 
J. (1996). Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. 
Journal of Cellular Physiology 168, 442–452. 
Safferling, K., Sütterlin, T., Westphal, K., Ernst, C., Breuhahn, K., James, M., Jäger, D., 
Halama, N., and Grabe, N. (2013). Wound healing revised: A novel reepithelialization 
mechanism revealed by in vitro and in silico models. J Cell Biol 203, 691–709. 
Santoro, M.M., and Gaudino, G. (2005). Cellular and molecular facets of keratinocyte 
reepithelization during wound healing. Experimental Cell Research 304, 274–286. 
Sati, S., and Cavalli, G. (2017). Chromosome conformation capture technologies and their 
impact in understanding genome function. Chromosoma 126, 33–44. 
Schneider, M.K., Ioanas, H.-I., Xandry, J., and Rudin, M. (2019). An in vivo wound healing 
model for the characterization of the angiogenic process and its modulation by 
pharmacological interventions. Sci Rep 9, 1–11. 
Schoenfelder, S., and Fraser, P. (2019). Long-range enhancer–promoter contacts in gene 
expression control. Nat Rev Genet 20, 437–455. 
Schön, M.P., Schön, M., and Klotz, K.-N. (2006). The Small Antitumoral Immune Response 
Modifier Imiquimod Interacts with Adenosine Receptor Signaling in a TLR7- and TLR8-
Independent Fashion. Journal of Investigative Dermatology 126, 1338–1347. 
Schwieger, M., Schüler, A., Forster, M., Engelmann, A., Arnold, M.A., Delwel, R., Valk, P.J., 
Löhler, J., Slany, R.K., Olson, E.N., et al. (2009). Homing and invasiveness of MLL/ENL 
leukemic cells is regulated by MEF2C. Blood 114, 2476–2488. 
Segre, J.A. (2006). Epidermal barrier formation and recovery in skin disorders. Journal of 
128 
 
Clinical Investigation; Ann Arbor 116, 1150–1158. 
Sen, G.L., Reuter, J.A., Webster, D.E., Zhu, L., and Khavari, P.A. (2010). DNMT1 Maintains 
Progenitor Function in Self-Renewing Somatic Tissue. Nature 463, 563–567. 
Simpson, C.L., Patel, D.M., and Green, K.J. (2011). Deconstructing the skin: 
cytoarchitectural determinants of epidermal morphogenesis. Nature Reviews Molecular Cell 
Biology 12, 565–580. 
Sharifi-Zarchi, A., Gerovska, D., Adachi, K., Totonchi, M., Pezeshk, H., Taft, R.J., Schöler, 
H.R., Chitsaz, H., Sadeghi, M., Baharvand, H., et al. (2017). DNA methylation regulates 
discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw 
mechanism. BMC Genomics 18. 
Shiratori, H., Feinweber, C., Knothe, C., Lötsch, J., Thomas, D., Geisslinger, G., Parnham, 
M.J., and Resch, E. (2016). High-Throughput Analysis of Global DNA Methylation Using 
Methyl-Sensitive Digestion. PLoS One 11. 
Shlyueva, D., Stampfel, G., and Stark, A. (2014). Transcriptional enhancers: from properties 
to genome-wide predictions. Nature Reviews Genetics 15, 272–286.  
Shoemaker, R., Deng, J., Wang, W., and Zhang, K. (2010). Allele-specific methylation is 
prevalent and is contributed by CpG-SNPs in the human genome. Genome Res 20, 883–
889. 
Song, Q., Decato, B., Hong, E.E., Zhou, M., Fang, F., Qu, J., Garvin, T., Kessler, M., Zhou, 
J., and Smith, A.D. (2013). A Reference Methylome Database and Analysis Pipeline to 
Facilitate Integrative and Comparative Epigenomics. PLOS ONE 8, e81148. 
Song, D., Qi, W., Lv, M., Yuan, C., Tian, K., and Zhang, F. (2018). Combined bioinformatics 
analysis reveals gene expression and DNA methylation patterns in osteoarthritis. Mol Med 
Rep 17, 8069–8078. 
Spicuglia, S., and Vanhille, L. (2012). Chromatin signatures of active enhancers. Nucleus 3, 
126–131. 
Sumida, H., Yanagida, K., Kita, Y., Abe, J., Matsushima, K., Nakamura, M., Ishii, S., Sato, 
S., and Shimizu, T. (2014). Interplay between CXCR2 and BLT1 Facilitates Neutrophil 
Infiltration and Resultant Keratinocyte Activation in a Murine Model of Imiquimod-Induced 
Psoriasis. The Journal of Immunology 192, 4361–4369. 
Sundaram, G.M., Quah, S., and Sampath, P. (2018). Cancer: the dark side of wound 
healing. The FEBS Journal 285, 4516–4534. 
Takahashi, H., Kato, S., Murata, M., and Carninci, P. (2012). CAGE- Cap Analysis Gene 
Expression: a protocol for the detection of promoter and transcriptional networks. Methods 
Mol Biol 786, 181–200. 
Tao, H., Berno, A.J., Cox, D.R., and Frazer, K.A. (2007). In vitro human keratinocyte 
migration rates are associated with SNPs in the KRT1 interval. PLoS One 2, e697–e697. 
Tao, H., Cox, D.R., and Frazer, K.A. (2006). Allele-specific KRT1 expression is a complex 
trait. PLoS Genet 2, e93–e93. 
Terrinoni, A., Smith, F.J.D., Didona, B., Canzona, F., Paradisi, M., Huber, M., Hohl, D., 
129 
 
David, A., Verloes, A., Leigh, I.M., et al. (2001). Novel and Recurrent Mutations in the Genes 
Encoding Keratins K6a, K16 and K17 in 13 Cases of Pachyonychia Congenita. Journal of 
Investigative Dermatology 117, 1391–1396. 
Thandapani, P. (2019). Super-enhancers in cancer. Pharmacology & Therapeutics 199, 
129–138. 
Thorey, I.S., Roth, J., Regenbogen, J., Halle, J.-P., Bittner, M., Vogl, T., Kaesler, S., 
Bugnon, P., Reitmaier, B., Durka, S., et al. (2001). The Ca2+-binding Proteins S100A8 and 
S100A9 Are Encoded by Novel Injury-regulated Genes. J. Biol. Chem. 276, 35818–35825. 
Tian, L., Khan, A., Ning, Z., Yuan, K., Zhang, C., Lou, H., Yuan, Y., and Xu, S. (2018). 
Genome-wide comparison of allele-specific gene expression between African and European 
populations. Hum Mol Genet 27, 1067–1077. 
Toivola, D.M., Boor, P., Alam, C., and Strnad, P. (2015). Keratins in health and disease. 
Current Opinion in Cell Biology 32, 73–81. 
Toivola, D.M., Zhou, Q., English, L.S., and Omary, M.B. (2002). Type II Keratins Are 
Phosphorylated on a Unique Motif during Stress and Mitosis in Tissues and Cultured Cells. 
Mol Biol Cell 13, 1857–1870. 
Tsoi, L.C., Patrick, M.T., and Elder, J.T. (2018). Research Techniques Made Simple: Using 
Genome-Wide Association Studies to Understand Complex Cutaneous Disorders. Journal of 
Investigative Dermatology 138, e23–e29. 
Tsoi, L.C., Spain, S.L., Knight, J., Ellinghaus, E., Stuart, P.E., Capon, F., Ding, J., Li, Y., 
Tejasvi, T., Gudjonsson, J.E., et al. (2012). Identification of fifteen new psoriasis 
susceptibility loci highlights the role of innate immunity. Nat Genet 44, 1341–1348. 
Uitto, J., Richard, G., and McGrath, J.A. (2007). DISEASES OF EPIDERMAL KERATINS 
AND THEIR LINKER PROTEINS. Exp Cell Res 313, 1995–2009. 
Vandiver, A.R., Irizarry, R.A., Hansen, K.D., Garza, L.A., Runarsson, A., Li, X., Chien, A.L., 
Wang, T.S., Leung, S.G., Kang, S., et al. (2015). Age and sun exposure-related widespread 
genomic blocks of hypomethylation in nonmalignant skin. Genome Biology 16, 80. 
Varma, S.R., Sivaprakasam, T.O., Mishra, A., Prabhu, S., M, R., and P, R. (2017). 
Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its 
evaluation using curcumin. European Journal of Pharmacology 813, 33–41. 
Verdone, L., Agricola, E., Caserta, M., and Di Mauro, E. (2006). Histone acetylation in gene 
regulation. Brief Funct Genomics 5, 209–221. 
Virtanen, M., Vahlquist, A., Kaye Smith, S., Gedde-Dahl, T., and Bowden, P.E. (2003). 
Splice Site and Deletion Mutations in Keratin (KRT1 and KRT10) Genes: Unusual 
Phenotypic Alterations in Scandinavian Patients with Epidermolytic Hyperkeratosis. Journal 
of Investigative Dermatology 121, 1013–1020. 
Wallace, L., Roberts-Thompson, L., and Reichelt, J. (2012). Deletion of K1/K10 does not 
impair epidermal stratification but affects desmosomal structure and nuclear integrity. J Cell 
Sci 125, 1750–1758. 
Walter, A., Schäfer, M., Cecconi, V., Matter, C., Urosevic-Maiwald, M., Belloni, B., 
Schönewolf, N., Dummer, R., Bloch, W., Werner, S., et al. (2013). Aldara activates TLR7-
130 
 
independent immune defence. Nature Communications 4, 1–13. 
Wang, H., Lou, D., and Wang, Z. (2019). Crosstalk of Genetic Variants, Allele-Specific DNA 
Methylation, and Environmental Factors for Complex Disease Risk. Front. Genet. 9. 
Wang, H., Maurano, M.T., Qu, H., Varley, K.E., Gertz, J., Pauli, F., Lee, K., Canfield, T., 
Weaver, M., Sandstrom, R., et al. (2012). Widespread plasticity in CTCF occupancy linked to 
DNA methylation. Genome Res 22, 1680–1688. 
Wojcik, S.M., Bundman, D.S., and Roop, D.R. (2000). Delayed Wound Healing in Keratin 6a 
Knockout Mice. Mol Cell Biol 20, 5248–5255. 
Wouters, J., Vizoso, M., Martinez-Cardus, A., Carmona, F.J., Govaere, O., Laguna, T., 
Joseph, J., Dynoodt, P., Aura, C., Foth, M., et al. (2017). Comprehensive DNA methylation 
study identifies novel progression-related and prognostic markers for cutaneous melanoma. 
BMC Medicine 15, 101. 
Xu, W., Wang, F., Yu, Z., and Xin, F. (2016). Epigenetics and Cellular Metabolism. Genetics 
& Epigenetics; London 8, 43–51. 
Yang, Y., Fear, J., Hu, J., Haecker, I., Zhou, L., Renne, R., Bloom, D., and McIntyre, L.M. 
(2014). LEVERAGING BIOLOGICAL REPLICATES TO IMPROVE ANALYSIS IN CHIP-SEQ 
EXPERIMENTS. Computational and Structural Biotechnology Journal 9, e201401002. 
Yang, X., Lu, H., Yan, B., Romano, R.-A., Bian, Y., Friedman, J., Duggal, P., Allen, C., 
Chuang, R., Ehsanian, R., et al. (2011). ΔNp63 versatilely regulates a broad NF-κB gene 
program and promotes squamous epithelial proliferation, migration and inflammation. 
Cancer Res 71, 3688–3700. 
Yin, X., Wineinger, N.E., Cheng, H., Cui, Y., Zhou, F., Zuo, X., Zheng, X., Yang, S., Schork, 
N.J., and Zhang, X. (2014). Common variants explain a large fraction of the variability in the 
liability to psoriasis in a Han Chinese population. BMC Genomics 15, 87. 
Zacher, B., Michel, M., Schwalb, B., Cramer, P., Tresch, A., and Gagneur, J. (2017). 
Accurate Promoter and Enhancer Identification in 127 ENCODE and Roadmap Epigenomics 
Cell Types and Tissues by GenoSTAN. PLOS ONE 12, e0169249. 
Zhang, X. (2012). Genome-wide association study of skin complex diseases. Journal of 
Dermatological Science 66, 89–97. 
Zhang, X., Yin, M., and Zhang, L. (2019). Keratin 6, 16 and 17—Critical Barrier Alarmin 
Molecules in Skin Wounds and Psoriasis. Cells 8. 








Supplementary Table 1. SYBR-QPCR primer sequences 
Gene name Forward primer Reverse primer 



















KRT10 5’ – 
CCTGGCTTCCTACTTGGACA – 
3’ 
5’ – TTGCCATGCTTTTCATACCA 
– 3’ 






KRT16 5’ – 
AAAGACTACAGTCCCTACTTC – 
3’ 
5’ – TTGTCAATCTGCAAAATGGG 
– 3’ 






NFKBIZ (long isoform) 5’ – 
TGCTGTCACGTACTTGGGTTA – 
3’ 
5’ – TGGGGCTCAACTTTGTGTTT 
– 3’ 
NFKBIZ (short isoform) 5’ – CTCGTCGGTGTCCTCCTG – 
3’ 
5’ – AAAGGGGCCTCTCTGCTG – 
3’ 
NFYB 5’ – 
AGATTGCAAAAGATGCCAAAG – 
3’ 
5’ – CGTTTCTCTTGATGGCACCT 
– 3’ 
Np63 5’ – 
GAGAGAGAGGGACTTGAGTTCT 
– 3’ 
5’ – GCTGCTGTCCTTTCTTCTGG 
– 3’ 
























IL1RL1 5’ – 
CACCTCTTGAGTGGTTTAAG – 





IL8 5’ – GTTTTTGAAGAGGGCTGAG 
– 3’  






List of qPCR primer sequences.  
Coordinates and size of amplified DNA fragment are provided.   








































NFKBIZ (long isoform) 
N/A 








































































































R code: grouped bar chart – Example provided 
library(ggplot2) 
library(tidyverse) 
#Import and setup data 
my_data <- read.csv("QPCR_dataset.csv") 
attach(my_data) 
head(my_data) 
#Grouped bar chart 
p <- ggplot(my_data, aes(fill=Condition, y=Fold_change, x=Cell_line)) + 
  geom_bar(position="dodge", stat="identity") 
#Manually assign colours to conditions 
print(p + scale_fill_manual(values = c("Condition_1" = "colour_1", "Condition_2" = "colour_2", 






R code: Heatmap 
library(pheatmap) 
# Create test matrix 
Genes_Score <- data.matrix(Genes_TPM_Score_R, row.names=1) 
Genes <- data.matrix(Genes_TPM_Score_R) 
colnames(Genes) = colnames(Genes) 
rownames(Genes) = rownames(Genes) 
#Genes Signature, euclidean distance 
pheatmap(Genes, scale = "column", clustering_distance_rows = "euclidean", clustering_distance_cols 
= "euclidean") 
#Gene Signature, no clustering, raw data 





Python code: ChIP-seq analysis – Example provided 
#Bowtie: fastq > sam 




#Samtools: sam > bam 
samtools view -Sb /Users/krisel/miniconda2/envs/bowtie/H3K27ac.sam > 
/Users/krisel/miniconda2/envs/samtools/H3K27ac.bam 
 
#Samtools: bam > sorted bam 
samtools sort /Users/krisel/miniconda2/envs/samtools/H3K27ac.bam -o 
/Users/krisel/miniconda2/envs/samtools/H3K27ac_sorted.bam 
 
Galaxy tools (v3.3.0.0.0): create normalised peaks | Deeptools: bamCompare – 
Example provided 
Settings:  
First BAM file: H3K27ac_sorted.bam 
Second BAM: Input_sorted.bam 
Bin size in bases: 25 
Method to use for scaling the largest sample to the smallest: read count 
How to compare the two files: Returns the scaled value of the first BAM file 
Compute an exact scaling factor: No 
Coverage file format: bigwig 
Region of the genome to limit the operation to: N/A 
Show advanced options: No 









#Read file path to sample sheet 
samples <- read.csv(file.path(system.file("extra", package = "DiffBind"), "H3K27acSampleSheet.csv")) 
names(samples) 
samples 
#Create DBA from files and sample sheet  
basedir <- system.file("extra", package="DiffBind") 
H3K27ac <- dba(sampleSheet = "H3K27acSampleSheet.csv", dir=basedir) 
op <- par(oma=c(5,7,1,1)) 
dev.off() 
H3K27ac 
#Correlation heatmap, using occupancy (peak caller score) data 
##Heatmap indicates correlation between the location of peaks between samples 
##For large plots change the width and height when exporting 
par(mar = rep(2, 4)) 
plot(H3K27ac) 
#Establishing a contrast between samples by tissue type 
H3K27ac_peakset_Tissue <- dba.peakset(H3K27ac, consensus=DBA_TISSUE) 
#6Visualise consensus peaks between replicates and calculate the % of peaks shared by at least 2 
replicates 
##Repeat for each sample 








FASTQC reports: screenshots of ‘Per sequence base quality’ provided for each ChIP-
data 
Dataset #1 (Rubin et al., 2017) 
H3K27ac: Day 0, replicate 1 
 




H3K27ac: Day 3, replicate 1 
 













CTCF: Day 0, no replicate 
 






CTCF: Day 6, replicate 1 
 
Dataset #2 (Kouwenhoven et al., 2015) 
H3K27ac: Day 0, replicate 1 
 




H3K27ac: Day 4, replicate 1 
 
 
H3K27ac: Day 7, replicate 1 
 





RNAPII: Day 2, replicate 1 
 




RNAPII: Day 7, replicate 1 
 
Dataset #3 (Klein et al., 2017) 




H3K27ac: Scratched cells, replicate 1 
 
H3K27ac: Scratched cells, replicate 2 
 




H3K4me1: Scratched cells, replicate 1 
 
H3K4me1: Scratched cells, replicate 2 
 




















Forward primer Reverse primer Product 
size 
(bp) 
1 KRT1_msre1 CCTAACCCTATGCCCTGGAG AAGTGGGGTCCTATGCTTCA 185 
2 KRT1_msre2 AACAGATGCCCATGACAGGT GCCCAGACACCTACAGACAT 163 
3 KRT1_msre3 GACTATTTCCCACCCCTCCC TCTGTCATGAAGGAGAGGCC 203 
4 KRT1_msre4 AACTCCTCTCACAAGACAGC AGGCGTGAACTACTGTACCT 178 
5 KRT1_msre5 AACCATAGCTACCACCTCCG AAGTCGATTTCTCAGGGGCA 195 
6 KRT77_msre GTAGCCTCCTGAGCCGTAG GTGATCGAGGATGGAGGAGG 169 
7 KRT1_seq1 
 
TAACCCTATGCCCTGGAGCT CTGATGGGGCGAAAGTGGAT 3061 
8 KRT1_seq2 
 
CTGTGGCTGAATTTCGACGG CCCACCTCAGCATTCCAAGT 2027 
9 KRT1_seq3 
 
GTGTGCTCAGCCCTGTGTAT TTGGGGAGTGAGAGGAAGGG 2829 
10 KRT1_seq4 AGAGGGCTTGGAAGGGAGTA TTCAACCCCTGTGTCTCTGC 2601 






Primer efficiencies for MSRE-qPCR primers that were not experimentally validated. 
  
Figure A3.1. Analysis of primer efficiencies for MSRE-qPCR primers. Mock digestions of genomic 
DNA at five serial dilutions (1:2) with a starting concentration of 2.5 ng (n = 3). Each dilution was set 
up in triplicates for a qPCR. Ct values acquired from qPCR are plotted as a scatterplot. Calculations 







Python code: Nanopore sequencing analysis – Example provided 
#Qcat: Merge all fastq files into single fastq file 
 
cat /Users/krisel/miniconda3/envs/qcat/Batch1/*.fastq > 
/Users/krisel/miniconda3/envs/qcat/merged_file.fastq 
 
#Qcat: Trim and demultipliex merged fastq file 
 
qcat -f /Users/krisel/miniconda3/envs/qcat/merged_file.fastq -b /Users/krisel/miniconda3/envs/qcat/ --trim 
--detect-middle 
 
#Minimap2: Alignment of demultiplexed files (barcoded fastq output from trim and demultiplex) 
 




#Samtools: convert sam > bam 
samtools view -Sb /Users/krisel/miniconda3/envs/minimap/Barcoded/barcode01.sam > 
/Users/krisel/miniconda3/envs/samtools/barcode01.bam 
 
##Samtools: convert bam > sorted bam 
samtools sort /Users/krisel/miniconda3/envs/samtools/barcode01.bam -o 
/Users/krisel/miniconda3/envs/samtools/barcode01_sorted.bam 
 
#Samtools: index sorted.bam files 
samtools index /Users/krisel/miniconda3/envs/samtools/barcode01_sorted.bam 
 
#BCFtools: mpileup 
bcftools mpileup -f /Users/krisel/miniconda3/envs/BCFtools/hg19.fa -d 8000 -r chr12:53055841-
155 
 
53058901 /Users/krisel/miniconda3/envs/BCFtools/barcode01_sorted.bam -a 
FORMAT/AD,FORMAT/ADF,FORMAT/ADR,FORMAT/DP,FORMAT/SP,INFO/AD,INFO/ADF,INFO/A
DR -Ob -o /Users/krisel/miniconda3/envs/BCFtools/barcode01_sorted.bcf 
 
#BCFtools: index file.bcf  
 
bcftools index /Users/krisel/miniconda3/envs/BCFtools/barcode01_.sorted.bcf 
 
#BCFtools: variant calling 
 
bcftools call --ploidy GRCh37 -Ov -r chr12:53055841-53058901 -m 
/Users/krisel/miniconda3/envs/BCFtools/barcode01sorted.bcf -o 
/Users/krisel/miniconda3/envs/BCFtools/DIRECTORY/barcode01sorted.vcf 
 
 
 
